Updated on 2025/07/04

All information, except for affiliations, is reprinted from the information registered on researchmap.

写真a

 
Hiroki Ito
 
Organization
Graduate School of Medicine Department of Medicine Urology Lecturer
School of Medicine Medical Course
Title
Lecturer
External link

Degree

  • Ph.D.(Medicine) ( 2015.3   Yokohama City University )

Research Interests

  • ニューロサイエンス

  • 膀胱がん

  • 腎がん

  • 排尿機能障害

  • 泌尿器科

  • エンドウロロジー

Research Areas

  • Life Science / Urology

Papers

  • Evaluation of Complication, Renal Function, and Recurrence-Free Survival in Hilar and Non-Hilar Tumors During Robot-Assisted Partial Nephrectomy: A Propensity Score-Matched Analysis. International journal

    Kentaro Muraoka, Daiki Takeya, Kazuhiro Nishimura, Seiichiro Honda, Yasuhiro Numata, Kota Kobayashi, Ryosuke Jikuya, Tomoyuki Tatenuma, Go Noguchi, Daiki Ueno, Mitsuru Komeya, Hiroki Ito, Yusuke Ito, Hisashi Hasumi, Kazuhide Makiyama

    International journal of urology : official journal of the Japanese Urological Association   2025.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To compare complications, perioperative outcomes, postoperative renal function, and recurrence-free survival (RFS) between robot-assisted partial nephrectomy (RAPN) for hilar and non-hilar tumors. METHODS: We retrospectively analyzed the medical records of patients who underwent RAPN between March 2016 and August 2023. Patient demographic characteristics were adjusted using 1:1 propensity score matching. RESULTS: A total of 618 patients (524 with non-hilar tumors and 94 with hilar tumors) were analyzed. Hilar tumors exhibited a larger tumor size, higher RENAL nephrometry score (RNS), and greater complexity than non-hilar tumors pre-matching (all p < 0.05). Propensity score matching resulted in 77 patients per group, with no significant baseline differences except for the L factor of the RNS. Before propensity score matching, hilar tumors were associated with a higher frequency of renal artery/vein clamping and intraperitoneal approaches, as well as significantly longer operative and warm ischemia times than non-hilar tumors. However, after matching, these differences were no longer significant. The adverse event rate was not significantly different between the hilar and non-hilar tumor groups. Trifecta achievement rates were significantly lower in hilar tumors before matching (p < 0.001) but were comparable after matching (p = 0.325). No significant differences were observed in the postoperative eGFR, preservation at 1, 3, and 12 months, or pentafecta rates. Before matching, RFS was significantly lower in hilar tumors (p = 0.015); however, this difference was not significant after matching (p = 0.186). CONCLUSION: Hilar tumors showed similar complications, renal function, and recurrence-free survival rates as non-hilar tumors, indicating that RAPN is safe and feasible for hilar tumors.

    DOI: 10.1111/iju.70156

    PubMed

    researchmap

  • Infectious Complications Following Mini-Endoscopic Combined Intrarenal Surgery at Japanese Tertiary Institutions. International journal

    Takahiko Watanabe, Hiroki Ito, Tetsuo Fukuda, Fukashi Yamamichi, Tadashi Tabei, Takaaki Inoue, Junichi Matsuzaki, Kazuki Kobayashi

    International journal of urology : official journal of the Japanese Urological Association   32 ( 6 )   703 - 709   2025.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: To identify risk factors of infectious complications following mini-endoscopic combined intrarenal surgery (ECIRS) in patients with renal or ureteral stones. METHODS: We retrospectively analyzed consecutive patients with renal or ureteral stones who underwent mini-ECIRSs at three Japanese tertiary institutions between 2015 and 2021. Data were collected and evaluated regarding patient backgrounds, stone characteristics, and postoperative complications. Among the various complications, multivariable logistic regression analysis was performed using preoperative and intraoperative factors for postoperative fever (≥ 38°C) and septic shock to identify independent risk factors. RESULTS: The data of 1432 cases were collected. Finally, 1035 cases of single-session mini-ECIRS were included in the analysis. In infectious complications, postoperative fever and septic shock were observed in 273 and 21 patients (26.4% and 2.0%). A multivariable logistic regression model identified female (p < 0.001), ureteral stones (p < 0.001), preoperative pyuria (p < 0.001), preoperative urinary tract infection (p = 0.045), preoperative percutaneous nephrostomy (p = 0.001), and operation time (p = 0.017) as predictors of postoperative fever. For septic shock, female (p < 0.001) was shown as a risk factor. CONCLUSIONS: To the best of our knowledge, this multicenter cohort study is the largest study investigating infectious complications following mini-ECIRS. Female was a common risk factor for both postoperative fever and septic shock, suggesting that surgeons should pay extra attention to vital signs during the procedure and postoperative infectious complications in mini-ECIRSs for these patients.

    DOI: 10.1111/iju.70037

    PubMed

    researchmap

  • Retrospective Comparison of Postoperative Outcomes Between Elderly and Non-Elderly Patients With Benign Prostatic Enlargement Using Holmium Laser Enucleation and Transurethral Vaporization of the Prostate at Multiple High-Volume Centers. International journal

    Hiroki Ito, Takuma Nirei, Takeshi Fukazawa, Hiroki Takizawa, Mari Hioki, Risa Shinoki, Yutaro Hayashi, Takashi Kawahara, Shuko Yoneyama, Kazuhide Makiyama, Akitoshi Takizawa, Kazuki Kobayashi

    Lower urinary tract symptoms   17 ( 2 )   e70010   2025.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: This retrospective study aimed to compare the surgical outcomes of holmium laser enucleation of the prostate (HoLEP) and transurethral vaporization techniques between the elderly and nonelderly patients with benign prostatic enlargement (BPE). METHODS: We retrospectively analyzed clinical data from two regional centers that used HoLEP and transurethral vaporization techniques for BPE treatment. The study population consisted of male patients with lower urinary tract symptoms, divided into elderly and nonelderly groups. RESULTS: Total 477 of 872 patients remained in the study, of which 198 were classified as elderly (age ≥ 75 years) and 279 as non-elderly (age < 75 years). The postoperative decrease in IPSS was significantly lower in the elderly group, and advanced age was associated with less IPSS decline only after vaporization (p = 0.003) but not after HoLEP. In both surgeries, the duration of postoperative catheterization was significantly longer in the elderly group than in the non-elderly group, and hemoglobin drop at 1 day postoperatively showed no age-related difference. The most common complication after HoLEP was intermittent incontinence, which was more frequent in the elderly group (15.0%) than in the non-elderly group (6.2%, p = 0.038). Regardless of age, the overall rate of need for medication at 6 months postoperatively was significantly higher after HoLEP (32/190, 16.8%) than after transurethral vaporization (30/287, 10.5%) (p = 0.042). The need for medication was higher in the elderly for both HoLEP and vaporization than in the non-elderly group with a specific cutoff of age. CONCLUSIONS: Elderly patients with BPE had relatively worse surgical outcomes, including a higher need for postoperative medications and prolonged catheterization. HoLEP demonstrated a reduction in IPSS regardless of age, and transurethral vaporization did not, although it was associated with a higher rate of intermittent incontinence.

    DOI: 10.1111/luts.70010

    PubMed

    researchmap

  • [Effect of Body Mass Index on Outcomes of Mini-ECIRS for Renal Stone].

    Tetsuo Fukuda, Hiroki Ito, Takahiko Watanabe, Tadashi Tabei, Fukashi Yamamichi, Takaaki Inoue, Kazuki Kobayashi, Junichi Matsuzaki

    Hinyokika kiyo. Acta urologica Japonica   71 ( 3 )   71 - 75   2025.3

     More details

    Language:Japanese  

    We retrospectively compared treatment outcomes and complications based on body mass index (BMI) in patients with renal stones treated with mini-endoscopic combined intrarenal surgery (ECIRS) using percutaneous tracts 20 Fr or smaller. Among 1,432 patients who had ECIRS performed at multiple registered facilities between January 2015 and December 2022, 870 patients with renal stones who underwent mini-ECIRS were included after excluding those with anatomical anomalies or incomplete clinical data. The patients were divided into two groups : BMI ≥30 (Group A) and BMI <30 (Group B). The treatment outcomes and complications were compared between the two groups. One month postoperatively, plain computed tomography (CT) and kidney ureter bladder radiography (KUB) were performed to assess stone fragmentation and hydronephrosis. According to postoperative imaging, stone-free was defined as residual fragments 4 mm or less on KUB and 2 mm or less on CT. Of the 870 patients, 86 were in Group A and 784 in Group B. The median (interquartile range) cumulative stone diameter was 33.8 (26.35-50.75) mm in Group A, and 32 (24-47) mm in Group B, respectively. The median operative time was 122.5 (92.25- 166.75) min in Group A and 114.5 (89.75-156) min in Group B. The mean and median (interquartile range) postoperative hospital stay were 5.9±2.5 days and 5 (4-7) days in Group A, and 5.4±3.3 days and 5 (4-6) days in Group B. Stone-free rates were 77.9% (67 cases) by KUB and 61.6% (53 cases) by CT in Group A, and 76.1% (597 cases) by KUB and 58.0% (455 cases) by CT in Group B. The incidence of postoperative fever (≥38.0°C) was 38.4% (33 cases) in Group A and 31.8% (249 cases) in Group B, while septic shock occurred in 2.3% (2 cases) of Group A and 2.6% (20 cases) of Group B. A statistically significant difference (p<0.05) was found in the postoperative hospital stay between the two groups, but no significant differences were observed in the stone-free rates or complication rates. Mini-ECIRS using percutaneous tracts of 20Fr or smaller for renal stones showed no significant difference in SFR and complications between patients with a BMI ≥30 and those with a BMI <30.

    DOI: 10.14989/ActaUrolJap_71_3_71

    PubMed

    J-GLOBAL

    researchmap

  • Spinal CRH facilitates the micturition reflex via the CRH2 receptor in rats with normal bladder and bladder outlet obstruction. International journal

    Risa Shinoki, Ryosuke Jikuya, Takuma Nirei, Takeshi Fukazawa, Hiroki Takizawa, Mari Hioki, Sachi Kawaura, Tomoyuki Tatenuma, Go Noguchi, Daiki Ueno, Yusuke Ito, Mitsuru Komeya, Kentaro Muraoka, Hisashi Hasumi, Kazuki Kobayashi, Masahito Takiguchi, Kengo Funakoshi, Kazuhide Makiyama, Naoki Aizawa, Hiroki Ito

    Scientific reports   15 ( 1 )   3604 - 3604   2025.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Lower urinary tract symptoms (LUTS) significantly affect patient quality of life. Treatment options for bladder outlet obstruction (BOO) due to benign prostatic hyperplasia (BPH) (a common cause of LUTS) are insufficient to relieve discomfort. As the incidence of BPH is increasing, new pharmacological targets for LUTS treatment are required. Corticotropin-releasing hormone (CRH) is a neuropeptide that controls normal micturition in rodents. Herein, we investigated the role of spinal CRH in regulating micturition in sham and BOO rats, and evaluated CRH as a therapeutic target for bladder dysfunction in BOO model Sprague-Dawley rats. Histological analysis, cystometry with intrathecal administration of CRH agonists/antagonists, western blotting, and real-time PCR assessed the role of CRH and its receptors (CRHR1 and CRHR2) in micturition in sham and BOO rats. CRH administration shortened the voiding interval, while pretreatment with antagonists against CRHR2 (but not CRHR1) suppressed CRH-induced frequent voiding. Western blotting confirmed CRHR1 expression in the dorsal root ganglia (DRG) and bladder, but not the spinal cord, of rats. Real-time PCR showed higher CRHR2 mRNA expression in the spinal cord and DRG than in the bladder in both groups. Overall, spinal CRH facilitates the micturition reflex via CRHR2, and is a promising therapeutic target for LUTS.

    DOI: 10.1038/s41598-025-87990-w

    PubMed

    researchmap

  • Editorial comment: "Underactive bladder as defined by the International Continence Society in the 2023 Japan Community Health Survey". International journal

    Hiroki Ito

    International journal of urology : official journal of the Japanese Urological Association   32 ( 1 )   60 - 61   2025.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/iju.15642

    PubMed

    researchmap

  • Comparison of renal function between the artery and vein clamp and artery-only clamp in robot-assisted partial nephrectomy for moderate- to high-complexity renal masses: A propensity-matched study. International journal

    Kentaro Muraoka, Ryosuke Jikuya, Koichi Uemura, Takuya Kondo, Tomoyuki Tatenuma, Mitsuru Komeya, Hiroki Ito, Yusuke Ito, Hisashi Hasumi, Kazuhide Makiyama

    International journal of urology : official journal of the Japanese Urological Association   31 ( 12 )   1366 - 1373   2024.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: Artery and vein (AV) clamps can control venous bleeding in the surgical field and prevent carbon dioxide embolism, especially when large veins are expected to open. However, whether AV clamps cause more renal damage than artery-only (AO) clamps remains unclear. This study aimed to compare renal function and blood loss in surgeries using AO and AV clamps based on high RENAL nephrometry scores (RNS) in robot-assisted partial nephrectomy (RAPN). METHODS: We retrospectively analyzed the medical records of 500 patients who underwent RAPN between March 2016 and December 2021. We performed 1:1 propensity matching for these patients. RESULTS: A total of 340 patients with pathological malignancies who were followed up for at least 12 months were included in this analysis. A total of 291 patients with AO clamping and 49 patients with AV clamping were included. Overall, the AV clamp group had higher total RNSs and larger diameters than the AO clamp group. Propensity score-matched analysis included 37 patients in each clamp group. The median warm ischemia times of the AV and AO clamps were 25 and 22 min, respectively, with no significant difference. There were no statistically significant differences between the groups in the amount of blood loss, rate of acute kidney injury (AKI), or renal function at 1, 3, or 12 months post-RAPN. CONCLUSION: Compared with the AO clamp, the AV clamp did not have a detrimental impact on blood loss or renal dysfunction. Consequently, AV clamps may be considered for patients presenting with moderate-to-high-complexity RNSs.

    DOI: 10.1111/iju.15567

    PubMed

    researchmap

  • [A Case of Primary Mediastinal Germ Cell Tumor Requiring Multidisciplinary Treatment Due to Circulatory Disturbance Associated with Cardiopulmonary Compression].

    Yasuhiro Numata, Koichi Uemura, Tomoyuki Tatenuma, Hiroki Ito, Mitsuru Komeya, Yusuke Ito, Kentaro Muraoka, Hisashi Hasumi, Kazuhide Makiyama, Jotaro Harada, Shoji Yamanaka, Satoshi Fujii

    Hinyokika kiyo. Acta urologica Japonica   70 ( 12 )   451 - 456   2024.12

     More details

    Language:Japanese  

    A 28-year-old male presented to his physician with a chief complaint of fever and cough. Contrastenhanced computed tomography revealed a 17×16×8 cm heterogeneous tumor in the anterior mediastinum, as well as right heart and inferior vena cava compression due to the tumor. He was referred to our hospital for close examination and treatment. Alpha fetoprotein (AFP) was 24,769 ng/ml, and percutaneous needle biopsy revealed a germ cell tumor with a York sac tumor component; therefore, Bleomycin, Etoposide and Cisplatin (BEP) therapy was started. Although AFP tended to decrease with BEP therapy, the tumor size remained unchanged, and right heart failure due to right heart system decompression led to cardiogenic shock. Consequently, veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was introduced on Day 25. Since cardiogenic shock continued even after VA-ECMO, anterior mediastinal tumor resection was attempted on Day 30 following consultation with the respiratory surgery, cardiovascular surgery, cardiology, and intensive care units. Because the tumor was strongly adherent, tumor resection was abandoned, and tumor reduction surgery was performed. Postoperatively, his cardiovascular status improved quickly, and he was weaned off VA-ECMO the day after surgery. AFP decreased to 22 ng/ml but re-elevated; therefore, EP therapy was introduced on Day 97 when AFP was 600 ng/ml. We report a case of a primary mediastinal germ cell tumor with circulatory disturbance due to cardiopulmonary compression. In cases similar to ours, multidisciplinary treatment in collaboration with multiple departments is necessary.

    DOI: 10.14989/ActaUrolJap_70_12_451

    PubMed

    J-GLOBAL

    researchmap

  • Tissue factor pathway inhibitor 2 (TFPI2) is a potential serum biomarker for clear cell renal carcinoma. International journal

    Hiroki Ito, Ryosuke Jikuya, Shohei Myoba, Tomoyuki Tatenuma, Go Noguchi, Daiki Ueno, Yusuke Ito, Mitsuru Komeya, Kentaro Muraoka, Masahiro Yao, Hisashi Hasumi, Noboru Nakaigawa, Kazuhide Makiyama

    Scientific reports   14 ( 1 )   28639 - 28639   2024.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Renal and ovarian clear cell carcinoma (CCC) are both characterized by a clear cytoplasm and exhibit similar genomic alterations and clinical characteristics. We hypothesized that both CCCs may share clinical biomarker. Tissue factor pathway inhibitor 2 (TFPI2), a serine protease inhibitor, has emerged as a promising serum biomarker for ovarian CCC, and we evaluated the efficacy of TFPI2 as a biomarker for renal cell carcinoma (RCC). Serum samples were collected from patients with RCC and healthy volunteers, and TFPI2 levels were measured. Expression of TFPI2 in each cell type was evaluated using single-cell RNA sequencing. Survival analyses according to TFPI2 expression levels were performed based on publicly available databases. Serum TFPI2 was significantly elevated in patients with RCC compared to healthy volunteers, particularly those with clear cell histology. Metastatic RCC tumors exhibited higher TFPI2 than localized RCCs. Moreover, higher TFPI2 correlated with higher Fuhrman grades in clear cell RCC. Publicly available databases showed an association between TFPI2 expression and overall survival, particularly in clear cell RCC. Single-cell RNA sequencing confirmed TFPI2 expression in clear cell RCC and normal kidney tubular epithelial cells. TFPI2 has emerged as a potential serum biomarker for RCC, offering avenues for improved detection and prognostication.

    DOI: 10.1038/s41598-024-80248-x

    PubMed

    researchmap

  • SETD2 regulates SLC family transporter-mediated sodium and glucose reabsorptions in renal tubule. International journal

    Taku Mitome, Hiromichi Wakui, Kengo Azushima, Tatsuki Uehara, Ryosuke Jikuya, Shinji Ohtake, Go Noguchi, Sachi Kawaura, Yasuhiro Iribe, Kota Aomori, Tomoyuki Tatenuma, Hiroki Ito, Takashi Kawahara, Mitsuru Komeya, Yusuke Ito, Kentaro Muraoka, Mitsuko Furuya, Ikuma Kato, Satoshi Fujii, Kiyotaka Nagahama, Akira Nishiyama, Tomohiko Tamura, Yayoi Kimura, Tatsukata Kawagoe, Nobuhisa Mizuki, Gang Huang, Hiroji Uemura, Masahiro Yao, Kazuhide Makiyama, Kouichi Tamura, Hisashi Hasumi

    Biochemical and biophysical research communications   734   150730 - 150730   2024.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A regulatory mechanism for SLC family transporters, critical transporters for sodium and glucose reabsorptions in renal tubule, is incompletely understood. Here, we report an important regulation of SLC family transporter by SETD2, a chromatin remodeling gene whose alterations have been found in a subset of kidney cancers. Kidney-specific inactivation of Setd2 resulted in hypovolemia with excessive urine excretion in mouse and interestingly, RNA-sequencing analysis of Setd2-deficient murine kidney exhibited decreased expressions of SLC family transporters, critical transporters for sodium and glucose reabsorptions in renal tubule. Importantly, inactivation of Setd2 in murine kidney displayed attenuated dapagliflozin-induced diuresis and glucose excretion, further supporting that SETD2 might regulate SLCfamily transporter-mediated sodium and glucose reabsorptions in renal tubule. These data uncover an important regulation of SLC family transporter by SETD2, which may illuminate a crosstalk between metabolism and epigenome in renal tubule.

    DOI: 10.1016/j.bbrc.2024.150730

    PubMed

    researchmap

  • Factors influencing operative time for mini-endoscopic combined intrarenal surgery for renal stones. International journal

    Hiroki Ito, Tetsuo Fukuda, Fukashi Yamamichi, Takahiko Watanabe, Yosuke Shibata, Tadashi Tabei, Takaaki Inoue, Junichi Matsuzaki, Kazuki Kobayashi

    Scientific reports   14 ( 1 )   27857 - 27857   2024.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Mini-endoscopic combined intrarenal surgery (ECIRS) offers improved advantages in the treatment of renal stones. However, the factors influencing the operative time remain poorly understood. This study aimed to identify the factors that enhance treatment planning and minimize complications. Clinical data from consecutive patients who underwent mini-ECIRS for renal stones and achieved a stone-free status between 2015 and 2021 at three high-volume centers in Japan were analyzed. The final treatment outcome was evaluated by computed tomography imaging at postoperative 1 month, and a successful outcome was defined as complete stone-free or residual stone fragments < 4 mm. Logistic and linear regression models were used to predict the operative duration of mini-ECIRS. An operative time of ≥ 120 min was significantly associated with punctured pole and body mass index (BMI), and septic shock was only observed in patients with operative times of ≥ 120 min. The multivariate model for the operative time for mini-ECIRS identified five clinical factors: punctured pole, number of stones, number of involved calyces, BMI, and preoperative nephrostomy. We believe these findings will help surgeons and patients plan suitable treatment strategies, predict the additional need for a second mini-ECIRS or retrograde intrarenal surgery alone, and avoid severe complications.

    DOI: 10.1038/s41598-024-79184-7

    PubMed

    researchmap

  • Impacts of urinary tract anomalies or history of upper urinary tract surgery on outcome of mini-ECIRS (endoscopic combined intrarenal surgery). International journal

    Yosuke Shibata, Hiroki Ito, Tetsuo Fukuda, Fukashi Yamamichi, Takahiko Watanabe, Tadashi Tabei, Takaaki Inoue, Junichi Matsuzaki, Kazuki Kobayashi

    Urolithiasis   52 ( 1 )   138 - 138   2024.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    This study assessed the impact of urinary tract anomalies or a history of upper urinary tract surgery (UTAS) on the minimally invasive endoscopic combined intrarenal surgery (mini-ECIRS) outcomes. Data from 1432 patients undergoing ECIRS for urolithiasis at three Japanese tertiary institutions between 2015 and 2021 were analyzed, with patients categorized into those with normal urinary tracts (non-UTAS) and those with UTAS (UTAS). We retrospectively examined the association between the UTAS and perioperative outcomes in mini-ECIRS. Of the 1096 cases in the final analysis, 1035 and 61 were identified as non-UTAS and UTAS, respectively. Stone-free rate (residual fragments > 2 mm, 62.8% vs. 62.7%), operation time (110.5 vs. 115.0 min), and hospital stay duration (5.6 vs. 5.7 days) showed no significant differences between non-UTAS and UTAS. The UTAS group demonstrated significantly higher rates of preoperative pyuria (86.2% vs. 71.1%), preoperative urinary tract infection (32.8% vs. 15.5%), preoperative stenting (52.5% vs. 31.0%), and preoperative nephrostomy (24.6% vs. 9.2%). However, the postoperative fever (26.3% vs. 25.0%) or septic shock (1.9% vs. 0%) were comparable between non-UTAS and UTAS. Stone burden and the number of calyces involved were significantly associated with a low stone-free rate (P < 0.001). Younger age, female sex, solitary stones, number of calyces involved, preoperative urinary tract infection, and absence of preoperative nephrostomy were identified as risk factors for perioperative complications. The UTAS was not associated with stone-free outcomes or perioperative complications. Mini-ECIRS demonstrated comparable stone-free outcomes and safety in patients with UTAS and those with normal urinary tracts.

    DOI: 10.1007/s00240-024-01638-4

    PubMed

    researchmap

  • [Two Cases of Metanephric Adenoma Operated on for Preoperative Diagnosis of Renal Malignancy].

    Takayuki Yamamoto, Hiroki Ito, Tomohiko Aigase, Hirota Nagasaka, Kota Aomori, Ryosuke Jikuya, Tomoyuki Tatenuma, Mitsuru Komeya, Yusuke Ito, Kentaro Muraoka, Hisashi Hasumi, Takashi Hibiya, Koji Okudera, Shoji Yamanaka, Satoshi Fujii, Kazuhide Makiyama

    Hinyokika kiyo. Acta urologica Japonica   70 ( 8 )   247 - 251   2024.8

     More details

    Language:Japanese  

    Metanephric adenoma is an extremely rare disease. We describe two cases of metanephric adenoma. Case 1 : A 17-year-old male adolescent developed gross hematuria, and urinalysis revealed positive protein and occult blood. He was referred to our department for further evaluation and likely tumor removal. Contrast-enhanced computed tomography (CT) showed a neoplasm (23 mm) with poor contrast effect during the early as well as the late contrast phase. Case 2 : A 61-year-old woman presented with an incidentally detected tumor in the lower pole of the right kidney ; contrast-enhanced CT revealed a large neoplasm (10 mm) with poor contrast effect during the early as well as late contrast phase. Both patients underwent robot-assisted partial nephrectomy (RAPN) under the preoperative diagnosis of papillary renal cell carcinoma. Metanephric adenoma is histopathologically indistinguishable from papillary renal cell carcinoma preoperatively, and histopathology and immunostaining are neceaasry for accurate diasnosis.

    DOI: 10.14989/ActaUrolJap_70_8_247

    PubMed

    J-GLOBAL

    researchmap

  • Enzalutamide Prolonged the Duration of Drug Use in Comparison to Abiraterone Acetate and Cabazitaxel after Upfront Docetaxel: A Large Japanese Database Study. International journal

    Katsuya Yamaguchi, Takashi Kawahara, Akihito Hashizume, Kimito Ousaka, Koichi Uemura, Yusuke Ito, Hiroki Ito, Kazuhide Makiyama, Hiroji Uemura

    Diseases (Basel, Switzerland)   12 ( 7 )   2024.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: In the United States, a total of 268,490 men were found to have prostate cancer in 2022, thus making it the most common cancer in men, accounting for 27% of all cancers in the male population. Among all cancers in men, it was the fifth leading cause of death, with 34,500 deaths and a mortality rate of 11%. In 2019, the total number of cases was 94,748, making it the leading cancer in males, accounting for 11% of all male cancers. In terms of mortality, it ranked seventh, with 13,217 deaths and a mortality rate of 1.6%. However, new treatment options for metastatic castration-sensitive prostate cancer (mCSPC) have emerged. Docetaxel has been shown to be effective for both mCSPC and castration-resistant prostate cancer (CRPC). Upfront docetaxel has not been approved in Japan, nor has it been validated in large-scale studies. Furthermore, several agents can be used after docetaxel treatment, but it is unclear which is the most effective. We used a large Japanese health insurance database to determine which agent would be the most effective as a next-line therapy in patients who had received docetaxel. MATERIALS AND METHODS: We used data from medical institutions using the Diagnosis Procedure Combination (DPC), which provides a comprehensive evaluation of medical classifications. The Medical Data Vision database covers approximately 23% of DPC hospitals in Japan. This study analyzed 2938 patients with mCSPC who received docetaxel, followed by CRPC, between April 2008 and December 2021. The study focused on three agents: enzalutamide, abiraterone acetate, and cabazitaxel. Other agents were excluded due to the small number of patients. The following data were analyzed: age, date of CRPC diagnosis, presence of bone metastasis, drug type, and prognosis. RESULTS: This study included 1997 patients with CRPC after upfront docetaxel therapy for mCSPC (enzalutamide [ENZ] group, n = 998; abiraterone acetate [ABI] group, n = 617; and cabazitaxel [CBZ] group, n = 382). The overall survival (OS) time from drug initiation was 456 days in the enzalutamide group, which was significantly longer than that in the cabazitaxel group (p = 0.017, HR 0.94) (ENZ: ABI p = 0.54, HR 0.94; ABI: CBZ p = 0.14, HR 0.75). OS was also compared for the third-line drug in the group that received enzalutamide as the second-line drug, the group that used abiraterone acetate as the third-line drug (ENZ-ABI group), and the group that used abiraterone acetate as the second-line drug. OS from the start of the third-line drug was compared between the ENZ-ABI group and the ABI-ENZ group, which received enzalutamide as the third-line drug, but showed no significant difference (269 vs. 281 days, p = 0.85; HR 1.03). CONCLUSION: ENZ was shown to prolong OS relative to cabazitaxel after the cessation of docetaxel. ENZ was associated with a longer duration of drug use than ABI and CBZ.

    DOI: 10.3390/diseases12070162

    PubMed

    researchmap

  • Enfortumab vedotin prolongs overall survival in metastatic urothelial carcinoma following pembrolizumab therapy in real-world data. International journal

    Koichi Uemura, Hiroki Ito, Ryosuke Jikuya, Takuya Kondo, Tomoyuki Tatenuma, Takashi Kawahara, Yusuke Ito, Mitsuru Komeya, Kentaro Muraoka, Hisashi Hasumi, Hiroji Uemura, Kazuhide Makiyama

    International journal of urology : official journal of the Japanese Urological Association   31 ( 6 )   678 - 684   2024.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: In December 2021, enfortumab vedotin (EV), an antibody-drug conjugate directed against nectin-4, was approved in Japan as a new treatment after platinum-containing chemotherapy and PD-1/PD-L1 inhibitors. This study evaluated, using real-world data, the efficacy and safety of EV therapy in patients with metastatic urothelial carcinoma (mUC). MATERIALS AND METHODS: Fifty-five patients with mUC who discontinued pembrolizumab therapy due to disease progression between June 2018 and April 2023 at Yokohama City University Hospital were evaluated retrospectively. Of the 55 patients, 25 received EV therapy (EV group) and 30 did not (non-EV group). All patients who underwent EV therapy were diagnosed with disease progression after the approval of EV in Japan. RESULTS: The median (range) follow-up period after pembrolizumab discontinuation was 6.3 (0.7-31.1) months. There were eight (32.0%) deaths due to cancer in the EV group and 27 (90.0%) in the non-EV group. The overall survival (OS) after pembrolizumab discontinuation was not reached in the EV group versus 2.6 months in the non-EV group (p < 0.001). A multivariate analysis revealed that EV therapy (EV vs. non-EV group; hazard ratio 0.26; 95% confidence interval 0.16-0.41; p < 0.001) was an independent prognostic factor for OS. CONCLUSION: EV prolonged OS in mUC following pembrolizumab therapy in real-world data.

    DOI: 10.1111/iju.15437

    PubMed

    researchmap

  • [Real-World Experience and Complications with Intermittent Balloon Catheters : A Predictor Analysis].

    Tomohiko Aigase, Hiroki Ito, Takahisa Suzuki, Tamami Sahoda, Yoko Azekoshi, Katsuyuki Tanaka

    Hinyokika kiyo. Acta urologica Japonica   70 ( 5 )   111 - 115   2024.5

     More details

    Language:Japanese  

    Intermittent balloon catheterization with a reusable and temporary balloon catheter that could be implanted and removed by the patient was developed in Japan in 1995. Although the intermittent balloon catheter has the potential to improve the patient's quality of life (QOL), appropriate information and guidelines are needed to prevent complications such as hematuria and urinary tract infection. This study aimed to assess the real-world practice, complications, and problems associated with the use of intermittent balloon catheters and provide useful information for future medical care. We conducted a questionnaire survey on patients with spinal cord lesions who currently use or have used intermittent balloon catheters in the past. Seventy-six patients with spinal cord lesions who visited Kanagawa Rehabilitation Hospital from August 2020 to March 2021 and gave consent for participating in this study were included. QOL scores before and after intermittent balloon catheter use showed significant improvement after use. Forty-six of the 76 (61.3%) patients had complications. Overall complications were significantly associated with male sex and possibly linked to non-traumatic spinal cord lesions.

    DOI: 10.14989/ActaUrolJap_70_5_111

    PubMed

    J-GLOBAL

    researchmap

  • Predictors of postoperative storage symptoms in male patients with lower urinary tract symptoms: A retrospective analysis of prostate surgery for benign prostatic enlargement. International journal

    Hiroki Ito, Masato Takanashi, Takeshi Fukazawa, Hiroki Takizawa, Mari Hioki, Risa Shinoki, Takashi Kawahara, Kazuhide Makiyama, Kazuki Kobayashi

    Lower urinary tract symptoms   16 ( 3 )   e12512   2024.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: This study investigated the effects of prostate surgery on storage symptoms in male patients with lower urinary tract symptoms (LUTS) from benign prostatic enlargement (BPE). This study aimed to identify patient characteristics associated with improved, unchanged, and deteriorated post-surgical storage symptoms and to identify the risk factors for non-improvement or deterioration. METHODS: A retrospective analysis of 586 prostate surgeries performed between 2016 and 2022 at Yokosuka Kyosai Hospital was conducted on patients with LUTS and at least one storage symptom preoperatively. Patients with active urinary tract infection, prostate/bladder cancer, urethral strictures, or dementia were excluded. The study enrolled 230 patients and assessed storage symptoms using the International Prostate Symptom Score (IPSS). RESULTS: Overall, storage symptoms improved, remained unchanged, and deteriorated in 87.0%, 5.7%, and 7.4% of patients, respectively. The patients in the deteriorated group were significantly older, whereas those in the no-change group had smaller prostate volumes. Patient-reported outcome scores (IPSS, IPSS-QoL, and BII) were significantly higher in the improved group. The predictors of non-improvement included low IPSS storage score, cardiovascular disease, and diabetes mellitus. Predictors of deterioration included advanced age and low IPSS storage score. CONCLUSIONS: Patients with severe LUTS showed greater postoperative improvement in storage symptoms. A low IPSS storage score predicted non-improvement and deterioration. Advanced age, low IPSS storage score, and a history of cardiovascular disease and diabetes mellitus were identified as key predictors. Awareness of these factors may guide preoperative counseling and improve decision-making in prostate surgery, ensuring more personalized and effective treatment strategies.

    DOI: 10.1111/luts.12512

    PubMed

    researchmap

  • Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. International journal

    Yuki Kita, Hikari Otsuka, Katsuhiro Ito, Takuto Hara, Soichiro Shimura, Takashi Kawahara, Minoru Kato, Sojun Kanamaru, Koji Inoue, Hiroki Ito, Atsushi Igarashi, Tomokazu Sazuka, Dai Takamatsu, Kohei Hashimoto, Takashige Abe, Sei Naito, Yoshiyuki Matsui, Hiroyuki Nishiyama, Hiroshi Kitamura, Takashi Kobayashi

    International journal of urology : official journal of the Japanese Urological Association   31 ( 5 )   552 - 559   2024.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: Immune checkpoint inhibitors and enfortumab vedotin have opened new avenues for sequential treatment strategies for locally advanced/metastatic urothelial carcinoma (la/mUC). In the pre-enfortumab vedotin era, many patients could not receive third-line treatment owing to rapid disease progression and poor general status. This study aimed to analyze real-world sequential treatment practices for la/mUC in Japan, with a focus on patients who do not receive third-line treatment. METHODS: We analyzed data for 1023 la/mUC patients diagnosed between January 2020 and December 2021 at 54 institutions from a Japanese nationwide cohort. RESULTS: At the median follow-up of 28.5 months, the median overall survival from first-line initiation for 905 patients who received systemic anticancer treatment was 19.1 months. Among them, 81% and 32% received second- and third-line treatment. Notably, 52% had their treatment terminated before the opportunity for third-line treatment. Multivariate logistic regression analysis revealed that low performance status (≥1), elevated neutrophil-to-lymphocyte ratio (≥3), and low body mass index (<21 kg/m2) at the start of first-line treatment were independent risk factors for not proceeding to third-line treatment (p = 0.0024, 0.0069, and 0.0058, respectively). In this cohort, 33% had one of these factors, 36% had two, and 15% had all three. CONCLUSIONS: This study highlights the high frequency of factors associated with poor tolerance to anticancer treatment in la/mUC patients. The findings suggest the need to establish optimal sequential treatment strategies, maximizing efficacy within time and tolerance constraints, while concurrently providing strong supportive care, considering immunological and nutritional aspects.

    DOI: 10.1111/iju.15411

    PubMed

    researchmap

  • Impacts of Complete Endophytic Renal Tumors on Surgical, Functional, and Oncological Outcomes of Robot-Assisted Partial Nephrectomy. International journal

    Hiroki Ito, Koichi Uemura, Maiko Ikeda, Ryosuke Jikuya, Takuya Kondo, Tomoyuki Tatenuma, Takashi Kawahara, Mitsuru Komeya, Yusuke Ito, Kentaro Muraoka, Hisashi Hasumi, Kazuhide Makiyama

    Journal of endourology   38 ( 4 )   347 - 352   2024.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Objective: Complete endophytic renal tumors (CERTs) are the most challenging for robot-assisted partial nephrectomy (RAPN). This study aimed to determine the impact of CERT on outcomes of RAPN. Methods: All RAPN cases for localized renal tumor undertaken at Yokohama City University Hospital between 2016 and 2023 were enrolled. Tumor characteristics and surgical, functional, and oncologic outcomes of RAPN were compared between CERT and non-CERT groups. Results: Consecutive 666 patients were enrolled, and 76 (11.4%) were identified as CERT (3 points of "E" score). CERT showed smaller tumor diameters (p < 0.001), more predominant hilar tumor (p = 0.029), higher "N" scores (p < 0.001) and "L" scores (p = 0.006) than non-CERT. The CERT group showed longer warm ischemia times (p < 0.001), more frequent positive surgical margins (p = 0.028), and relatively lower trifecta achievement rates (p = 0.101) than the non-CERT group. In multivariable analysis, the CERT was an independent predictor for trifecta achievement but not for pentafecta achievement. Conclusions: CERT was associated with longer warm ischemia time, positive surgical margin, and lower trifecta achievement, but not with surgical complication and pentafecta achievement in RAPN. This study suggested that CERT had limited influence on long-term renal functional preservation; however, it had strong impacts on short-term surgical outcome.

    DOI: 10.1089/end.2023.0608

    PubMed

    researchmap

  • Influence of tract location on the outcomes of endoscopic combined intrarenal surgery: A retrospective analysis of 1000 cases. International journal

    Tadashi Tabei, Hiroki Ito, Takaaki Inoue, Takahiko Watanabe, Tetsuo Fukuda, Fukashi Yamamichi, Junichi Matsuzaki, Kazuki Kobayashi

    International journal of urology : official journal of the Japanese Urological Association   31 ( 4 )   349 - 354   2024.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: This study aimed to investigate the influence of tract location on surgical outcomes in endoscopic combined intrarenal surgery (ECIRS), considering the location of residual stones. METHODS: From January 2015 to December 2021, 1417 consecutive patients underwent ECIRS in three hospitals. After excluding patients with preoperative percutaneous nephrostomy, intended multi-stage procedures, those with a tract in the renal pelvis, and those with multiple tracts, 1000 patients were retrospectively analysed by comparing three groups based on tract location: group 1 (upper calyx), group 2 (middle calyx), and group 3 (lower calyx). A multivariate logistic regression model was implemented to assess whether the tract location independently affected the stone-free status. RESULTS: Patient characteristics were significantly different among the groups in terms of age, stone laterality, presence of calyceal stones, and hydronephrosis. There were no differences in stone-free rate (SFR) among the three groups. Multivariate analysis indicated that the tract location (group 1 or 2 compared with group 3) did not significantly affect the stone-free status (odds ratio = 1.4, 0.9-1.9, p = 0.066). Surgical duration significantly varied among the groups, with the shortest time observed in group 1. Organ injury was observed exclusively in group 1 (1.13%). Residual fragments were predominantly found in the lower calyx, with the calyx associated with the tract being the second most common location. CONCLUSIONS: Tract location does not significantly affect SFR. To improve the SFR, observation of the lower calyx and tract placement is important.

    DOI: 10.1111/iju.15363

    PubMed

    researchmap

  • Surgical proficiency in laparoscopic radical cystectomy with extracorporeal urinary diversion and its adequacy for the execution of robot-assisted radical cystectomy with intracorporeal urinary diversion.

    Atsuto Suzuki, Hiroki Ito, Koichi Uemura, Kentaro Muraoka, Tomoyuki Tatenuma, Kimito Osaka, Yumiko Yokomizo, Narihiko Hayashi, Hisashi Hasumi, Kazuhide Makiyama

    Asian journal of endoscopic surgery   17 ( 2 )   e13289   2024.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: The number of facilities adopting intracorporeal urinary diversion (ICUD) using robots instead of extracorporeal urinary diversion (ECUD) is increasing. However, guidance on how to introduce robot-assisted radical cystectomy (RARC) + ICUD in each urological institute remains unclear. This study aimed to verify the feasibility of the transition from laparoscopic radical cystectomy (LRC) + ECUD to RARC + ICUD. METHODS: We retrospectively analyzed 26 consecutive patients who underwent ICUD with an ileal conduit after RARC between 2018 and 2020 (RARC + ICUD early group). We then compared these patients with 26 consecutive patients who underwent ECUD with an ileal conduit after LRC between 2012 and 2019 (LRC + ECUD late group) at Yokohama City University Hospital. RESULTS: In the RARC + ICUD early group compared with the LRC + ECUD late group, the median total operation time was 516 versus 532.5 min (P = .217); time to cystectomy, 191 versus 206.5 min (P = .234); time of urinary diversion with an ileal conduit, 198 versus 220 min (P = .016); postoperative maximum C-reactive protein levels, 6.98 versus 12.46 mg/L (P = .001); number of days to oral intake, 3 versus 5 days (P = .003); length of hospital stay, 17 versus 32 days (P < .001). The postoperative complication rates (within 90 days) were 23.1% and 42.3% in the RARC + ICUD early and LRC + ECUD late groups, respectively (P = .237). Clavien-Dindo classification ≥3 was noted in 1 and 4 patients in the RARC + ICUD early and LRC + ECUD late groups, respectively (P = .350). CONCLUSION: Regarding perioperative outcomes, the RARC + ICUD early group was not inferior to the LRC + ECUD late group. This study suggests the feasibility of a transition from LRC + ECUD to RARC + ICUD.

    DOI: 10.1111/ases.13289

    PubMed

    researchmap

  • Impact of chronic kidney disease stages on surgical and functional outcomes in robot-assisted partial nephrectomy for localized renal tumors. International journal

    Hiroki Ito, Kentaro Muraoka, Koichi Uemura, Ryosuke Jikuya, Takuya Kondo, Tomoyuki Tatenuma, Takashi Kawahara, Mitsuru Komeya, Yusuke Ito, Hisashi Hasumi, Kazuhide Makiyama

    Journal of robotic surgery   18 ( 1 )   109 - 109   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The influence of chronic kidney disease stage on robot-assisted partial nephrectomy outcomes remains underexplored. This study aimed to assess the impact of chronic kidney disease stage on functional and surgical outcomes of robot-assisted partial nephrectomy and identify preoperative predictors of significant postoperative 1-year renal-function loss (RFL). Clinical data of 408 patients who underwent robot-assisted partial nephrectomy at Yokohama City University Hospital between 2016 and 2023 were retrospectively reviewed. The da Vinci Surgical System was applied in all patients, and outcomes assessed included surgical parameters, postoperative estimated glomerular filtration rate, trifecta and pentafecta achievements, and complications. Significant RFL was defined as estimated glomerular filtration rate reduction ≥ 25% from baseline. Higher chronic kidney disease stages correlated with older age, hypertension, diabetes, and solitary kidneys. Postoperative estimated glomerular filtration rate decline was most pronounced in patients with chronic kidney disease stages 4-5. Although the chronic kidney disease stage did not significantly affect most surgical parameters, pentafecta achievement was higher in patients with chronic kidney disease stage 3 than in those with stages 4-5. Two patients required hemodialysis after robot-assisted partial nephrectomy. Multivariable logistic regression analysis showed that preoperative hemoglobin level and maximum tumor diameter were significant predictive factors for significant RFL. In conclusion, preoperative CKD stage did not influence on surgical outcome except for pentafecta achievement. RAPN may be feasible for patients with CKD stages 4-5 because of no rapid progression to hemodialysis induction and no procedure-related mortality. Preoperative hemoglobin levels and tumor diameter emerged as predictors of significant RFL.

    DOI: 10.1007/s11701-024-01873-2

    PubMed

    researchmap

  • Predicting Prostate Surgery Outcomes from Standard Clinical Assessments of Lower Urinary Tract Symptoms To Derive Prognostic Symptom and Flowmetry Criteria. International journal

    Hiroki Ito, Kentaro Sakamaki, Grace J Young, Peter S Blair, Hashim Hashim, J Athene Lane, Kazuki Kobayashi, Madeleine Clout, Paul Abrams, Christopher Chapple, Sachin Malde, Marcus J Drake

    European urology focus   10 ( 1 )   197 - 204   2024.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Assessment of male lower urinary tract symptoms (LUTS) needs to identify predictors of symptom outcomes when interventional treatment is planned. OBJECTIVE: To develop a novel prediction model for prostate surgery outcomes and validate it using a separate patient cohort and derive thresholds for key clinical parameters. DESIGN, SETTING, AND PARTICIPANTS: From the UPSTREAM trial of 820 men seeking treatment for LUTS, analysis of bladder diary (BD), International Prostate Symptom Score (IPSS), IPSS-quality of life, and uroflowmetry data was performed for 176 participants who underwent prostate surgery and provided complete data. For external validation, data from a retrospective database of surgery outcomes in a Japanese urology department (n = 227) were used. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Symptom improvement was defined as a reduction in total IPSS of ≥3 points. Multiple logistic regression, classification tree analysis, and random forest models were generated, including versions with and without BD data. RESULTS AND LIMITATIONS: Multiple logistic regression without BD data identified age (p = 0.029), total IPSS (p = 0.0016), and maximum flow rate (Qmax; p = 0.066) as predictors of outcomes, with area under the receiver operating characteristic curve (AUC) of 77.1%. Classification tree analysis without BD data gave thresholds of IPSS <16 and Qmax ≥13 ml/s (AUC 75.0%). The random forest model, which included all clinical parameters except BD data, had an AUC of 94.7%. Internal validation using the bootstrap method showed reasonable AUCs (69.6-85.8%). Analyses using BD data marginally improved the model fits. External validation gave comparable AUCs for logistic regression, classification tree analysis, and random forest models (all without BD; 70.9%, 67.3%, and 68.5%, respectively). Limitations include the significant number of men with incomplete baseline data and limited assessments in the external validation cohort. CONCLUSIONS: Outcomes of prostate surgery can be predicted preoperatively using age, total IPSS, and uroflowmetry data, with prognostic thresholds of 16 for IPSS and 13 ml/s for Qmax. PATIENT SUMMARY: This study identified key preoperative factors that can predict outcomes of prostate surgery for bothersome urinary symptoms, including which patients are at risk of a poor outcome.

    DOI: 10.1016/j.euf.2023.06.013

    PubMed

    researchmap

  • [A Case of Testicular Torsion of Retractile Testis Requiring Orchidectomy].

    Yasuhiro Numata, Hiroki Ito, Mitsuteru Matsuoka, Taku Sasaki, Yutaro Hayashi, Takahiko Watanabe, Masahiro Inoue, Daiki Ueno, Kazuki Kobayashi

    Hinyokika kiyo. Acta urologica Japonica   70 ( 1 )   21 - 23   2024.1

     More details

    Language:Japanese  

    We report a case of testicular torsion in an 8-year-old who was referred to our hospital for right groin pain. He was diagnosed with right retractile testis during a 12-month check-up. However, instead of performing orchiopexy, he was placed under observation until the age of 5, after which he did not seek medical attention. Physical examination revealed swelling and tenderness in the right inguinal region and no palpable testis in the right scrotum. Ultrasound and computed tomography revealed right testicular torsion, and emergency surgery was performed. Intraoperative findings revealed a dark and ischemic testis that was twisted at 180°in the right inguinal region. There was no improvement in blood flow even after the testicular torsion was released; therefore, right orchidectomy with left orchiopexy was performed. Although the incidence of testicular torsion is higher in patients with an undescended testis than in those with a normally positioned scrotal position testis, reports of testicular torsion associated with a retractile testis are rare.

    DOI: 10.14989/ActaUrolJap_70_1_21

    PubMed

    J-GLOBAL

    researchmap

  • Models to predict the surgical outcome of mini-ECIRS (endoscopic combined intrarenal surgery) for renal and/or ureteral stones. International journal

    Hiroki Ito, Kentaro Sakamaki, Tetsuo Fukuda, Fukashi Yamamichi, Takahiko Watanabe, Tadashi Tabei, Takaaki Inoue, Junichi Matsuzaki, Kazuki Kobayashi

    Scientific reports   13 ( 1 )   22848 - 22848   2023.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    To establish a safer and more efficient treatment strategy with mini-endoscopic combined intrarenal surgery (ECIRS), the present study aimed to develop models to predict the outcomes of mini-ECIRS in patients with renal and/or ureteral stones. We retrospectively analysed consecutive patients with renal and/or ureteral stones who underwent mini-ECIRS at three Japanese tertiary institutions. Final treatment outcome was evaluated by CT imaging at 1 month postoperatively and stone free (SF) was defined as completely no residual stone or residual stone fragments ≤ 2 mm. Three prognostic models (multiple logistic regression, classification tree analysis, and machine learning-based random forest) were developed to predict surgical outcomes using preoperative clinical factors. Clinical data from 1432 ECIRS were pooled from a database registered at three institutions, and 996 single sessions of mini-ECIRS were analysed in this study. The overall SF rate was 62.3%. The multiple logistic regression model consisted of stone burden (P < 0.001), number of involved calyces (P < 0.001), nephrostomy prior to mini-ECIRS (P = 0.091), and ECOG-PS (P = 0.110), wherein the area under the curve (AUC) was 70.7%. The classification tree analysis consisted of the number of involved calyces with an AUC of 61.7%. The random forest model showed that the top predictive variable was the number of calyces involved, with an AUC of 91.9%. Internal validation revealed that the AUCs for the multiple logistic regression model, classification tree analysis and random forest models were 70.4, 69.6 and 85.9%, respectively. The number of involved calyces, and a smaller stone burden implied a SF outcome. The machine learning-based model showed remarkably high accuracy and may be a promising tool for physicians and patients to obtain proper consent, avoid inefficient surgery, and decide preoperatively on the most efficient treatment strategies, including staged mini-ECIRS.

    DOI: 10.1038/s41598-023-50022-6

    PubMed

    researchmap

  • Predictive factors for pentafecta achievement in robot-assisted partial nephrectomy for intermediate highly complex RENAL tumors (RENAL score ≥ 7). International journal

    Koichi Uemura, Hiroki Ito, Maiko Ikeda, Koichiro Uehara, Tomoyuki Tatenuma, Mitsuru Komeya, Yusuke Ito, Kentaro Muraoka, Hisashi Hasumi, Kazuhide Makiyama

    International journal of urology : official journal of the Japanese Urological Association   30 ( 12 )   1096 - 1102   2023.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: To investigate the predictive factors for pentafecta achievement of robot-assisted partial nephrectomy (RAPN) for intermediate highly complex renal tumors (RENAL score ≥ 7). METHODS: We retrospectively analyzed the data of 247 patients with renal tumors with a RENAL score ≥ 7 who underwent RAPN. Baseline characteristics and perioperative outcomes were compared between the pentafecta achieved group and the unachieved group. A multivariable logistic regression model was used to identify the predictive factors for pentafecta achievement for cT1 renal tumors with a RENAL score ≥ 7. RESULTS: Of the 247 patients, 75 (30.3%) patients were in the achieved group and 172 (69.7%) patients were in the unachieved group. The median warm ischemia time and total operation time were 18 min versus 23 min (p < 0.001) and 179 min versus 201 min (p < 0.001) in the achieved and unachieved groups, respectively. In the unachieved group, six patients (3.4%) had major perioperative complications (Clavien-Dindo classification system ≥3). The median preservation rates of estimated GFR at the 1-year postoperative period were 96.5% versus 83.0% (p < 0.001) in the achieved and unachieved groups. Multivariable logistic regression models revealed that age and tumor size were independent predictive factors for pentafecta achievement for cT1 renal tumors with a RENAL score ≥ 7. There were no significant differences in cancer-free survival between the two groups (p = 0.456). CONCLUSION: Age and tumor size were independent predictive factors for pentafecta achievement, although there was no difference in oncological outcomes between the pentafecta achieved group and the unachieved group in RAPN for cT1 renal tumors with a RENAL score ≥ 7.

    DOI: 10.1111/iju.15274

    PubMed

    researchmap

  • Predictive factors for the success of trial without catheter for men with urinary retention. International journal

    Masato Takanashi, Hiroki Ito, Takeshi Fukazawa, Hiroki Takizawa, Mari Hioki, Risa Shinoki, Takashi Kawahara, Kazuki Kobayashi

    Lower urinary tract symptoms   15 ( 5 )   173 - 179   2023.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To investigate the trial of spontaneous urination without catheter (TWOC) outcomes for men with acute urinary retention, determine successful TWOC predictors, and evaluate the impact of add-on medication therapy on TWOC. METHODS: This retrospective study included men with acute urinary retention and post-void residual (PVR) >250 mL who underwent TWOC between July 2009 and July 2019. Patients were divided into a medicated group who received alpha1 blocker on urinary retention diagnosis and a naïve group who did not. The trial was defined as unsuccessful if the PVR was >150 mL or if the patient experienced difficulty emptying their bladder with abdominal discomfort or pain, and a transurethral catheter was reinserted. RESULTS: Among 576 men with urinary retention, 269 (46.7%) constituted the medicated group and 307 (53.3%) the naïve. The naïve group comprised more elderly patients (P = 0.010) with higher Eastern Cooperative Oncology Group performance status (PS) (P = 0.001) and smaller prostate volume (P = 0.028) than the other. In the medicated group, 153 men received additional oral medication before TWOC to increase the success rate. There were significant age differences (P = 0.041) in the medicated group and significant median PS differences (P = 0.010) in the naïve group between the successful and unsuccessful outcomes of TWOC. The multivariate logistic regression model demonstrated that age <80 years in medicated patients (P = 0.042, odds ratio [OR] 1.701) and PS <2 in naïve patients (P = 0.001, OR 2.710) were significant independent predictors of successful TWOC outcomes. CONCLUSIONS: This is the first study classifying patients with urinary retention according to medication status. Both medicated and naïve groups had different patient backgrounds and TWOC outcome predictors, suggesting a discrepant etiology behind urinary retention. Hence, acute urinary retention management in men should vary based on medication status for male lower urinary tract symptoms when urinary retention is diagnosed.

    DOI: 10.1111/luts.12492

    PubMed

    researchmap

  • Administration of Enfortumab Vedotin after Immune-Checkpoint Inhibitor and the Prognosis in Japanese Metastatic Urothelial Carcinoma: A Large Database Study on Enfortumab Vedotin in Metastatic Urothelial Carcinoma. International journal

    Takashi Kawahara, Akihito Hasizume, Koichi Uemura, Katsuya Yamaguchi, Hiroki Ito, Teppei Takeshima, Hisashi Hasumi, Jun-Ichi Teranishi, Kimito Ousaka, Kazuhide Makiyama, Hiroji Uemura

    Cancers   15 ( 17 )   2023.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Enfortumab vedotin shows promise as a targeted therapy for advanced urothelial carcinoma, particularly in patients who have previously received platinum-based chemotherapy and an immune-checkpoint inhibitor. The EV-301 phase III trial demonstrated significantly improved overall survival and response rates compared to standard chemotherapy. However, more data, especially from larger real-world studies, are needed to further assess its effectiveness in Japanese patients. METHODS: A total of 6007 urothelial cancer patients inducted with pembrolizumab as a second-line treatment were analyzed. Among them, 563 patients received enfortumab vedotin after pembrolizumab, while 443 patients received docetaxel or paclitaxel after pembrolizumab, and all were included in the study for efficacy as a life prolonging agent. RESULTS: The enfortumab vedotin group showed a longer overall survival than the paclitaxel/docetaxel group (p = 0.013, HR: 0.71). In multivariate analysis, enfortumab vedotin induction was the independent risk factor for overall survival (p = 0.013, HR: 0.70). There were no significant differences in cancer-specific survival. CONCLUSIONS: Enfortumab vedotin prolonged the overall survival for Japanese advanced or metastatic urothelial carcinoma patients compared to paclitaxel or docetaxel after pembrolizumab treatment.

    DOI: 10.3390/cancers15174227

    PubMed

    researchmap

  • Lower urinary tract symptoms are elevated with depression in Japanese women. International journal

    Sahoko Ninomiya, Takashi Kawahara, Sohgo Tsutsumi, Hiroki Ito, Kazuhide Makiyama, Hiroji Uemura

    Lower urinary tract symptoms   15 ( 4 )   116 - 121   2023.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: Depression might worsen lower urinary tract symptoms (LUTS), but the correlation is still disputed. This study examined the influence of depression on LUTS in Japanese women. METHODS: This study used a web-based questionnaire to evaluate the mental status of depression and LUTS. The mental status of depression was evaluated using the Quick Inventory of Depressive Symptomatology-Japanese version (QIDS-J), and LUTS was assessed based on the Overactive Bladder Symptom Score (OABSS) and responses to the International Consultation on Incontinence Questionnaire-Short Form. RESULTS: A total of 4151 of 5400 (76.9%) women responded to the questionnaire. The mean age was 48.3 ± 13.8 years. The OABSS gradually increased with the QIDS-J score. The incidence of overactive bladder (OAB) and urgency urinary incontinence (UUI) also increased along with the QIDS-J score. In the younger age group (20-39 years old), the risks of OAB and UUI were higher than in the elderly group (7.42 for OAB and 7.44 for UUI). CONCLUSIONS: This study revealed that worsening of LUTS was correlated with depression.

    DOI: 10.1111/luts.12478

    PubMed

    researchmap

  • Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma. International journal

    Ryosuke Jikuya, Todd A Johnson, Kazuhiro Maejima, Jisong An, Young-Seok Ju, Hwajin Lee, Kyungsik Ha, WooJeung Song, Youngwook Kim, Yuki Okawa, Shota Sasagawa, Yuki Kanazashi, Masashi Fujita, Seiya Imoto, Taku Mitome, Shinji Ohtake, Go Noguchi, Sachi Kawaura, Yasuhiro Iribe, Kota Aomori, Tomoyuki Tatenuma, Mitsuru Komeya, Hiroki Ito, Yusuke Ito, Kentaro Muraoka, Mitsuko Furuya, Ikuma Kato, Satoshi Fujii, Haruka Hamanoue, Tomohiko Tamura, Masaya Baba, Toshio Suda, Tatsuhiko Kodama, Kazuhide Makiyama, Masahiro Yao, Brian M Shuch, Christopher J Ricketts, Laura S Schmidt, W Marston Linehan, Hidewaki Nakagawa, Hisashi Hasumi

    EBioMedicine   92   104596 - 104596   2023.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Birt-Hogg-Dubé (BHD) syndrome, caused by germline alteration of folliculin (FLCN) gene, develops hybrid oncocytic/chromophobe tumour (HOCT) and chromophobe renal cell carcinoma (ChRCC), whereas sporadic ChRCC does not harbor FLCN alteration. To date, molecular characteristics of these similar histological types of tumours have been incompletely elucidated. METHODS: To elucidate renal tumourigenesis of BHD-associated renal tumours and sporadic renal tumours, we conducted whole genome sequencing (WGS) and RNA-sequencing (RNA-seq) of sixteen BHD-associated renal tumours from nine unrelated BHD patients, twenty-one sporadic ChRCCs and seven sporadic oncocytomas. We then compared somatic mutation profiles with FLCN variants and RNA expression profiles between BHD-associated renal tumours and sporadic renal tumours. FINDINGS: RNA-seq analysis revealed that BHD-associated renal tumours and sporadic renal tumours have totally different expression profiles. Sporadic ChRCCs were clustered into two distinct clusters characterized by L1CAM and FOXI1 expressions, molecular markers for renal tubule subclasses. Increased mitochondrial DNA (mtDNA) copy number with fewer variants was observed in BHD-associated renal tumours compared to sporadic ChRCCs. Cell-of-origin analysis using WGS data demonstrated that BHD-associated renal tumours and sporadic ChRCCs may arise from different cells of origin and second hit FLCN alterations may occur in early third decade of life in BHD patients. INTERPRETATION: These data further our understanding of renal tumourigenesis of these two different types of renal tumours with similar histology. FUNDING: This study was supported by JSPS KAKENHI Grants, RIKEN internal grant, and the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research.

    DOI: 10.1016/j.ebiom.2023.104596

    PubMed

    researchmap

  • Comparison of the short-term efficacy and safety of bipolar transurethral electro vaporization and holmium laser enucleation of the prostate for moderate and large benign prostatic enlargement. International journal

    Yutaro Hayashi, Shuko Yoneyama, Akitoshi Takizawa, Kazuki Kobayashi, Hiroki Ito

    BMC urology   23 ( 1 )   50 - 50   2023.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: To compare the efficacy and safety of bipolar transurethral vaporization of the prostate (B-TUVP) with holmium laser enucleation of the prostate (HoLEP) for moderate [prostate volume (PV) 30-80 ml] and large (≥ 80 ml) benign prostatic enlargement (BPE). MATERIALS AND METHODS: Male patients with lower urinary tract symptom (LUTS) or urinary retention who underwent B-TUVP or HoLEP treatment in two regional centers were respectively enrolled. Patient characteristics and treatment outcomes were retrospectively compared between B-TUVP and HoLEP. RESULTS: In patients with moderate and large prostate volume,B-TUVP showed shorter operative time (P < 0.001) and less hemoglobin decrease (P < 0.001) than in HoLEP. In uncatheterised patients, voiding symptoms and patients' quality of life improved after B-TUVP and HoLEP, but these improvement rates were consistently bigger in HoLEP than in B-TUVP. In catheterised patients, the rate of achieving catheter-free status after surgery was higher in HoLEP than in B-TUVP for patients with PV > 80 ml.(P < 0.001) The incidence of postoperative fever was higher in B-TUVP than in HoLEP for patients with PV 30-80 ml (P < 0.001) but not for those with PV > 80 ml.(P=0.08) The Incidence of postoperative stress incontinence(SUI) was higher in HoLEP than in B-TUVP for patients with moderate and large prostate volume. CONCLUSIONS: There are few studies that investigated the short-term efficacy and safety of second-generation B-TUVP in comparison with HoLEP for moderate and large BPE. Improvement in LUTS and achievement of catheter-free status were predominant in HoLEP, and these outcomes were more prominent in patients with large BPE of PV > 80 ml. However, B-TUVP resulted in less blood loss, shorter operative duration, and less SUI suggesting that B-TUVP is also well-tolerated surgical modality.

    DOI: 10.1186/s12894-023-01215-8

    PubMed

    researchmap

  • Predictive factors for the success of trial catheter removal for women with urinary retention. International journal

    Masato Takanashi, Hiroki Ito, Takeshi Fukazawa, Risa Shinoki, Tadashi Tabei, Takashi Kawahara, Kazuki Kobayashi

    Lower urinary tract symptoms   15 ( 1 )   4 - 10   2023.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To investigate the outcome, determine the predictors for the success of, and evaluate the efficacy of pharmacokinetic therapy on trial catheter removal for women with urinary retention. METHODS: Inclusion criteria were female patients with acute urinary retention defined as painful, palpable, or percussive bladder, when the patient is unable to pass any urine, accompanied by postvoid residual (PVR) > 250 ml, and who underwent trial catheter removal between July 2009 and July 2019. Before trial catheter removal, alpha-blockers alone or alpha-blockers and parasympathomimetics (bethanechol or distigmine bromide) were used to facilitate spontaneous voiding in some cases. RESULTS: Fifty-nine of 104 (56.7%) women with urinary retention were catheter-free post trial. There was no significant difference between successful and non-successful trials in average age (p = .392), median ECOG (Eastern Cooperative Oncology Group) performance status (p = .374), diabetes mellitus (p = .842), dementia (p = .801), previous history of cerebrovascular events (p = .592), or intrapelvic surgery (p = .800). Oral medications were administered for 39/59 (66.1%) in the success group and 30/45 (66.7%) patients in the non-success groups (p = .598). Serum albumin (3.2 ± 0.7 g/dl and 2.8 ± 0.8 g/dl, p = .039) and total protein values (6.5 ± 0.8 g/dl and 6.0 ± 1.0 g/dl, p = .038) at diagnosis of urinary retention were higher in the success group than the non-success group, respectively. Multivariate logistic regression found that a serum albumin >3 g/dl was an independent predictor of successful trial catheter removal for women with urinary retention (p = .030, odds ratio [OR] 3.3, 95% confidence interval [CI] of OR 1.1-9.9). Age < 70 years old was a likely predictor of successful trial catheter removal (p = .066, OR 4.8, 95% CI of OR 0.9-25.0). CONCLUSIONS: This is the first retrospective study to investigate the predictive factors for successful trial catheter removal in women with urinary retention. A serum albumin value >3 mg/dl at diagnosis of urinary retention was a significant independent predictor of catheter-free status after trial catheter removal, and age < 70 years-old was a possible contributor. There was no evidence that oral medication contributed to catheter-free status.

    DOI: 10.1111/luts.12464

    PubMed

    researchmap

  • [A SUCCESSFUL CASE OF LYMPHATIC EMBOLIZATION IN A PATIENT WITH PROLONGED LYMPHATIC LEAKAGE AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CANCER].

    Koichiro Uehara, Hiroki Ito, Maiko Ikeda, Koichi Uemura, Tomoyuki Tatenuma, Yusuke Ito, Mitsuru Komeya, Kentaro Muraoka, Hisashi Hasumi, Kazuhide Makiyama

    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology   114 ( 4 )   133 - 136   2023

     More details

    Language:Japanese  

    A 57-years-old woman was referred to our urological department due to a 7.2-cm tumor in the left kidney, detected on computed tomography (CT). Dynamic CT of the kidney confirmed the diagnosis of left renal cancer, with lung metastasis (cT2aN0M1). The patient had a poor prognosis (IMDC classification), given the following risk factors: Time from initial diagnosis to initiation of systemic therapy < 1year, hemoglobin of 8.4 g/dL, calcium of 10.7 mg/dL, and platelet of 74.2×104/mm3. Laparoscopic left radical nephrectomy was performed before systemic drug treatment because the solitary lung metastasis was relatively small (10 mm) and the patient had symptoms of hematuria and fever. The pathological diagnosis was a clear cell carcinoma with renal sinus invasion (pT3a). Four days postoperatively, the patient developed lymphatic leakage, and was unresponsive to diet and conservative treatment. Lymphatic embolization with iodized poppy oil fatty acid ethyl ester was performed 22 days postoperatively. Contrast material leakage from the left renal hilar lymph node was observed before embolization. Post-embolization CT confirmed no contrast leakage. The patient resumed oral feeding on the 28th postoperative day, and the drain was successfully removed the next day. She was discharged on the 35th postoperative day. On follow-up, increased lung metastases were observed on CT. She was treated with the combination of ipilimumab and nivolumab. After one course of treatment, a CT scan showed a further increased in lung metastases (RECIST: PD). Thus, she was initiated on cabozantinib monotherapy. Lymphatic embolization may be a safe and effective treatment for lymphatic leakage that does not improve with conservative treatment.

    DOI: 10.5980/jpnjurol.114.133

    PubMed

    J-GLOBAL

    researchmap

  • [COMPARING LAPAROSCOPIC AND ROBOT-ASSISTED PYELOPLASTY FOR URETERO-PELVIC JUNCTION OBSTRUCTION: INITIAL EXPERIENCE FROM A SINGLE CENTER].

    Tomoyuki Tatenuma, Hiroki Ito, Mitsuru Komeya, Yusuke Ito, Kentaro Muraoka, Hisashi Hasumi, Narihiko Hayashi, Kazuhide Makiyama

    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology   114 ( 1 )   1 - 7   2023

     More details

    Language:Japanese  

    (Objective) To compare the initial results of robot-assisted laparoscopic pyeloplasty (RALP) and laparoscopic pyeloplasty (LP) for uretero-pelvic junction obstruction (UPJO). (Methods) Between April 2008 to October 2021, we identified 104 cases of UPJO where LP was performed and 18 cases where RALP was performed at our hospital. We retrospectively analyzed their perioperative outcomes. Furthermore, we recorded the operative times for each cases of LP and RALP. (Results) The median operative time for RALP was 141 minutes, which was significantly shorter than that for LP (204 minutes). No patient in the RALP group demonstrated any Clavien-Dindo complications (≥grade 3). During the observation period, improvement of symptoms was observed in all cases. The median suturing time in RALP was 38 minutes. Compared with the last 20 cases of LP, the time to expose the uretero-pelvic junction, the time of renal pelvis incision, and suturing time were significantly shorter in RALP. In addition, the console and suturing times were stable since the initial stage. In cases with a high grade of hydronephrosis, there was a large variation in the time to expose the uretero-pelvic junction and suture the renal pelvis and ureter in LP; however, this variation was smaller in RALP. (Conclusion) At our hospital, RALP for UPJO is considered to be a safe procedure. In the future, it is necessary to consider the long-term results and effectiveness of RALP.

    DOI: 10.5980/jpnjurol.114.1

    PubMed

    J-GLOBAL

    researchmap

  • Clinical Factors to Predict Difficult Ureter during Ureteroscopic Lithotripsy. International journal

    Masashi Imano, Tadashi Tabei, Hiroki Ito, Junichi Ota, Kazuki Kobayashi

    Minimally invasive surgery   2023   2584499 - 2584499   2023

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To identify risk factors for difficult ureters during ureteroscopic lithotripsy and to determine the appropriate indications for preoperative stenting. METHODS: We retrospectively analyzed 156 ureteroscopic procedures for upper urinary tract stones after excluding those with preoperative stenting or percutaneous nephrostomy. Traceability of the ureter was assessed by two urologists. Traceability was defined as positive if either or both urologists discerned the ureter in all slices on preoperative plain computed tomography. Patients' backgrounds were compared between the nondifficult ureter and difficult ureter groups. A multivariate logistic regression model was used to evaluate the relationships between difficult ureters and other clinical factors. RESULTS: Of 156 patients, 31 (19.9%) were classified into the difficult ureter group. The positive traceability was higher in the nondifficult ureter group (48.3% vs. 83.2%, P < 0.001). The major axis was smaller in the difficult ureter group than in the nondifficult ureter group (8.8 ± 3.9 mm vs. 10.9 ± 4.5 mm, P < 0.018). A major axis <8 mm (odds ratio: 4.495, 95% confidence interval: 1.791-11.278, and P=0.001), negative traceability (odds ratio: 7.565, 95% confidence interval: 2.693-21.248, and P < 0.001), smoking status (odds ratio: 3.196, 95% confidence interval: 1.164-8.773, and P=0.024), and absence of diabetes mellitus (odds ratio: 5.813, 95% confidence interval: 1.121-30.142, and P=0.036) were identified as independent predictors of difficult ureters on multivariate logistic regression analysis. CONCLUSION: Patients with smaller stones, negative traceability, ongoing tobacco consumption, and absence of diabetes mellitus were at higher risk of difficult ureters. In these patients, preoperative stenting may be considered.

    DOI: 10.1155/2023/2584499

    PubMed

    researchmap

  • Prostate Surgery for Men with Lower Urinary Tract Symptoms: Do We Need Urodynamics to Find the Right Candidates? Exploratory Findings from the UPSTREAM Trial. International journal

    Grace J Young, Chris Metcalfe, J Athene Lane, Amanda L Lewis, Paul Abrams, Peter S Blair, Hiroki Ito, Christopher Chapple, Marcus J Drake

    European urology focus   8 ( 5 )   1331 - 1339   2022.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Identifying men whose lower urinary tract symptoms (LUTS) may benefit from surgery is challenging. OBJECTIVE: To identify routine diagnostic and urodynamic measures associated with treatment decision-making, and outcome, in exploratory analyses of the UPSTREAM trial. DESIGN, SETTING, AND PARTICIPANTS: A randomised controlled trial was conducted including 820 men, considering surgery for LUTS, across 26 hospitals in England (ISCTRN56164274). INTERVENTION: Men were randomised to a routine care (RC) diagnostic pathway (n = 393) or a pathway that included urodynamics (UDS) in addition to RC (n = 427). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Men underwent uroflowmetry and completed symptom questionnaires, at baseline and 18 mo after randomisation. Regression models identified baseline clinical and symptom measures that predicted recommendation for surgery and/or surgical outcome (measured by the International Prostate Symptom Score [IPSS]). We explored the association between UDS and surgical outcome in subgroups defined by routine measures. RESULTS AND LIMITATIONS: The recommendation for surgery could be predicted successfully in the RC and UDS groups (area under the receiver operating characteristic curve 0.78), with maximum flow rate (Qmax) and age predictors in both groups. Surgery was more beneficial in those with higher symptom scores (eg, IPSS >16), age <74 yr, Qmax <9.8 ml/s, bladder outlet obstruction index >47.6, and bladder contractility index >123.0. In the UDS group, urodynamic measures were more strongly predictive of surgical outcome for those with Qmax >15, although patient-reported outcomes were also more predictive in this subgroup. CONCLUSIONS: Treatment decisions were informed with UDS, when available, but without evidence of change in the decisions reached. Despite the small group sizes, exploratory analyses suggest that selective use of UDS could detect obstructive pathology, missed by routine measures, in certain subgroups. PATIENT SUMMARY: Baseline clinical and symptom measurements were able to predict treatment decisions. The addition of urodynamic test results, while useful, did not generally lead to better surgical decisions and outcomes over routine tests alone.

    DOI: 10.1016/j.euf.2021.11.010

    PubMed

    researchmap

  • Roughness of the renal tumor surface could predict the surgical difficulty of robot-assisted partial nephrectomy.

    Tomoyuki Tatenuma, Hiroki Ito, Kentaro Muraoka, Yusuke Ito, Hisashi Hasumi, Narihiko Hayashi, Keiichi Kondo, Noboru Nakaigawa, Kazuhide Makiyama

    Asian journal of endoscopic surgery   15 ( 3 )   591 - 598   2022.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: Preoperative prediction of surgical difficulty of partial nephrectomy (PN) is essential to minimize the perioperative complications and to achieve a good surgical outcome. Recently, various scoring systems have been used to evaluate the difficulty of PN including R.E.N.A.L (Radius, Exophytic/Endophytic, Nearness, Anterior/Posterior, Location) nephrometry score. There were no scoring systems evaluating the roughness of the renal tumor surface and we hypothesized that the roughness of the renal tumor surface might affect the surgical difficulty of robot-assisted partial nephrectomy (RAPN). This study aimed to evaluate the impact of roughness of the renal tumor surface on the surgical outcome of RAPN. METHODS: Overall, 161 patients underwent RAPN performed by the same surgeon between May 2016 and April 2019. We divided those tumors into two groups, like "roughness positive (tumor with roughness of tumor surface)" and "roughness negative (tumor without roughness of tumor surface)" according to the roughness of the endophytic region on preoperative computed tomography images. Clinical and pathological outcomes were compared between the two groups. RESULTS: Eighty-five and 78 tumors were identified roughness negative and positive, respectively. Cases with roughness positive showed a significantly longer operative time, console time, and ischemia time and had greater blood loss than those with roughness negative. Significant and independent predictors of ischemia time and estimated glomerular filtration rate (eGFR) decrease were roughness of tumor surface, tumor size (not for eGFR decrease), and N score of the R.E.N.A.L nephrometry score. CONCLUSION: Roughness of renal tumor surface was significantly and positively associated with ischemia time and the eGFR decrease rate.

    DOI: 10.1111/ases.13058

    PubMed

    researchmap

  • Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers. International journal

    Ryosuke Jikuya, Koichi Murakami, Akira Nishiyama, Ikuma Kato, Mitsuko Furuya, Jun Nakabayashi, Jordan A Ramilowski, Haruka Hamanoue, Kazuhiro Maejima, Masashi Fujita, Taku Mitome, Shinji Ohtake, Go Noguchi, Sachi Kawaura, Hisakazu Odaka, Takashi Kawahara, Mitsuru Komeya, Risa Shinoki, Daiki Ueno, Hiroki Ito, Yusuke Ito, Kentaro Muraoka, Narihiko Hayashi, Keiichi Kondo, Noboru Nakaigawa, Koji Hatano, Masaya Baba, Toshio Suda, Tatsuhiko Kodama, Satoshi Fujii, Kazuhide Makiyama, Masahiro Yao, Brian M Shuch, Laura S Schmidt, W Marston Linehan, Hidewaki Nakagawa, Tomohiko Tamura, Hisashi Hasumi

    iScience   25 ( 6 )   104463 - 104463   2022.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Our understanding of how each hereditary kidney cancer adapts to its tissue microenvironment is incomplete. Here, we present single-cell transcriptomes of 108,342 cells from patient specimens including from six hereditary kidney cancers. The transcriptomes displayed distinct characteristics of the cell of origin and unique tissue microenvironment for each hereditary kidney cancer. Of note, hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated kidney cancer retained some characteristics of proximal tubules, which were completely lost in lymph node metastases and present as an avascular tumor with suppressed T cells and TREM2-high macrophages, leading to immune tolerance. Birt-Hogg-Dubé (BHD)-associated kidney cancer exhibited transcriptomic intratumor heterogeneity (tITH) with increased characteristics of intercalated cells of the collecting duct and upregulation of FOXI1-driven genes, a critical transcription factor for collecting duct differentiation. These findings facilitate our understanding of how hereditary kidney cancers adapt to their tissue microenvironment.

    DOI: 10.1016/j.isci.2022.104463

    PubMed

    researchmap

  • Real-world data in elderly men from Yokosuka City 15 years after introducing prostate-specific antigen-based population screening. International journal

    Takuma Nirei, Tadashi Tabei, Naoki Sakai, Hideshige Koh, Minoru Yoshida, Atsushi Fujikawa, Hiroki Ito, Sohgo Tsutsumi, Souichi Furuhata, Sumio Noguchi, Masataka Taguri, Kazuki Kobayashi

    Molecular and clinical oncology   16 ( 2 )   38 - 38   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Mass screening based on prostate-specific antigen (PSA) reduces mortality in prostate cancer. However, the effectiveness of this screening in the elderly has not been demonstrated. In the city of Yokosuka, Japan, PSA screening has been conducted since 2001 and the present study examined the real-world status of PSA-based population screening in the elderly. It retrospectively evaluated 1,117 prostate cancer patients >75 years of age. The patients were divided into two groups: The screened group comprising patients diagnosed by PSA-based population screening or workplace screening and PSA follow-up patients at urology clinics; and the non-screened group comprising patients detected by other methods. Overall survival (OS), cancer-specific survival (CSS) and factors contributing to shorter CSS between the groups were compared. In patients >75 years of age, the screened group had significantly longer OS (171 vs. 154 months; P=0.019) and CSS (median not reached; P=0.020) but screening was not an independent factor associated with prolonged OS or CSS on multivariate analysis. The factors contributing to shorten CSS in the elderly were ≥T3 (odds ratio: 3.301 [1.704-6.369], P<0.001), M1 (odds ratio: 4.856 [2.809-8.393], P<0.001) and Gleason score ≥8 (odds ratio: 4.691 [2.479-8.876], P<0.001). In those with metastasis, PSA screening was not associated with prolonged OS or CSS. Real-world data 15 years after introducing PSA-based population screening was not an independent factor for both OS and CSS in multivariate analyses for patients >75 years of age.

    DOI: 10.3892/mco.2021.2471

    PubMed

    researchmap

  • Use of the International Consultation on Incontinence Questionnaires Bladder Diary in Men Seeking therapy for Lower Urinary Tract Symptoms. International journal

    Hiroki Ito, Paul Abrams, Amanda L Lewis, Grace J Young, Peter S Blair, Nikki Cotterill, J Athene Lane, Marcus J Drake

    European urology focus   8 ( 1 )   66 - 74   2022.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Completion rates and correspondence to other measures need to be established for the International Consultation on Incontinence Questionnaire (ICIQ) bladder diary (ICIQ-BD) in the assessment of male lower urinary tract symptoms (LUTS). OBJECTIVE: To evaluate ICIQ-BD completion rates, frequency, volume, and sensation reporting for men. DESIGN, SETTING, AND PARTICIPANTS: Baseline data from the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM) randomised controlled trial evaluating 820 men at 26 UK hospitals, looking at the ICIQ-BD, uroflowmetry, International Prostate Symptom Score, and ICIQ symptom score for male LUTS (ICIQ-MLUTS), were assessed. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The ICIQ-BD, IPSS, ICIQ-MLUTS, and uroflowmetry data at baseline obtained from UPSTREAM were assessed. Correlations were analysed by Pearson's correlation coefficient, and comparison between groups were performed using paired or unpaired t tests or Tukey's test. All statistical tests were two sided and the strength of evidence was presented using p values. RESULTS AND LIMITATIONS: Of the participants, 25.0% (205/820) provided complete voiding and bedtime information for 3 d, 41.2% (338/820) omitted bedtime information, and the remainder omitted some or all voiding information. Median values (minimum - maximum) of 24-h, daytime, and night-time frequencies were 9.7 (3.3-24.0), 7.7 (3.3-22.7), and 1.7 (0.0-5.7), respectively. The mean voided volume per micturition for day and night times were 175.8 ± 74.2 and 264.4 ± 150.7 ml (p < 0.001), respectively. For fully completed diaries, day- and night-time frequency showed a weak-to-moderate correlation with symptom score questionnaires. More severe nocturia was generally reported in symptom scores than in the ICIQ-BD. In patients with high bother for increased daytime frequency (symptom), the mean daytime frequency (ICIQ-BD) was 9.6 ± 3.2 versus 7.6 ± 2.2 for low bother (p < 0.001). High bother for nocturia showed night-time frequency of 2.3 ± 1.2 versus 1.5 ± 1.1 for low bother (p < 0.001). For fully and partially completed diaries, ICIQ-BD sensation scores correlated weakly with symptom scores. Voided volumes from the bladder diary and uroflowmetry correlated weakly. CONCLUSIONS: Two-thirds of men (543/820) fully completed voiding information in the ICIQ-BD, but many omitted bedtime information, limiting the ability to quantify nocturia and diagnose nocturnal polyuria. PATIENT SUMMARY: Most men with urinary symptoms complete a bladder diary fully but may fail to indicate bedtimes. Extra information from a diary helps support symptom questionnaires to explain a patient's urinary habits.

    DOI: 10.1016/j.euf.2021.12.009

    PubMed

    researchmap

  • [EFFICACY OF SCHEDULED INTRAVENOUS OR ORAL ACETAMINOPHEN ADMINISTRATION AFTER ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY].

    Shuhei Yokokawa, Tadashi Tabei, Katsuya Yamaguchi, Sohgo Tsutsumi, Masashi Imano, Ken Miyama, Hiroki Ito, Kazuki Kobayashi

    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology   113 ( 3 )   103 - 109   2022

     More details

    Language:Japanese  

    (Purpose) To determine the efficacy of scheduled intravenous or oral acetaminophen administration after robotic-assisted laparoscopic radical prostatectomy (RARP) in our hospital. (Subjects and methods) We retrospectively analyzed 173 patients who underwent RARP at our hospital between April 2019 and December 2020. The patients were divided into three groups (A, B, and C) according to the use of postoperative analgesia. Group A patients were administered acetaminophen only when needed. Group B patients were administered intravenous acetaminophen every 6 h from the day of surgery to postoperative day 2. Group C patients were prescribed oral acetaminophen from 3 to 7 days postoperatively in addition to being administered intravenous acetaminophen (similar to group B). Multivariate analysis was performed to determine whether scheduled intravenous or oral acetaminophen administration reduced unscheduled analgesic use. (Results) There were 110, 33, and 30 patients in groups A, B, and C, respectively. Significant differences in lymph node dissection rates were observed between groups A and B (70.9% vs 36.4%; P=0.001) and groups A and C (70.9% vs 33.3%; P< 0.001); furthermore, significant differences in the frequency of preoperative androgen blockade therapy were observed between groups A and C (20% vs 3.3%; P=0.029). Logistic regression analysis showed that only scheduled intravenous and oral administration of acetaminophen on postoperative days 0 to 2 was an independent factor for postoperative pain (group A vs group B: OR=0.127; 0.046-0.355; P< 0.001 and group A vs group C: OR=0.133; 0.046-0.390; P< 0.001). On postoperative days 3 to 7, there was no significant difference in the unscheduled use of analgesics between groups A and B. Only 1 of the 30 group C patients received unscheduled analgesia. (Conclusions) Scheduled intravenous or oral administration of acetaminophen may reduce unscheduled analgesic use after RARP.

    DOI: 10.5980/jpnjurol.113.103

    PubMed

    J-GLOBAL

    researchmap

  • Calyceal Diverticula Disease: Diagnosis and Management Options in the Era of Non-Contrast CT Scan. International journal

    Faris Abushamma, Hiroki Ito, Omar Aboumarzouk, Anthony Timoney, Neil Collin, Francis X Keeley

    Urologia internationalis   106 ( 7 )   688 - 692   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: Calyceal diverticula (CD) are traditionally diagnosed by contrast studies. However, non-contrast CT is the standard imaging modality for kidney stones. Therefore, we aimed to determine if the lack of contrast imaging affected outcomes of the management of symptomatic CD with stone. MATERIALS AND METHODS: This is a retrospective study of patients diagnosed with CD with intracalyceal stone from 2000 to 2017 analyzing demographics, clinical data, and success of different treatment options. The timing of CD diagnosis is correlated to the success of the first treatment. RESULTS: Forty-eight patients were found. CD was diagnosed prior to intervention in 20 (42%) cases and intraoperatively during flexible ureteroscopy in 17 (35%) and 11 (23%) cases were diagnosed after failed intervention, mainly ESWL. We found that the success rate of treatment was highly affected by the timing and modality of diagnosis. Preoperative diagnosis of CD was associated with 69% success rate of the first intervention. In contrast, there was a 0% success rate of first treatment if CD was not diagnosed with contrast imaging. Furthermore, univariate analysis showed no significant association between sociodemographics and clinical variables and success treatment (p > 0.05). CONCLUSIONS: The delay in diagnosing CD with stone contributes significantly to the success rate and the number of treatments.

    DOI: 10.1159/000518051

    PubMed

    researchmap

  • [Mucinous Adenocarcinoma of the Prostate Diagnosed after Transurethral Treatment of a Prostatic Abscess].

    Shuhei Yokokawa, Hiroki Ito, Risa Shinoki, Yukio Tsuura, Kazuki Kobayashi

    Hinyokika kiyo. Acta urologica Japonica   67 ( 9 )   427 - 431   2021.9

     More details

    Language:Japanese  

    A 70-year-old man visited his doctor because of hip pain and gross hematuria. Digital rectal examination and computed tomography revealed a prostatic abscess. Although antibiotics were prescribed, his symptoms did not improve; he was transferred to our hospital, where transurethral fenestration of the prostatic abscess was performed. During prostatic fenestration, a papillary mucous membrane was confirmed inside the cavity of the prostatic abscess. Pathological examination revealed a mucinous adenocarcinoma of the prostate. Although hormonal therapy was administered, magnetic resonance imaging revealed tumor extension necessitating robot-assisted radical prostatectomy. Mucinous adenocarcinoma of the prostate is rare, and to our knowledge this is the first report of mucinous adenocarcinoma of the prostate diagnosed after transurethral treatment of a prostatic abscess.

    DOI: 10.14989/ActaUrolJap_67_9_427

    PubMed

    J-GLOBAL

    researchmap

  • Impact of depression on overactive bladder. International journal

    Takashi Kawahara, Sahoko Ninomiya, Sohgo Tsutsumi, Hiroki Ito, Masahiro Yao, Hiroji Uemura

    International journal of urology : official journal of the Japanese Urological Association   28 ( 2 )   245 - 246   2021.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/iju.14434

    PubMed

    researchmap

  • A Case of Renal Pelvic Cancer with a Complete Duplication of the Renal Pelvis and Ureter. International journal

    Takuma Nirei, Tadashi Tabei, Hiroki Ito, Kazuki Kobayashi

    Case reports in oncology   14 ( 1 )   202 - 206   2021

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    This paper describes a case of renal pelvic cancer with a complete duplication of the renal pelvis and ureter, which is substantially rare. A 76-year-old man was referred to the hospital because of gross hematuria for 2 years. A tumor was detected in the upper right kidney using enhanced computed tomography and magnetic resonance imaging scan, and the downstream ureter was suspected to open into the prostate. Retrograde ureteroscopy via the ectopic ureter orifice showed a hemorrhagic papillary tumor consistent with imaging findings. Laparoscopic radical nephroureterectomy was performed and the prostate was preserved because the tumor was only in the renal pelvis. Histopathological examination showed the tumor as a high-grade urothelial carcinoma. There was no sign of recurrence at one and a half years after operation. Ureteroscopy was effective in detecting an upper urinary tract tumor, even via ectopic ureter orifice, and preserving the prostate was possible.

    DOI: 10.1159/000513625

    PubMed

    researchmap

  • Short-term efficacy and safety of second generation bipolar transurethral vaporization of the prostate (B-TUVP) for large benign prostate enlargement: Results from a retrospective feasibility study. International journal

    Takeshi Fukazawa, Hiroki Ito, Masato Takanashi, Risa Shinoki, Tadashi Tabei, Takashi Kawahara, Francis X Keeley Jr, Marcus J Drake, Kazuki Kobayashi

    PloS one   16 ( 12 )   e0261586   2021

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: To investigate the efficacy and safety of a second-generation bipolar transurethral electro vaporization of the prostate (B-TUVP) with the new oval-shaped electrode for large benign prostatic enlargement (BPE) with prostate volume (PV) ≥100ml. MATERIALS AND METHODS: 100 patients who underwent second-generation B-TUVP with the oval-shaped electrode for male lower urinary tract symptom (LUTS) or urinary retention between July 2018 and July 2020 were enrolled in this study. The patients' characteristics and treatment outcome were retrospectively compared between patients with PV <100ml and ≥100ml. RESULTS: 17/41 (41.5%) cases of PV ≥100ml and 24/59 cases (40.7%) of PV <100ml were catheterised due to urinary retention. The duration of post-operative catheter placement and hospital-stay of PV ≥100ml (3.1±1.3 and 5.6±2.3 days) were not different from PV <100ml (2.7±1.2 and 5.0±2.4 days). In uncatheterised patients (N = 59), post-void residual urine volume (PVR) significantly decreased after surgery in both groups, however, maximum uroflow rate (Qmax) significantly increased after surgery only in PV <100ml but not in PV ≥100ml. Voiding symptoms and patients' QoL derived from International Prostate Symptom Score (IPSS), IPSS-QoL (IPSS Quality of Life Index) and BPH Impact Index (BII) scores, significantly improved after B-TUVP in both groups. Catheter free status after final B-TUVP among patients with preoperative urinary retention was achieved in 18/24 (75.0%) and 14/17 (82.1%) cases in patient with <100ml and ≥100ml, respectively. There was no significant difference in post-operative Hb after B-TUVP, which was 97.0±5.4% of baseline for PV <100ml and 96.9±6.1% for PV ≥100ml and no TUR syndrome was observed. CONCLUSIONS: This is the first study investigating short-term efficacy and safety of second-generation B-TUVP with the oval-shaped electrode on large BPE. B-TUVP appears to be effective and safe for treating moderate-to-severe lower urinary tract symptoms and urinary retention in patients with large BPE.

    DOI: 10.1371/journal.pone.0261586

    PubMed

    researchmap

  • Impact of smoking habit on overactive bladder symptoms and incontinence in women. International journal

    Takashi Kawahara, Hiroki Ito, Masahiro Yao, Hiroji Uemura

    International journal of urology : official journal of the Japanese Urological Association   27 ( 12 )   1078 - 1086   2020.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To examine the correlation between smoking habit and lower urinary tract symptoms in women. METHODS: We first screened 10 000 female patients to examine their smoking habit. A total of 7004 samples were successfully collected for further analysis through a urinary continence survey. The ratio of current smoking to non-smoking participants was set as 1:3 to allow thorough assessment of the impact of cigarette smoking on lower urinary tract symptoms. RESULTS: A total of 4756 complete responses were obtained for the Overactive Bladder Symptom Score and International Consultation on Incontinence Questionnaire-Short Form questionnaire. The current smokers (2.54 ± 2.91, 2.48 ± 4.01) and ex-smokers (2.27 ± 2.50, 2.25 ± 3.50) showed significantly higher Overactive Bladder Symptom Score and International Consultation on Incontinence Questionnaire-Short Form scores than the non-smokers (1.70 ± 2.05, 1.49 ± 2.73) (P < 0.0001, P < 0.0001 and P < 0.0001, P < 0.0001, respectively). The prevalence of urgency was affected by the smoking status. Younger participants (aged 20-39 years) showed a stronger influence of their smoking habit than older participants (aged ≥40 years). Urgency urinary incontinence was also affected by the smoking status. CONCLUSIONS: The prevalence of urgency and urgency urinary incontinence is correlated with age and smoking habit, and both current and ex-smokers show an increased prevalence of urgency and urgency urinary incontinence compared with non-smokers, especially younger women.

    DOI: 10.1111/iju.14357

    PubMed

    researchmap

  • The impact of smoking on male lower urinary tract symptoms (LUTS). International journal

    Takashi Kawahara, Hiroki Ito, Hiroji Uemura

    Scientific reports   10 ( 1 )   20212 - 20212   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Lower urinary tract symptoms (LUTS) are substantially prevalent and increase with age. Research on smoking as a risk factor for LUTS has been inconclusive. The present study examined the association between smoking habits and male LUTS in a population-based study using a web-based questionnaire. We firstly screened a total of 10,000 male participants who were selected according to the age distribution in the Japanese population in government data, in order to check smoking habits. We then performed a web-based survey to further investigate factors associated with LUTS, using the Overactive Bladder Symptom Score (OABSS), International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), and International Prostate Symptom Score (IPSS) questionnaire. Finally, 9042 participants (non-smokers, n = 3545; ex-smokers, n = 3060; and current-smokers, n = 2437) completed the full continence survey. Current-smokers (2.54 ± 2.73, 1.98 ± 3.57, 5.75 ± 7.02) and ex-smokers (2.80 ± 2.52, 1.81 ± 3.10, 6.58 ± 6.96) showed significantly higher OABSS total, ICIQ-SF total, and IPSS total scores than non-smokers (1.98 ± 2.40, 1.35 ± 2.90, 4.23 + -/6.33) (p: < 0.0001, < 0.0001, < 0.0001, respectively). In comparison to non-smokers, the prevalence of risk ratio for day-time frequency, nocturia, urgency urinary incontinence (UUI), OAB, and IPSS ≥ 8 were 1.2 1.2 1.4 1.5 1.5, respectively, in current-smokers and 1.3, 1.5, 1.5, 4.5, 1.8 in ex-smokers. The relative risk of OAB, nocturia, UUI, and IPSS ≥ 8 in ex- and current-smokers in comparison to non-smokers was high in the young age groups in comparison to the elderly groups. Current-smokers and ex-smokers showed a higher prevalence of male LUTS. This phenomenon was highly observed in relatively young age groups.

    DOI: 10.1038/s41598-020-77223-7

    PubMed

    researchmap

  • Grading Severity and Bother Using the International Prostate Symptom Score and International Consultation on Incontinence Questionnaire Male Lower Urinary Tract Symptoms Score in Men Seeking Lower Urinary Tract Symptoms Therapy. International journal

    Hiroki Ito, Grace J Young, Amanda L Lewis, Peter S Blair, Nikki Cotterill, J Athene Lane, Kentaro Sakamaki, Marcus J Drake, Paul Abrams

    The Journal of urology   204 ( 5 )   1003 - 1011   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: We established severity banding ranges, bother assessment and key item content in principal patient reported outcomes measures in men seeking therapy for lower urinary tract symptoms. MATERIALS AND METHODS: Data for International Prostate Symptom Score (I-PSS) and International Consultation on Incontinence Questionnaire Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) were derived from a study evaluating 820 men at 26 United Kingdom hospitals. ROC curves were used to establish severity bandings. RESULTS: Classification tree showed that thresholds between mild-moderate and moderate-severe severity bands were 15 and 27 for I-PSS, 16 and 26 for ICIQ-MLUTS/severity, and 22 and 81 for ICIQ-MLUTS/bother, respectively. Highest area under the ROC curve and lowest Akaike's information criteria of univariate logistic regression indicated that ICIQ-MLUTS/bother was more related to global quality of life than were I-PSS and ICIQ-MLUTS/severity. The symptoms affecting I-PSS-quality of life (QoL) were only fully identified by ICIQ-MLUTS, because 2 key symptoms (urinary incontinence and post-micturition dribble) are not measured by I-PSS. ICIQ-MLUTS demonstrated that bother of some lower urinary tract symptoms is disproportionate to severity, and that persisting high bother levels following surgery are more likely due to storage (18% to 25%) and post-voiding (18% to 28%) lower urinary tract symptoms than voiding lower urinary tract symptoms (5% to 13%). Symptom improvement after surgery was uncertain if baseline I-PSS-QoL score was less than 3. CONCLUSIONS: The severity threshold scores were measured for the 2 key lower urinary tract symptoms patient reported outcomes measures, and the results indicate suitable categories of symptom severity for use in men referred for urological care. The ICIQ-MLUTS measures all the lower urinary tract symptoms affecting quality of life and includes individual symptom bother scores.

    DOI: 10.1097/JU.0000000000001149

    PubMed

    researchmap

  • Reply by Authors. International journal

    Hiroki Ito, Grace J Young, Amanda L Lewis, Peter S Blair, Nikki Cotterill, J Athene Lane, Kentaro Sakamaki, Marcus J Drake, Paul Abrams

    The Journal of urology   204 ( 5 )   1011 - 1011   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/JU.0000000000001149.02

    PubMed

    researchmap

  • Does screening for prostate cancer improve cancer-specific mortality in Asian men? Real-world data in Yokosuka City 15 years after introducing PSA-based population screening. International journal

    Tadashi Tabei, Masataka Taguri, Naoki Sakai, Hideshige Koh, Minoru Yosida, Atsushi Fujikawa, Takuma Nirei, Sohgo Tsutsumi, Hiroki Ito, Souichi Furuhata, Takashi Kawahara, Yasuhide Miyoshi, Sumio Noguchi, Hiroji Uemura, Kazuki Kobayashi

    The Prostate   80 ( 11 )   824 - 830   2020.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Studies of prostate-specific antigen (PSA)-based population screening have been conducted in western countries, but there is little data in Asian populations. The objective of this study was to determine the efficacy of PSA screening in Asian men using real-world data over a period of 15 years after introducing population screening in Yokosuka City, Japan. METHODS: We investigated patients with pathologically diagnosed prostate cancer at four hospitals and two clinics across the Yokosuka area (Miura peninsula) between April 2001 and March 2015. Patients were divided into two groups; the S group consisted of those diagnosed by PSA-based population screening in Yokosuka City and the NS group consisted of those diagnosed by methods other than screening. Cancer-specific survival (CSS) and overall survival (OS) rates were calculated using the Kaplan-Meier method with the log-rank test to compare survival between the two groups. Clinical and pathological factors for cancer-specific mortality were assessed with Cox regression analyses to calculate the hazard ratio (HR) and 95% confidence interval (CI). RESULTS: A total of 3094 patients had been diagnosed with prostate cancer over the 15-year period. The median follow-up period was 77 months. The S group and the NS group consisted of 977 and 2117 patients, respectively. Patients in the S group were younger (age: 71 years vs 73 years, P < .001) and had a lower Charlson comorbidity index (CCI) with favorable oncological factors, such as lower initial PSA, Gleason score (GS), and risk category. Kaplan-Meier curves for OS and CSS revealed significant differences between the two groups (OS: P < .001, CSS: P < .001). Analysis with Cox proportional hazards model indicated the NS group (HR: 1.584, 95% CI, 1.065-2.356, P = .023), a CCI > 4 (HR: 1.552, 95% CI, 1.136-2.120, P = .006), a GS ≥ 8 (HR: 4.869, 95% CI, 2.631-9.001, P < .001), and nonlocalized cancer (locally advanced; HR: 2.632, 95% CI, 1.676-4.133, P < .001, advanced; HR: 9.468, 95% CI, 6.279-14.278, P < .001) as independent risk factors for cancer-specific mortality. CONCLUSIONS: PSA-based population screening of prostate cancer might be useful in the Japanese population.

    DOI: 10.1002/pros.23997

    PubMed

    researchmap

  • Probabilistic, spinally-gated control of bladder pressure and autonomous micturition by Barrington's nucleus CRH neurons. International journal

    Hiroki Ito, Anna C Sales, Christopher H Fry, Anthony J Kanai, Marcus J Drake, Anthony E Pickering

    eLife   9   2020.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Micturition requires precise control of bladder and urethral sphincter via parasympathetic, sympathetic and somatic motoneurons. This involves a spino-bulbospinal control circuit incorporating Barrington's nucleus in the pons (Barr). Ponto-spinal glutamatergic neurons that express corticotrophin-releasing hormone (CRH) form one of the largest Barr cell populations. BarrCRH neurons can generate bladder contractions, but it is unknown whether they act as a simple switch or provide a high-fidelity pre-parasympathetic motor drive and whether their activation can actually trigger voids. Combined opto- and chemo-genetic manipulations along with multisite extracellular recordings in urethane anaesthetised CRHCre mice show that BarrCRH neurons provide a probabilistic drive that generates co-ordinated voids or non-voiding contractions depending on the phase of the micturition cycle. CRH itself provides negative feedback regulation of this process. These findings inform a new inferential model of autonomous micturition and emphasise the importance of the state of the spinal gating circuit in the generation of voiding.

    DOI: 10.7554/eLife.56605

    PubMed

    researchmap

  • [A CASE OF DISSEMINATED INTRAVASCULAR COAGULATION CAUSED BY ADVANCED PROSTATE CANCER].

    Takeshi Fukazawa, Tadashi Tabei, Takuma Nirei, Risa Shinoki, Sogo Tsutsumi, Masashi Imano, Hiroki Ito, Kazuki Kobayashi

    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology   111 ( 3 )   94 - 97   2020

     More details

    Language:Japanese  

    The 79 years old man was referred to our department due to high value of serum prostate specific antigen (39.54 ng/ml). The magnetic resonance imaging demonstrated diffuse low signal at his prostate. Bone scintigraphy revealed multiple metastatic lesion. Needle biopsy was performed for definite diagnosis. Systemic purpura showed after prostate needle biopsy although he had noticed local purpura at his back before the examination. He was diagnosed as disseminated intravascular coagulation (DIC) syndrome due to advanced prostate cancer. Treatment with anti-DIC therapy, blood transfusion, subcutaneous injection of degarelix acetate settled the DIC. Abiraterone hydrochloride and prednisolone was added as we confirmed Gleason score5+4 in the pathological examination. He has been alive for 15 months after diagnosis without desease progression.

    DOI: 10.5980/jpnjurol.111.94

    PubMed

    J-GLOBAL

    researchmap

  • [A CASE OF PELVIC CONGESTION SYNDROME SUCCESSFULLY TREATED WITH ENDOVASCULAR THERAPY].

    Takeshi Fukazawa, Tadashi Tabei, Takuma Nirei, Risa Shinoki, Sogo Tsutsumi, Masashi Imano, Hiroki Ito, Kazuki Kobayashi, Jun Yoshigi

    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology   111 ( 4 )   150 - 153   2020

     More details

    Language:Japanese  

    An 84-year-old woman was referred for lower abdominal pain lasting more than six months. Computed tomography showed a left ovarian varicose vein and a peri-uterine venous plexus. Due to suspected pelvic congestion syndrome, left ovarian venography and left ovarian embolization were performed. Blood flowed back through the dilated left ovarian vein and through the uterine venous plexus to the right ovarian vein. Embolization of the left ovarian vein with a sclerosing agent resulted in the disappearance of the venous congestion. Preoperative Visual Analogue Scale was 7, which decreased to 3 after the operation. As a result, improvements in QOL were recognized. Although pelvic congestion syndrome is a treatable disease, its recognition as a urological disease is low. Here, we have reported a case of pelvic congestion syndrome in which symptoms improved with treatment and have discussed its pathophysiology and treatment.

    DOI: 10.5980/jpnjurol.111.150

    PubMed

    J-GLOBAL

    researchmap

  • A case of allograft ureteral stone successfully treated with antegrade ureteroscopic lithotripsy: use of a 3D-printed model to determine the ideal approach. International journal

    Shinnosuke Kuroda, Takashi Kawahara, Junichi Teranishi, Taku Mochizuki, Hiroki Ito, Hiroji Uemura

    Urolithiasis   47 ( 5 )   467 - 471   2019.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We present the case of a 46-year-old man who underwent successful antegrade ureteroscopy for lithiasis in his allograft ureter. At a scheduled follow-up 15 years after transplantation, computed tomography (CT) detected a 12-mm renal stone in the renal pelvis of the transplanted kidney. During his follow-up, gross hematuria was seen; the stone moved to the ureter, causing hydronephrosis. Ultrasound and non-contrast CT revealed hydronephrosis and a 15-mm stone in the transplanted ureter. Considering the stone size, location, and the difficulty of the access to the anastomosed ureteral orifice, percutaneous ureteroscopic approach was planned. Due to the anatomical difficulty regarding his allograft kidney, we planned to prepare a 3D image and model for selecting the best percutaneous approach. The procedure was performed and a stone-free status was acquired without complication. Under precise simulation, we performed successful antegrade ureteroscopy for lithiasis in the allograft ureter supported by 3D imaging. Use of a 3D printed model may aid in a safe and effective procedure for lithiasis in the allograft kidney and ureter.

    DOI: 10.1007/s00240-019-01153-x

    PubMed

    researchmap

  • Influence of sildenafil on the purinergic components of nerve-mediated and urothelial ATP release from the bladder of normal and spinal cord injured mice. International journal

    Basu Chakrabarty, Hiroki Ito, Manuela Ximenes, Nobuyuki Nishikawa, Bahareh Vahabi, Anthony J Kanai, Anthony E Pickering, Marcus J Drake, Christopher H Fry

    British journal of pharmacology   176 ( 13 )   2227 - 2237   2019.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND AND PURPOSE: PDE inhibitors such as sildenafil alleviate lower urinary tract symptoms; however, a complete understanding of their action on the bladder remains unclear. We are investigating the effects of sildenafil, on post and preganglionic nerve-mediated contractions of the mouse bladder, and neuronal and urothelial ATP release. EXPERIMENTAL APPROACH: Bladders were used from young (12 weeks), aged (24 months), and spinal cord transected (SCT), mice, for in vitro contractility experiments. An arterially perfused in situ whole mouse model was used to record bladder pressure. Nerve-mediated contractions were generated by electrical field stimulation (EFS) of postganglionic nerve terminals or the pelvic nerve. ATP release during EFS in intact detrusor strips, and during stretch of isolated mucosa strips, was measured using a luciferin-luciferase assay. KEY RESULTS: Sildenafil (20 μM) inhibited nerve-mediated contractions in young mice, with an increase in f1/2 values in force-frequency relationships, demonstrating a greater effect at low frequencies. Sildenafil reduced the atropine-resistant, purinergic component of nerve-mediated contractions, and suppressed neuronal ATP release upon EFS in vitro. Sildenafil reduced the preganglionic pelvic nerve stimulated bladder pressure recordings in situ; comparable to in vitro experiments. Sildenafil reduced stretch-induced urothelial ATP release. Sildenafil also relaxed nerve-mediated contractions in aged and SCT mice. CONCLUSION AND IMPLICATIONS: Sildenafil has a greater effect on the low-frequency, purinergic-mediated contractions and suppresses neuronal ATP release. In addition, sildenafil reduces stretch-induced urothelial ATP release. These results demonstrate a novel action of sildenafil to selectively inhibit ATP release from nerve terminals innervating detrusor smooth muscle and the urothelium.

    DOI: 10.1111/bph.14669

    PubMed

    researchmap

  • Sildenafil, a phosphodiesterase type 5 inhibitor, augments sphincter bursting and bladder afferent activity to enhance storage function and voiding efficiency in mice. International journal

    Hiroki Ito, Basu Chakrabarty, Marcus J Drake, Christopher H Fry, Anthony J Kanai, Anthony E Pickering

    BJU international   124 ( 1 )   163 - 173   2019.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: To investigate the influence of low-dose sildenafil, a phosphodiesterase type 5 inhibitor (PDE5-I), on the function of the mouse lower urinary tract (LUT). MATERIALS AND METHODS: Adult male mice were decerebrated and arterially perfused with a carbogenated Ringer's solution to establish the decerebrate arterially perfused mouse (DAPM). To allow distinction between central neural and peripheral actions of sildenafil, experiments were conducted in both the DAPM and in a 'pithed' DAPM, which has no functional brainstem or spinal cord. The action of systemic and intrathecal sildenafil on micturition was assessed in urethane-anaesthetised mice. RESULTS: In the DAPM, systemic perfusion of sildenafil (30 pm) decreased the voiding threshold pressure [to a mean (sem) 84.7 (3.8)% of control] and increased bladder compliance [to a mean (sem) 140.2 (8.3)% of control, an effect replicated in the pithed DAPM]. Sildenafil was without effect on most voiding variables but significantly increased the number of bursts of the external urethral sphincter (EUS) per void in DAPM [to a mean (sem) 130.1 (6.9)% of control at 30 pm] and in urethane-anaesthetised mice [to a mean (sem) 117.5 (5.8)% of control at 14 ng/kg]. Sildenafil (10 and 30 pm) increased pelvic afferent activity during both bladder filling and the isovolumetric phase [to a mean (sem) 205.4 (30.2)% of control at 30 pm]. Intrathecal application of sildenafil (5 μL of either 150 pm or 1.5 nm) did not alter cystometry and EUS-electromyography variables in urethane-anaesthetised mice. CONCLUSIONS: Low-dose sildenafil increases bladder compliance, increases pelvic nerve afferent activity, and augments the bursting activity of the EUS. We propose that the novel actions on afferent traffic and sphincter control may contribute to its beneficial actions to restore storage and voiding efficiency in LUT dysfunction.

    DOI: 10.1111/bju.14664

    PubMed

    researchmap

  • Clinical and Patient-reported Outcome Measures in Men Referred for Consideration of Surgery to Treat Lower Urinary Tract Symptoms: Baseline Results and Diagnostic Findings of the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM). International journal

    Amanda L Lewis, Grace J Young, Paul Abrams, Peter S Blair, Christopher Chapple, Cathryn M A Glazener, Jeremy Horwood, John S McGrath, Sian Noble, Gordon T Taylor, Hiroki Ito, Mohammed Belal, Melissa C Davies, Andrew J Dickinson, Charlotte L Foley, Steve Foley, Simon Fulford, Mohsen M Gammal, Mary Garthwaite, Mark R E Harris, Petre C Ilie, Robert Jones, Samer Sabbagh, Robert G Mason, Ester McLarty, Vibhash Mishra, Jaswant Mom, Roland Morley, Salvatore Natale, Tharani Nitkunan, Tobias Page, David Payne, Tina G Rashid, Kasra Saeb-Parsy, Sarb S Sandhu, Adrian Simoes, Gurpreet Singh, Mark Sullivan, Heidi V Tempest, Srinivasa Viswanath, Roger M H Walker, J Athene Lane, Marcus J Drake

    European urology focus   5 ( 3 )   340 - 350   2019.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Clinical evaluation of male lower urinary tract symptoms (MLUTS) in secondary care uses a range of assessments. It is unknown how MLUTS evaluation influences outcome of therapy recommendations and choice, notably urodynamics (UDS; filling cystometry and pressure flow studies). OBJECTIVE: To report participants' sociodemographic and clinical characteristics, and initial diagnostic findings of the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM). UPSTREAM is a randomised controlled trial evaluating whether symptoms are noninferior and surgery rates are lower if UDS is included. DESIGN, SETTING, AND PARTICIPANTS: A total of 820 men (≥18 yr of age) seeking treatment for bothersome LUTS were recruited from 26 National Health Service hospital urology departments. INTERVENTION: Care pathway based on routine, noninvasive tests (control) or routine care plus UDS (intervention arm). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome is International Prostate Symptom Score (IPSS) and the key secondary outcome is surgery rates 18 mo after randomisation. International Consultation on Incontinence Questionnaires were captured for MLUTS, sexual function, and UDS satisfaction. Baseline clinical and patient-reported outcome measures (PROMs), and UDS findings were informally compared between arms. Trends across age groups for urinary and sexual PROMs were evaluated with a Cuzick's test, and questionnaire items were compared using Pearson's correlation coefficient. RESULTS AND LIMITATIONS: Storage LUTS, notably nocturia, and impaired sexual function are prominent in men being assessed for surgery. Sociodemographic and clinical evaluations were similar between arms. Overall mean IPSS and quality of life scores were 18.94 and 4.13, respectively. Trends were found across age groups, with older men suffering from higher rates of incontinence, nocturia, and erectile dysfunction, and younger men suffering from increased daytime frequency and voiding symptoms. Men undergoing UDS testing expressed high satisfaction with the procedure. CONCLUSIONS: Men being considered for surgery have additional clinical features that may affect treatment decision making and outcomes, notably storage LUTS and impaired sexual function. PATIENT SUMMARY: We describe initial assessment findings from a large clinical study of the treatment pathway for men suffering with bothersome urinary symptoms who were referred to hospital for further treatment, potentially including surgery. We report the patient characteristics and diagnostic test results, including symptom questionnaires, bladder diaries, flow rate tests, and urodynamics.

    DOI: 10.1016/j.euf.2019.04.006

    PubMed

    researchmap

  • PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer. International journal

    Takashi Kawahara, Yukari Ishiguro, Shinji Ohtake, Ikuma Kato, Yusuke Ito, Hiroki Ito, Kazuhide Makiyama, Keiichi Kondo, Yasuhide Miyoshi, Yasushi Yumura, Narihiko Hayashi, Hisashi Hasumi, Kimito Osaka, Kentaro Muraoka, Koji Izumi, Jun-Ichi Teranishi, Hiroji Uemura, Masahiro Yao, Noboru Nakaigawa

    BMC urology   18 ( 1 )   97 - 97   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Bladder cancers have been characterized as a tumor group in which the immunological response is relatively well preserved. Programmed death ligand 1 (PD-L1, B7-H1, CD274) has been shown to be expressed in several malignancies, including bladder cancer. However, the clinicopathological impact of this biomarker has not yet been established. In the present study, a quantitative real-time polymerase chain reaction (qPCR) was performed using paired normal and cancerous bladder cancer tissue to investigate PD-1/PD-L1 gene expression. METHODS: We examined the mRNA expression of PD-1/PD-L1 by a qPCR using 58 pairs of normal and cancerous human bladder tissue specimens. We also examined the correlation with the expressions of the STAT1 and NFAT genes, which are thought to be upstream and downstream of the PD-L1 pathway, respectively. RESULTS: There were no significant differences between normal and cancerous tissue in the expression of the PD-1 and PD-L1 genes (p = 0.724 and p = 0.102, respectively). However, PD-1 and PD-L1 were both more highly expressed in high-grade bladder cancer than in low-grade bladder cancer (p < 0.050 and p < 0.010). PD-L1 was positively correlated with the expressions of both the STAT1 (r = 0.681, p < 0.001) and the NFATc1 genes (r = 0.444. p < 0.001). CONCLUSIONS: PD-1 and PD-L1 might be a new biomarker that correlates with the pathological grade of bladder cancer. PD-L1 might function as a mediator of stage progression in bladder cancer and STAT1-NFAT pathway might associate this function.

    DOI: 10.1186/s12894-018-0414-8

    PubMed

    researchmap

  • Systematic Review of Caliceal Diverticulum. International journal

    Hiroki Ito, Omar M Aboumarzouk, Faris Abushamma, Francis X Keeley Jr

    Journal of endourology   32 ( 10 )   961 - 972   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: We performed a systematic review of the literature regarding the diagnosis and treatment of caliceal diverticulum (CD). METHODS: The search strategy was conducted according to the Cochrane review guidelines for systematic reviews and Preferred Reporting Items for Systematic reviews and Meta-Analyses checklist. RESULTS: In total 1189 titles and abstracts were reviewed, of which 101 were selected for article evaluation. Of these 101 articles, 40 were selected for inclusion after full article evaluations. In the extracted article, intravenous urography (IVU), rather than CT urography, was the main imaging tool for diagnosis, although many articles had failed to provide any imaging modality information. The extracted articles included 88, 153, and 487 patients who underwent shock wave lithotripsy (SWL), flexible ureteroscopy/retrograde intrarenal surgery (fURS/RIRS), and percutaneous nephrolithotomy (PCNL), respectively. Stone-free rates were 21.3% (SWL), 61.4% (fURS/RIRS), and 83.0% (PCNL). The complication rates were 8.0% (SWL), 3.3% (fURS/RIRS), and 11.9% (PCNL). There was incomplete and inconsistent reporting of even basic clinical parameters, such as the size and location of the CD, number of stones, outcomes, and complications. There was a striking lack of follow-up data, despite a known high recurrence rate. The literature on laparoscopic management was too sparse to analyze. CONCLUSIONS: This meta-analysis revealed that there are not enough high-quality studies to evaluate the ideal strategy for the diagnosis and treatment of CDs. This systematic review emphasizes (a) the importance of contrast imaging for CD diagnosis, (b) higher success rates but also higher complication rates in PCNL compared with SWL and FURS, and (c) the need for standardized reporting of outcomes to include complications, number of interventions, symptom resolution, stone clearance, and CD ablation.

    DOI: 10.1089/end.2018.0332

    PubMed

    researchmap

  • Characterization of mouse neuro-urological dynamics in a novel decerebrate arterially perfused mouse (DAPM) preparation. International journal

    Hiroki Ito, Marcus J Drake, Christopher H Fry, Anthony J Kanai, Anthony E Pickering

    Neurourology and urodynamics   37 ( 4 )   1302 - 1312   2018.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    AIM: To develop the decerebrate arterially perfused mouse (DAPM) preparation, a novel voiding model of the lower urinary tract (LUT) that enables in vitro-like access with in vivo-like neural connectivity. METHODS: Adult male mice were decerebrated and arterially perfused with a carbogenated, Ringer's solution to establish the DAPM. To allow distinction between central and peripheral actions of interventions, experiments were conducted in both the DAPM and in a "pithed" DAPM which has no brainstem or spinal cord control. RESULTS: Functional micturition cycles were observed in response to bladder filling. During each void, the bladder showed strong contractions and the external urethral sphincter (EUS) showed bursting activity. Both the frequency and amplitude of non-voiding contractions (NVCs) in DAPM and putative micromotions (pMM) in pithed DAPM increased with bladder filling. Vasopressin (>400 pM) caused dyssynergy of the LUT resulting in retention in DAPM as it increased tonic EUS activity and basal bladder pressure in a dose-dependent manner (basal pressure increase also noted in pithed DAPM). Both neuromuscular blockade (vecuronium) and autonomic ganglion blockade (hexamethonium), initially caused incomplete voiding, and both drugs eventually stopped voiding in DAPM. Intravesical acetic acid (0.2%) decreased the micturition interval. Recordings from the pelvic nerve in the pithed DAPM showed bladder distention-induced activity in the non-noxious range which was associated with pMM. CONCLUSIONS: This study demonstrates the utility of the DAPM which allows a detailed characterization of LUT function in mice.

    DOI: 10.1002/nau.23471

    PubMed

    researchmap

  • Age-related changes in function and gene expression of the male and female mouse bladder. International journal

    Jun Kamei, Hiroki Ito, Naoki Aizawa, Harumi Hotta, Toshio Kojima, Yasunori Fujita, Masafumi Ito, Yukio Homma, Yasuhiko Igawa

    Scientific reports   8 ( 1 )   2089 - 2089   2018.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We investigated age-related changes in in vivo and in vitro functions and gene expression of the bladder of male and female mice. Mature and aged (12 and 27-30 month old) C57BL/6 mice of both sexes were used. Frequency volume, conscious free-moving cystometry and detrusor contractile and relaxant properties in in vitro organ bath were evaluated. mRNA expression level of muscarinic, purinergic, and β-adrenergic receptors and gene expression changes by cDNA microarray analysis of the bladder were determined. Cystometry demonstrated storage and voiding dysfunctions with ageing in both sexes. Detrusor strips from aged mice showed weaker contractile responses particularly in the cholinergic component and weaker relaxant responses to isoproterenol. These age-related impairments were generally severer in males. mRNA expression of bladder tissue was decreased for M3 muscarinic receptors in aged males and β2-adrenoceptors in aged females. cDNA microarray analysis results, albeit substantial sex difference, indicated "cell-to-cell signaling and interaction" as the most common feature of age-related gene expression. In summary, aged mice demonstrated voiding and storage dysfunctions resembling to detrusor hyperactivity with impaired contractility (DHIC), which were more pronounced in males. Genomic changes associated with aging may contribute to the age-related bladder functional deterioration in mice.

    DOI: 10.1038/s41598-018-20406-0

    PubMed

    researchmap

  • Comparison of Outcomes between Two Methods to Extract Stone Fragments during Flexible Ureteroscopic Lithotripsy. International journal

    Tadashi Tabei, Hiroki Ito, Kazuki Kobayashi, Takashi Kawahara, Junichi Matsuzaki

    BioMed research international   2018   4526721 - 4526721   2018

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: To retrospectively compare the operative and clinical outcomes of flexible ureteroscopic lithotripsy (fURSL) with stone extraction performed either by a surgeon (SE) who manipulates the retrieval basket or by having the surgical assistant (AE) manipulate the retrieval basket with the aim of clarifying which method provides a greater stone-free postoperative status. METHODS: The study group consisted of patients who underwent fURSL with SE or AE at our institution between April 2015 and December 2016. Demographic, clinical, stone, and operative variables were compared between the two groups. Multivariate logistic regression was used to identify risk factors associated with a stone-free and non-stone-free status postoperatively. RESULTS: Our analysis included 196 cases of renal stones treated using fURSL, with 109 who underwent AE and 87 who underwent SE. The rate of stone-free status was higher for the SE group (90.8%) than for the AE group (61.5%; P < 0.001). The method of extraction was identified as an independent predictor of stone-free status (P < 0.001, odds ratio (SE compared to AE), 9.133, 95% confidence interval, 3.736-22.322). CONCLUSION: The stone-free rate is improved by having the surgeon perform the stone extraction as part of the fURSL procedure.

    DOI: 10.1155/2018/4526721

    PubMed

    researchmap

  • A new prediction model for operative time of flexible ureteroscopy with lithotripsy for the treatment of renal stones. International journal

    Shinnosuke Kuroda, Hiroki Ito, Kentaro Sakamaki, Tadashi Tabei, Takashi Kawahara, Atsushi Fujikawa, Kazuhide Makiyama, Masahiro Yao, Hiroji Uemura, Junichi Matsuzaki

    PloS one   13 ( 2 )   e0192597   2018

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    This study aimed to develop a prediction model for the operative time of flexible ureteroscopy (fURS) for renal stones. We retrospectively evaluated patients with renal stones who had been treated successfully and had stone-free status determined by non-contrast computed tomography (NCCT) 3 months after fURS and holmium laser lithotripsy between December 2009 and September 2014 at a single institute. Correlations between possible factors and the operative time were analyzed using Spearman's correlation coefficients and a multivariate linear regression model. The P value < 0.1 was used for entry of variables into the model and for keeping the variables in the model. Internal validation was performed using 10,000 bootstrap resamples. Flexible URS was performed in 472 patients, and 316 patients were considered to have stone-free status and were enrolled in this study. Spearman's correlation coefficients showed a significant positive relationship between the operation time and stone volume (ρ = 0.417, p < 0.001), and between the operation time and maximum Hounsfield units (ρ = 0.323, p < 0.001). A multivariate assessment with forced entry and stepwise selection revealed six factors to predict the operative time of fURS: preoperative stenting, stone volume, maximum Hounsfield unit, surgeon experience, sex, and sheath diameter. Based on this finding, we developed a model to predict operative time of fURS. The coefficient of determination (R2) in this model was 0.319; the mean R2 value for the prediction model was 0.320 ± 0.049. To our knowledge, this is the first report of a model for predicting the operative time of fURS treatment of renal stones. The model may be used to reliably predict operative time preoperatively based on patient characteristics and the surgeons' experience, plan staged URS, and avoid surgical complications.

    DOI: 10.1371/journal.pone.0192597

    PubMed

    researchmap

  • A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy. International journal

    Yoko Saitoh-Maeda, Takashi Kawahara, Yasuhide Miyoshi, Sohgo Tsutsumi, Daiji Takamoto, Kota Shimokihara, Yuutaro Hayashi, Taku Mochizuki, Mari Ohtaka, Manami Nakamura, Yusuke Hattori, Jun-Ichi Teranishi, Yasushi Yumura, Kimito Osaka, Hiroki Ito, Kazuhide Makiyama, Noboru Nakaigawa, Masahiro Yao, Hiroji Uemura

    BMC urology   17 ( 1 )   87 - 87   2017.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Recently, sarcopenia has been reported as a new predictor for patient outcomes or likelihood of post-operative complications. The purpose of this study was to evaluate the association of the psoas muscle volume with the length of hospitalization among patients undergoing radical cystectomy. METHODS: A total of 63 (80.8%) male patients and 15 (19.2%) female patients who underwent radical cystectomy for their bladder cancer in our institution from 2000 to 2015 were analyzed. The psoas muscle index (PMI) was calculated by normalizing the psoas muscle area calculated using axial computed tomography at the level of the umbilicus (cm2) by the square of the body height (m2). Longer hospitalization was defined as hospitalization exceeding 30 days after surgery. RESULTS: The median PMIs (mean ± standard deviation) were 391 (394 ± 92.1) and 271 (278 ± 92.6) cm2/m2 in men and women, respectively. Thus, the PMIs of male patients were significantly larger than those of females (p < 0.001). Based on the differences in gender, we analyzed 63 male patients for a further analysis. In male patients, those hospitalized longer showed a significantly smaller PMI than those normally discharged (377 ± 93.1 vs. 425 ± 83.4; p = 0.04). Similarly, male patients with a small PMI (<400) had a significantly worse overall survival (p = 0.02) than those with a large PMI (≥400). CONCLUSIONS: The presence of sarcopenia was found to be associated with significantly longer hospitalization after radical cystectomy in male patients. Furthermore, in men, a PMI <400 may suggest a significantly worse prognosis.

    DOI: 10.1186/s12894-017-0279-2

    PubMed

    researchmap

  • Fracture Risk in Prostate Cancer during Hormonal Therapy. International journal

    Takashi Kawahara, Shusei Fusayasu, Shinji Ohtake, Hiroki Ito, Yasuhide Miyoshi, Masahiro Yao, Hiroji Uemura

    Current urology   10 ( 2 )   111 - 112   2017.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000447162

    PubMed

    researchmap

  • Modified C index: Novel predictor of postoperative renal functional loss of laparoscopic partial nephrectomy. International journal

    Hiroki Ito, Kazuhide Makiyama, Takashi Kawahara, Kimito Osaka, Koji Izumi, Yumiko Yokomizo, Noboru Nakaigawa, Masahiro Yao

    Canadian Urological Association journal = Journal de l'Association des urologues du Canada   11 ( 5 )   E215-E221   2017.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: We aimed to develop a scoring system to quantify the distance between the renal hilum and renal tumour, termed the modified C index (m-CI), and to predict renal functional loss (RFL) following laparoscopic partial nephrectomy (LPN). METHODS: The m-CI was measured by using computed tomography in 113 patients who underwent LPN between May 2003 and June 2014. The RFL following LPN was calculated by examining the estimated glomerular filtration rate (eGFR) and radioisotope renography one year postoperatively. The Pythagorean theorem was used to calculate the distance from the tumour centre to the renal hilum. The distance was divided by the tumour radius to obtain the m-CI. The correlation between the m-CI and the postoperative RFL were evaluated using Pearson's coefficient values. Multivariate logistic regression models were used to assess the potential predictive factors of RFL following LPN. The correlation between the m-CI and the operative time, ischemia time, and blood loss during LPN were also evaluated by the unpaired t-test. RESULTS: Pearson's coefficient values between the postoperative RFL and the m-CI and C index were 0.294 and 0.173, respectively. In the multivariate analysis, the resected volume (p=0.031) and m-CI (p=0.036) significantly correlated with the postoperative RFL following LPN. The operative time (p<0.001), ischemia time (p=0.028), and blood loss (p=0.047) during LPN was significantly longer and larger, respectively, in the group with shorter m-CI (≤4.5) than in the group with the longer m-CI (>4.5). CONCLUSIONS: The present study demonstrates that the m-CI can predict RFL following LPN, as well as the surgical difficulty.

    DOI: 10.5489/cuaj.4192

    PubMed

    researchmap

  • Synergic Suppressive Effect of Silodosin and Imidafenacin on Non-Voiding Bladder Contractions in Male Rats with Subacute Bladder Outlet Obstruction. International journal

    Rino Sugiyama, Naoki Aizawa, Hiroki Ito, Tetsuya Fujimura, Motofumi Suzuki, Tohru Nakagawa, Hiroshi Fukuhara, Haruki Kume, Yukio Homma, Yasuhiko Igawa

    Lower urinary tract symptoms   9 ( 2 )   94 - 101   2017.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: To investigate single or combined effect of silodosin, an α1A-adrenoceptor antagonist, and imidafenacin, an antimuscarinic agent, on bladder function in a subacute bladder outlet obstruction (BOO) model of male rats. METHODS: Partial BOO was created in male Wistar rats by ligating the urethra with a steel rod. On day 10 after surgery, when frequent voiding was most remarkable on voiding behavior measurement in a metabolic cage, cystometric investigations in a conscious restrained condition were conducted with cumulative intravenous administration of silodosin alone (0.1, 1, 10, and 100 µg/kg), imidafenacin alone (1, 3, and 10 µg/kg), or a combination of the two drugs. RESULTS: When compared with the Sham rats, the BOO rats showed an increase in bladder capacity, residual volume, mean amplitude and the number of non-voiding contractions (NVCs), accompanied with an increase in bladder weight. In the BOO rats, silodosin alone at 100 µg/kg significantly decreased the number of NVCs, whereas imidafenacin alone at 3 and 10 µg/kg significantly decreased both the number and mean amplitude of NVCs. The combination administration with lower doses (silodosin at 10 µg/kg and imidafenacin at 1 µg/kg) significantly suppressed both the number and mean amplitude of NVCs. CONCLUSIONS: The present results indicate a suppressive effect of silodosin or imidafenacin alone and a synergic effect of the combination of these two drugs on NVCs in a subacute BOO model of male rats.

    DOI: 10.1111/luts.12109

    PubMed

    researchmap

  • One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival. International journal

    Hiroki Ito, Keiichi Kondo, Takashi Kawahara, Tomohiro Kaneta, Ukihide Tateishi, Daiki Ueno, Kazuhiro Namura, Kazuki Kobayashi, Yasuhide Miyoshi, Yasushi Yumura, Kazuhide Makiyama, Narihiko Hayashi, Hisashi Hasumi, Kimito Osaka, Yumiko Yokomizo, Jun-Ichi Teranishi, Yusuke Hattori, Tomio Inoue, Hiroji Uemura, Masahiro Yao, Noboru Nakaigawa

    Cancer chemotherapy and pharmacology   79 ( 5 )   855 - 861   2017.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: We evaluated 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography (FDG PET/CT) results as outcome predictors for patients with metastatic renal cell carcinoma (RCC) treated by everolimus (EVL), an inhibitor of mammalian target of rapamycin. METHODS: We retrospectively reviewed 30 patients who were treated with EVL for metastatic RCC between May 2010 and March 2015, by evaluating their FDG PET/CT result before and 1 month after starting EVL treatment. We examined the relationships between each patient's maximum standardized uptake value (max SUVmax) assessed by FDG PET/CT on progression-free survival (PFS) and overall survival (OS). RESULTS: Median PFS for all 30 patients was 3.77 months (range 0.72-24.56 months) and median OS after EVL treatment of all 30 patients was 11.67 months (range 1.0-62.98 months). Enrolled patients were divided into two groups by max SUVmax prior to EVL (median = 7.6) and at 1 month after EVL treatment (median = 5.7). PFS were significantly shorter in higher max SUVmax prior to EVL (<7.6, PFS 7.8 vs 3.5 months, log-rank P = 0.017) and at 1 month after EVL (<5.7, PFS 10.6 vs 2.7 months, log-rank P = 0.002) than lower max SUVmax. OS were also significantly shorter in higher max SUVmax prior to EVL (<7.6, OS 18.1 vs 7.5 months, log-rank P = 0.010) and at 1 month after EVL (<5.7, OS 17.2 vs 7.5 months, log-rank P = 0.009) than lower max SUVmax. Multivariate Cox hazard regression analysis indicated that max SUVmax at 1 month after EVL is an independent predictor of both PFS and OS in patients treated with EVL although univariate regression analysis showed max SUVmax before EVL is a possible predictor. CONCLUSIONS: Max SUVmax assessed by FDG PET/CT prior to EVL and at 1 month after EVL treatment can accurately predict PFS and can guide decisions on whether to continue or change treatments for patients with EVL-treated RCC who suffer from adverse events.

    DOI: 10.1007/s00280-017-3275-z

    PubMed

    researchmap

  • Effects of Sildenafil, a Phosphodiesterase Type 5 Inhibitor, on the Primary Single Afferent Activity of the Rat Bladder. International journal

    Naoki Aizawa, Hiroki Ito, Rino Sugiyama, Tetsuya Fujimura, Hiroshi Fukuhara, Haruki Kume, Yukio Homma, Yasuhiko Igawa

    Lower urinary tract symptoms   9 ( 1 )   57 - 61   2017.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: We investigated the direct effects of sildenafil, a phosphodiesterase type 5 inhibitor, on the single-unit mechanosensitive afferent activities (SAAs) primarily originated from the bladder in the rat. METHODS: Female Sprague-Dawley rats were anesthetized with urethane. SAAs were recorded from the left L6 dorsal roots and classified by conduction velocity as Aδ- or C-fibers. A catheter was inserted into the bladder dome, and a separate catheter was placed in the carotid artery and external iliac vein for monitoring of blood pressure and sildenafil-administration, respectively. After measuring control SAA during constant filling cystometry with saline, the procedure was repeated with cumulative intravenous administrations of sildenafil (1, 3 and 10 mg/kg). RESULTS: Thirteen single units were isolated (Aδ-fibers: n = 6, C-fibers: n = 7) from 11 rats. After sildenafil-administrations, SAAs of Aδ-fibers significantly decreased in a dose-dependent manner, whereas SAAs of C-fibers decreased significantly only at the highest dose used. In addition, blood pressure significantly decreased after sildenafiladministration even at the lowest dose used. Bladder compliance significantly increased after sildenafil administration at higher doses. CONCLUSIONS: These results indicate that sildenafil can inhibit Aδ-fibers (partly also C-fibers) of the primary bladder mechanosensitive afferents of the rat although these effects may be partially influenced by systemic hypotension. The present results support the view that the NO/cGMP signaling pathway plays an inhibitory role in the bladder afferent transduction, and thus improves storage symptoms.

    DOI: 10.1111/luts.12095

    PubMed

    researchmap

  • Effect of Amplatz Sheath on Cystolithotripsy for Women with Large Bladder Stone. International journal

    Tadashi Tabei, Takashi Kawahara, Shinnosuke Kuroda, Hiroki Ito, Kazuki Kobayashi, Hiroji Uemura, Junichi Matsuzaki

    BioMed research international   2017   9341042 - 9341042   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: This study compared the effect of endourological procedures with or without the Amplatz sheath (AS) on cystolithotripsy. METHODS: We retrospectively analysed 18 patients who underwent treatment for bladder stone over 30 mm. This study consisted of two groups, namely, patients who underwent cystolithotripsy with an AS (AS group) and those who underwent standard procedure without an AS (SP group). The stone-free rate, total energy used for operation, operation time, days of admission after operation, and complication of both groups were compared. RESULTS: The number of patients in the AS and SP groups was 10 and 8, respectively. Significant differences were not found between these two groups with regard to age, stone burden, stone volume, number of stones, and history of neurogenic bladder. All patients in both groups achieved a stone-free state. Total energy was significantly increased and operation time was shorter in the AS group. No significant difference was observed in terms of days of admission after operation. Any complications were not increased by the use of AS. Struvite was the most common stone component in both groups. CONCLUSION: Use of an AS can shorten the operation time of cystolithotripsy without increasing perioperative complication.

    DOI: 10.1155/2017/9341042

    PubMed

    researchmap

  • Muro-Neuro-Urodynamics; a Review of the Functional Assessment of Mouse Lower Urinary Tract Function. International journal

    Hiroki Ito, Anthony E Pickering, Yasuhiko Igawa, Anthony J Kanai, Christopher H Fry, Marcus J Drake

    Frontiers in physiology   8   49 - 49   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: Mouse urodynamic tests are fundamental to understanding normal lower urinary tract (LUT) function. These experiments also contribute to our understanding of neurological dysfunction, pathophysiological processes, and potential mechanisms of therapy. Objectives: Systematic assessment of published evidence on urodynamics, advantages and limitations of different urodynamic measurements in mice, and consideration of potential implications for the clinical field. Methods: A search using specific search-terms for urodynamic studies and mice was conducted on PubMed (from inception to 1 July 2016). Results: We identified 55 studies examining or describing mouse neuro-urodynamics. We summarize reported features of mouse urodynamic function deriving from frequency-volume chart (FVC) measurements, voiding spot assays, filling cystometry, and pressure-flow studies. Similarly, an influence of the diurnal cycle on voiding is observed in mice and should be considered when interpreting rodent urodynamic studies, especially FVC measurements and voiding spot assays. Anaesthesia, restraint conditions, or filling rate influence mouse neuro-urodynamics. Mouse cystometric studies have observed intravesical pressure oscillations that accompany urine flow, attributed to high frequency opening and closing of the urethra. This characterization is not seen in other species, except rats. In contrast to human clinical urodynamics, the terminology of these examinations has not been standardized although many rodent urodynamic studies have been described. Conclusion: Mice have many anatomical and physiological similarities to humans and they are generally cost effective, and allow investigation of the effects of aging because of their short lifespan. There are some differences between mouse and human urodynamics. These must be considered when interpreting LUT function in mice, and translational value of murine disease models.

    DOI: 10.3389/fphys.2017.00049

    PubMed

    researchmap

  • The impact of gender difference on operative time in laparoscopic partial nephrectomy for T1 renal tumor and the utility of retroperitoneal fat thickness as a predictor of operative time. International journal

    Hiroki Ito, Kazuhide Makiyama, Takashi Kawahara, Kimito Osaka, Koji Izumi, Yumiko Yokomizo, Noboru Nakaigawa, Masahiro Yao

    BMC cancer   16 ( 1 )   944 - 944   2016.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: To investigate the impact of biological gender on operative parameters, especially operative time, in laparoscopic partial nephrectomy (LPN) for T1 renal tumor. METHODS: One hundred and eleven (28 female and 83 male) patients and 64 (20 female and 44 male) patients with renal tumors suspected to be RCC cT1aN0M0 who underwent retroperitoneal and transperitoneal LPN, respectively, were analyzed. The influence of sex on operative factors including retroperitoneal fat tissue thickness, determined on CT, was analyzed. The correlation between operative time and gender was evaluated by unpaired t-test and linear logistic regression model. RESULTS: In both retroperitoneal and transperitoneal LPN, the retroperitoneal fat tissue thickness was greater in men than in women. In retroperitoneal LPN, the operative time was significantly longer in men than in women. In contrast, in transperitoneal LPN, no gender difference was observed in regard to the operative time. In retroperitoneal LPN, linear logistic regression assessment showed that gender, retroperitoneal fat tissue thickness, and tumor size were significantly associated with operative time. Coefficient of determination of the prediction model was 0.317. CONCLUSIONS: The operative time of retroperitoneal LPN is significantly correlated with gender, maximum tumor diameter, and retroperitoneal fat tissue thickness. We have developed a prediction model for the operative time of retroperitoneal LPN based on preoperative parameters. Interestingly, in transperitoneal LPN, a gender difference in operative time was not apparent, and also predicting operative time might be difficult.

    PubMed

    researchmap

  • Developing a preoperative predictive model for ureteral length for ureteral stent insertion. International journal

    Takashi Kawahara, Kentaro Sakamaki, Hiroki Ito, Shinnosuke Kuroda, Hideyuki Terao, Kazuhide Makiyama, Hiroji Uemura, Masahiro Yao, Hiroshi Miyamoto, Junichi Matsuzaki

    BMC urology   16 ( 1 )   70 - 70   2016.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Ureteral stenting has been a fundamental part of various urological procedures. Selecting a ureteral stent of optimal length is important for decreasing the incidence of stent migration and complications. The aim of the present study was to develop and internally validate a model for predicting the ureteral length for ureteral stent insertion. METHODS: This study included a total of 127 patients whose ureters had previously been assessed by both intravenous urography (IVU) and CT scan. The actual ureteral length was determined by direct measurement using a 5-Fr ureteral catheter. Multiple linear regression analysis with backward selection was used to model the relationship between the factors analyzed and actual ureteral length. Bootstrapping was used to internally validate the predictive model. RESULTS: Patients all of whom had stone disease included 76 men (59.8%) and 51 women (40.2%), with the median and mean (± SD) ages of 60 and 58.7 (±14.2) years. In these patients, 53 (41.7%) right and 74 (58.3%) left ureters were analyzed. The median and mean (± SD) actual ureteral lengths were 24.0 and 23.3 (±2.0) cm, respectively. Using the bootstrap methods for internal validation, the correlation coefficient (R2) was 0.57 ± 0.07. CONCLUSION: We have developed a predictive model, for the first time, which predicts ureteral length using the following five preoperative characteristics: age, side, sex, IVU measurement, and CT calculation. This predictive model can be used to reliably predict ureteral length based on clinical and radiological factors and may thus be a useful tool to help determining the optimal length of ureteral stent.

    PubMed

    researchmap

  • Preventive Effects of Long-Term Caloric Restriction on Aging Related In Vivo Bladder Dysfunction and Molecular Biological Changes in the Bladder and Dorsal Root Ganglia in Rats. International journal

    Hiroki Ito, Jun Kamei, Naoki Aizawa, Yasunori Fujita, Motofumi Suzuki, Hiroshi Fukuhara, Tetsuya Fujimura, Toshio Kojima, Yukio Homma, Yoshinobu Kubota, Masafumi Ito, Karl-Erik Andersson, Yasuhiko Igawa

    The Journal of urology   196 ( 5 )   1575 - 1583   2016.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: We evaluated aging related bladder dysfunctions and biological changes in the bladder and dorsal root ganglia in rats. We also investigated whether long-term caloric restriction may have preventive effects on these changes. MATERIALS AND METHODS: Male Fischer 344 rats were divided into a young group (age 6 months) and an old group (age 25 to 28 months), each with free access to normal food, and an old group (age 25 to 28 months) with food restricted to 3 days per week. Conscious cystometry, cDNA microarray analysis, immunohistochemistry and oxidative stress measurements of the bladder and dorsal root ganglia were performed. RESULTS: The old group with free access to normal food showed higher threshold pressure, more nonvoiding contractions and lower bladder compliance than the young group with free access to food. Old rats with free access showed greater post-void residual volume and lower voiding efficiency than old rats with caloric restriction and young rats. In the old group with free access 83 genes in the bladder and 48 in the L6 dorsal root ganglia were up-regulated compared with old rats with caloric restriction and young rats. These genes were mostly related to immune and inflammatory responses. Immunohistochemistry showed stronger expression of the immune response protease Gzm (granzyme) B and the collagenase Mmp13 (matrix metalloproteinase-13) in the bladder of old rats with free access vs old rats with caloric restriction and young rats. The level of malondialdehyde, an oxidative stress marker, was higher in the bladder of old rats with free access than in young rats but there was no difference between old rats with caloric restriction and young rats with free access to food. CONCLUSIONS: In rats aging leads to storage and voiding dysfunctions associated with immune and inflammatory related responses in the bladder and dorsal root ganglia, and with increased oxidative stress in the bladder. Caloric restriction reduced these aging related changes.

    DOI: 10.1016/j.juro.2016.05.104

    PubMed

    researchmap

  • [A Case of Endoscopic Combined Intrarenal Surgery for Multiple Encrusted Stones on a Forgotten Ureteral Stent Left for 4 Years].

    Kimitsugu Usui, Takuo Asai, Tadashi Tabei, Hiroki Ito, Mitsuru Komeya, Atsushi Fujikawa, Junichi Matsuzaki

    Hinyokika kiyo. Acta urologica Japonica   62 ( 11 )   585 - 589   2016.11

     More details

    Language:Japanese  

    A 43-year-old man underwent extracorporeal shock wave lithotripsy (ESWL) for a left ureteral stone and implantation of a loop stent for the treatment of stone pain in February 2011. However, he was lost to follow-up before the complete removal of the stones and stent. He presented to our hospital with left back pain in March 2015. An abdominal radiograph and a noncontrast computed tomography showed extensive stone formation throughout the stent. A single cystolithotripsy and a double endoscopic combined intrarenal surgery (ECIRS)were performed. All the stones and the encrusted ureteral stent were successfully removed.

    DOI: 10.14989/ActaUrolJap_62_11_585

    PubMed

    J-GLOBAL

    researchmap

  • Risk factors of systemic inflammation response syndrome after endoscopic combined intrarenal surgery in the modified Valdivia position. International journal

    Tadashi Tabei, Hiroki Ito, Kimitsugu Usui, Shinnosuke Kuroda, Takashi Kawahara, Hideyuki Terao, Atsushi Fujikawa, Kazuhide Makiyama, Masahiro Yao, Junichi Matsuzaki

    International journal of urology : official journal of the Japanese Urological Association   23 ( 8 )   687 - 92   2016.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To identify risk factors of developing systemic inflammation response syndrome after endoscopic combined intrarenal surgery in the modified Valdivia position for renal stone treatment. METHODS: We retrospectively analyzed 370 consecutive patients who underwent endoscopic combined intrarenal surgery procedures in the modified Valdivia position to treat renal stones. Antibiotic therapy based on preoperative urine cultures was administered to all patients from induction of anesthesia until at least postoperative day 3. Postoperative systemic inflammation response syndrome was diagnosed if the patient met two or more systemic inflammation response syndrome criteria. A multivariate logistic regression model with backward selection was used to evaluate the relationships between the incidence of systemic inflammation response syndrome after endoscopic combined intrarenal surgery and other clinical factors. RESULTS: Of the 370 patients, 61 patients (16.5%) were diagnosed with systemic inflammation response syndrome after endoscopic combined intrarenal surgery. Significant differences were found between the non-systemic inflammation response syndrome and systemic inflammation response syndrome groups with regard to female sex (29.8% vs 44.3%, P = 0.027), history of febrile urinary tract infection (16.5% vs 32.8%, P = 0.015) and number of involved calyces (2.68 vs 4.1, P < 0.001). Multivariate analysis found three independent predictors of postoperative systemic inflammation response syndrome: the number of involved calyces (P = 0.017), stone surface area (P = 0.021) and history of febrile urinary tract infection (P = 0.005). CONCLUSIONS: The number of involved calyces larger than four, stone surface area >500 mm(2) and a history of febrile urinary tract infection independently predicted the development of systemic inflammation response syndrome after endoscopic combined intrarenal surgery. This is the first study to identify the independent predictors of systemic inflammation response syndrome after endoscopic combined intrarenal surgery in the modified Valdivia position.

    DOI: 10.1111/iju.13124

    PubMed

    researchmap

  • Impact of Accidental Tumor Incision During Laparoscopic Partial Nephrectomy on the Oncologic and Clinical Outcomes. International journal

    Hiroki Ito, Kazuhide Makiyama, Takashi Kawahara, Kimito Osaka, Koji Izumi, Yumiko Yokomizo, Noboru Nakaigawa, Shoji Yamanaka, Masahiro Yao

    Clinical genitourinary cancer   14 ( 4 )   e291-7   2016.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: To investigate the impact of accidental tumor incision (ATI) during laparoscopic partial nephrectomy (LPN) on the treatment outcome of LPN and to determine the predictive factors for ATI. PATIENTS AND METHODS: Consecutive 156 patients with renal tumors suspicious of renal cell carcinoma cT1N0M0 undergoing laparoscopic partial nephrectomy at Yokohama City University between May 2003 and November 2014 were retrospectively evaluated. The analyzed clinical factors included maximum tumor diameter, the R.E.N.A.L. Nephrometry Score, occurrence of ATI during surgery, and the postoperative pathological findings including the presence of a pseudocapsule. Port site metastasis, tumor seeding, and local recurrence were investigated by routine follow-up computed tomography during the postoperative period. RESULTS: Among enrolled 156 procedures, 12 (7.7%) showed ATI during surgery. Positive surgical margin and local tumor recurrence were observed in 5 and 1 cases in the non-ATI group, respectively, as compared with in no cases in the ATI group. Port site metastasis or tumor seeding was not observed in either group. Multivariate analysis indicated that pseudocapsule formation significantly correlated with ATI (P = .022) and that maximum tumor diameter was a possible predictor of ATI (P = .054). CONCLUSION: To our knowledge, there are no previous studies to evaluate the impact of ATI, and we here, for the first time, report that the risk of ATI is influenced by the presence of a pseudocapsule, and, to some degree, by the tumor size. Moreover, we also show that ATI during laparoscopic partial nephrectomy is not necessarily associated with poor outcomes such as local tumor recurrence.

    DOI: 10.1016/j.clgc.2015.11.013

    PubMed

    researchmap

  • Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer. International journal

    Jun Kasuga, Takashi Kawahara, Daiji Takamoto, Sachi Fukui, Takashi Tokita, Tomoyuki Tadenuma, Masaki Narahara, Syusei Fusayasu, Hideyuki Terao, Koji Izumi, Hiroki Ito, Yusuke Hattori, Jun-Ichi Teranishi, Takeshi Sasaki, Kazuhide Makiyama, Yasuhide Miyoshi, Masahiro Yao, Yasushi Yumura, Hiroshi Miyamoto, Hiroji Uemura

    BMC cancer   16   396 - 396   2016.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR), a simple marker of the systemic inflammatory response, has been demonstrated to correlate with patient outcomes for various solid malignancies. We investigated the utility of the pretreatment NLR as a prognosticator in patients who presented with penile cancer. METHODS: A total of 41 patients who underwent complete blood count with differential and subsequent radical penectomy from 1988 to 2014 were analyzed. We assessed the correlation between the NLR and the prognosis of penile cancer. RESULTS: The median and mean (± SD) NLRs in 41 penile cancer patients were 3.42 and 5.03 ± 4.99, respectively. Based on the area under receiver operator characteristic curve, the cut-off value of NLR was determined to be 2.82. Patients with a high NLR (≥2.82) showed a significantly poorer cancer-specific survival (p = 0.023) than those with a low NLR. CONCLUSIONS: The pretreatment NLR may function as a biomarker that precisely predicts the prognosis in patients with penile cancer.

    DOI: 10.1186/s12885-016-2443-6

    PubMed

    researchmap

  • Bone management in Japanese patients with prostate cancer: hormonal therapy leads to an increase in the FRAX score. International journal

    Takashi Kawahara, Shusei Fusayasu, Koji Izumi, Yumiko Yokomizo, Hiroki Ito, Yusuke Ito, Kayo Kurita, Kazuhiro Furuya, Hisashi Hasumi, Narihiko Hayashi, Yasuhide Myoshi, Hiroshi Miyamoto, Masahiro Yao, Hiroji Uemura

    BMC urology   16 ( 1 )   32 - 32   2016.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Osteoporosis is a common consequence of androgen deprivation therapy (ADT) for prostate cancer. Up to 20 % of men on ADT have suffered from fractures within 5 years. The WHO Fracture Risk Assessment Tool (FRAX) has been utilized to predict the 10-year probability of major osteoporotic and hip fracture. However, to date, no large studies assessing the utility of the FRAX score in prostate cancer patients with or without ADT have been performed. We herein evaluated the impact of ADT on the FRAX score in prostate cancer patients. METHODS: The assessment of the FRAX score was performed in a total of 1220 prostate cancer patients, including patients who underwent brachytherapy (n = 547), radical prostatectomy (n = 200), external beam radiation therapy (n = 264) and hormonal therapy alone (n = 187) at Yokohama City University Hospital (Yokohama, Japan). We evaluated the effect of ADT on the FRAX score. RESULTS: Using the FRAX model, the median and mean 10-year probability of a major osteoporotic fracture according to the clinical risk factors alone was 7.9 % (8.8 ± 4.3 %), while the 10-year probability of hip fracture risk was 2.7 % (3.5 ± 3.1 %). In the ADT group, the duration of ADT was correlated with both major osteoporotic risk and hip fracture risk (R(2) = 0.141, p < 0.001 and R(2) = 0.166, p < 0.001, respectively). A comparison between the ADT (n = 187) and non-ADT (n = 399) groups demonstrated that the major fracture risk was > 20 % higher and the hip fracture risk was > 3 % higher in the ADT group than in the non-ADT group (ADT: 10 (5.3 %) and 118 (63.1 %), non-ADT 13 (3.3 %) and 189 (47.4 %), p < 0.001 and p < 0.001, respectively). CONCLUSIONS: These results suggested that the longer duration of ADT led to an increased FRAX score, and the FRAX score may be a predictor of bone management treatment, particularly in prostate cancer patients.

    DOI: 10.1186/s12894-016-0151-9

    PubMed

    researchmap

  • Predicting the mineral composition of ureteral stone using non-contrast computed tomography. International journal

    Takashi Kawahara, Hiroshi Miyamoto, Hiroki Ito, Hideyuki Terao, Manabu Kakizoe, Yoshitake Kato, Hitoshi Ishiguro, Hiroji Uemura, Masahiro Yao, Junichi Matsuzaki

    Urolithiasis   44 ( 3 )   231 - 9   2016.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We investigated the correlation between computed tomography (CT) density of ureteral stones and their mineral composition. A total of 346 patients who underwent ureteroscopic lithotripsy for calculi all fragments of which were acquired at a single institution from 2009 to 2011 were analyzed. The maximum and mean CT densities were measured preoperatively. A mineral analysis revealed calcium oxalate in 203 (58.7 %), mixed calcium oxalate and calcium phosphate in 78 (23.0 %), calcium phosphate in 18 (5.2 %), uric acid in 8 (2.3 %), struvite in 3 (0.9 %), and cysteine in 5 (1.4 %). The mean Hounsfield units (HUs) of the CT density were 1046 HUs in calcium oxalate, 1101 HUs in mixed calcium oxalate and calcium phosphate, 835 HUs in calcium phosphate, 549 HUs in uric acid, 729 HUs in struvite, and 698 HUs in cystine. The HUs in calcium oxalate were significantly higher than those in uric acid (p < 0.01) and struvite (p < 0.01). Those in monohydrate stones were significantly higher, compared with dehydrate stones (p < 0.05). We analyzed the largest number of stones than each published study to correlate their mineral composition and CT density. Calcium component stones showed significantly higher CT densities than other types.

    DOI: 10.1007/s00240-015-0823-z

    PubMed

    researchmap

  • Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy. International journal

    Takashi Kawahara, Kazuhiro Furuya, Manami Nakamura, Kentaro Sakamaki, Kimito Osaka, Hiroki Ito, Yusuke Ito, Koji Izumi, Shinji Ohtake, Yasuhide Miyoshi, Kazuhide Makiyama, Noboru Nakaigawa, Takeharu Yamanaka, Hiroshi Miyamoto, Masahiro Yao, Hiroji Uemura

    BMC cancer   16   185 - 185   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: There is no reliable biomarker for predicting the prognosis of patients who undergo radical cystectomy for bladder cancer. Recent studies have shown that the neutrophil-to-lymphocyte ratio (NLR) could function as a useful prognostic factor in several types of malignancies. This study aimed to assess the usefulness of NLR in bladder cancer. METHODS: A total of 74 patients who underwent radical cystectomy in our institutions from 1999 to 2014 were analyzed. The NLR was calculated using the patients' neutrophil and lymphocyte counts before radical cystectomy. An immunohistochemical analysis was also performed to detect tumor infiltrating neutrophils (CD66b) and lymphocytes (CD8) in bladder cancer specimens. RESULTS: A univariate analysis showed that the patients with a high NLR (≥2.38; HR = 4.84; p = 0.007), high C-reactive protein level (>0.08; HR = 10.06; p = 0.030), or pathological lymph node metastasis (HR = 4.73; p = 0.030) had a significantly higher risk of cancer-specific mortality. Kaplan-Meier and log-rank tests further revealed that NLR was strongly correlated with overall survival (p = 0.018), but not progression-free survival (p = 0.137). In a multivariate analysis, all of these were found to be independent risk factors (HR = 4.62, 10.8, and 12.35, respectively). The number of CD8-positive lymphocytes was significantly increased in high-grade (p = 0.001) and muscle-invasive (p = 0.012) tumors, in comparison to low-grade and non-muscle-invasive tumors, respectively. CONCLUSIONS: The NLR predicted the prognosis of patients who underwent radical cystectomy and might therefore function as a reliable biomarker in cases of invasive bladder cancer.

    DOI: 10.1186/s12885-016-2219-z

    PubMed

    researchmap

  • Functional role of the transient receptor potential melastatin 8 (TRPM8) ion channel in the urinary bladder assessed by conscious cystometry and ex vivo measurements of single-unit mechanosensitive bladder afferent activities in the rat. International journal

    Hiroki Ito, Naoki Aizawa, Rino Sugiyama, Shuzo Watanabe, Nobuyuki Takahashi, Masaomi Tajimi, Hiroshi Fukuhara, Yukio Homma, Yoshinobu Kubota, Karl-Erik Andersson, Yasuhiko Igawa

    BJU international   117 ( 3 )   484 - 94   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To evaluate the role of the transient receptor potential melastatin 8 (TRPM8) channel on bladder mechanosensory function by using L-menthol, a TRPM8 agonist, and RQ-00203078 (RQ), a selective TRPM8 antagonist. MATERIALS AND METHODS: Female Sprague-Dawley rats were used. In conscious cystometry (CMG), the effects of intravesical instillation of L-menthol (3 mm) were recorded after intravenous (i.v.) pretreatment with RQ (3 mg/kg) or vehicle. The direct effects of RQ on conscious CMG and deep body temperature were evaluated with cumulative i.v. administrations of RQ at 0.3, 1, and 3mg/kg. Single-unit mechanosensitive bladder afferent activities (SAAs) were monitored in a newly established ex vivo rat bladder model to avoid systemic influences of the drugs. Recordings were performed after cumulative intra-aortic administration of RQ (0.3 and 3 mg/kg) with or without intra-vesical L-menthol instillation (3 mm). RESULTS: Intravesical L-menthol decreased bladder capacity and voided volume, which was counteracted by RQ-pretreatment. RQ itself increased bladder capacity and voided volume, and lowered deep body temperature in a dose-dependent manner. RQ decreased mechanosensitive SAAs of C-fibres, and inhibited the activation of SAAs induced by intravesical L-menthol. CONCLUSION: Our results suggest that TRPM8 channels have a role in activation of bladder afferent pathways during filling of the bladder in the normal rat. This effect seems, at least partly, to be mediated via mechanosensitive C-fibres.

    DOI: 10.1111/bju.13225

    PubMed

    researchmap

  • Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer. International journal

    Takashi Kawahara, Yumiko Yokomizo, Yusuke Ito, Hiroki Ito, Hitoshi Ishiguro, Jun-ichi Teranishi, Kazuhide Makiyama, Yasuhide Miyoshi, Hiroshi Miyamoto, Masahiro Yao, Hiroji Uemura

    BMC cancer   16   111 - 111   2016.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR), a simple marker of the systemic inflammatory response in critical care patients, has been suggested as an independent prognostic factor for several solid malignancies. We investigated the utility of pretreatment NLR as a prognosticator in patients who presented with metastatic prostate cancer. METHODS: We first investigated the correlation between NLR and prostate-specific antigen (PSA) levels in 1464 men who had both tests and were found to have prostate cancer on their biopsies at our institution from 1999 to 2015. We then assessed the relationship between pretreatment NLR and the prognosis in 48 patients who were diagnosed with prostate cancer metastasized to the lymph node and/or bone. RESULTS: The NLR value was significantly elevated in men with higher PSA than in those with lower PSA (p < 0.001). In patients with metastatic prostate cancer, NLR (cut-off point of 3.37 determined by the AUROC curve) was correlated with both cancer-specific (p = 0.018) and overall (p = 0.008) survivals. CONCLUSIONS: Pretreatment NLR may function as a new biomarker that precisely predicts the prognosis in patients with metastatic prostate cancer.

    DOI: 10.1186/s12885-016-2134-3

    PubMed

    researchmap

  • Retrograde intrarenal surgery for urinary stone disease in patients with solitary kidney: A retrospective analysis of the efficacy and safety. International journal

    Shinnosuke Kuroda, Atsushi Fujikawa, Tadashi Tabei, Hiroki Ito, Hideyuki Terao, Masahiro Yao, Junichi Matsuzaki

    International journal of urology : official journal of the Japanese Urological Association   23 ( 1 )   69 - 73   2016.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: To compare outcomes of retrograde intrarenal surgery for urolithiasis between patients with solitary kidneys and patients who have single-side urolithiasis with bilateral kidneys. METHODS: We retrospectively analyzed outcomes of retrograde intrarenal surgery in solitary kidney patients (group A) carried out during 2007-2014, and in patients with bilateral kidneys with comparable stone burdens (group B). Stone-free status was defined as no residual fragment on computed tomography 1 month later. RESULTS: There were 19 patients in group A (mean age 62.5 ± 18.4 years, range 14-76 years). The mean stone diameter and burden were 6.0 mm (range 3-24 mm) and 10.42 ± 6.92 mm, respectively. The stone-free rate was 94.7%, and no repeat procedure was required. The glomerular filtration rate tended to rise post-surgery (postoperative day 1: 48.67 ± 15.92 mL/min, 100.2%, P = 0.940; postoperative month 1: 51.32 ± 16.90 mL/min, 105.7%, P = 0.101) compared with preoperative rates. The stone-free rate and surgery time were not significantly different between the two groups, although post-surgical hospitalization time was longer for group A (4.05 vs 3.08 days, P = 0.037). The change in glomerular filtration rate was not significantly different between groups A and B (postoperative day 1: +0.101 vs +0.547 mL/min, respectively, P = 0.857; postoperative month 1: +2.749 vs 3.161 mL/min, respectively, P = 0.882). No significant difference was found in terms of complication rate. CONCLUSIONS: Retrograde intrarenal surgery in solitary kidney patients is as safe and effective as in bilateral kidney patients.

    DOI: 10.1111/iju.12951

    PubMed

    researchmap

  • Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy. International journal

    Shinji Ohtake, Takashi Kawahara, Ryo Kasahara, Hiroki Ito, Kimito Osaka, Yusuke Hattori, Jun-Ichi Teranishi, Kazuhide Makiyama, Nobuhiko Mizuno, Susumu Umemoto, Yasuhide Miyoshi, Noboru Nakaigawa, Hiroshi Miyamoto, Masahiro Yao, Hiroji Uemura

    BioMed research international   2016   9846823 - 9846823   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Introduction and Objectives. Neutrophil-to-lymphocyte ratio (NLR) has been suggested to be a simple marker of the systemic inflammatory response in critical care patients. We previously assessed the utility of NLR as a biomarker to predict tumor recurrence and cancer death in bladder cancer patients who underwent radical cystectomy. In this study, we evaluated the prognostic impact of NLR in bladder cancer patients who received gemcitabine and nedaplatin (GN) chemotherapy. Methods. A total of 23 patients who received GN chemotherapy for advanced bladder cancer were enrolled in this study. The cut-off point of NLR according to the sensitivity and specificity levels was derived from the area under receiver operator characteristics (AUROC) curve plotted for disease progression or overall mortality. Results. The NLR cut-off point was determined as 4.14 for both tumor progression and overall mortality. Median progression-free survival (PFS)/overall survival (OS) in the higher NLR group (NLR ≥ 4.14) and lower NLR group (NLR < 4.14) were 194/468 days versus 73/237 days, respectively. Kaplan-Meier analysis showed that higher NLR significantly correlated with poorer PFS (p = 0.011) and OS (p = 0.045). Conclusions. NLR may serve as a new biomarker to predict responses to GN-based chemotherapy in advanced bladder cancer patients and/or their prognosis.

    PubMed

    researchmap

  • Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy. International journal

    Yoko Maeda, Takashi Kawahara, Mitsuyuki Koizumi, Hiroki Ito, Yohei Kumano, Mari Ohtaka, Takuya Kondo, Taku Mochizuki, Yusuke Hattori, Jun-Ichi Teranishi, Yasushi Yumura, Yasuhide Miyoshi, Masahiro Yao, Hiroshi Miyamoto, Hiroji Uemura

    BioMed research international   2016   6197353 - 6197353   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Introduction. The neutrophil-to-lymphocyte ratio (NLR), which can be easily calculated from routine complete blood counts of the peripheral blood, has been suggested to serve as a prognostic factor for some solid malignancies. In the present study, we aimed to determine the relationship between NLR in prostate cancer patients undergoing radical prostatectomy (RP) and their prognosis. Materials and Methods. We assessed NLR in 73 men (patients) who received RP for their prostate cancer. We also performed immunohistochemistry for CD8 and CD66b in a separate set of RP specimens. Results. The median NLR in the 73 patients was 1.85. There were no significant correlations of NLR with tumor grade (p = 0.834), pathological T stage (p = 0.082), lymph node metastasis (p = 0.062), or resection margin status (p = 0.772). Based on the area under the receiver operator characteristic curve (AUROC) to predict biochemical recurrence after RP, potential NLR cut-off point was determined to be 2.88 or 3.88. However, both of these cut-off points did not precisely predict the prognosis. There were no statistically significant differences in the number of CD66b-positive neutrophils or CD8-positive lymphocytes between stromal tissues adjacent to cancer glands and stromal tissues away from cancer glands and between different grades or stages of tumors. Conclusions. There was no association between NLR and biochemical failure after prostatectomy.

    DOI: 10.1155/2016/6197353

    PubMed

    researchmap

  • Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy. International journal

    Takashi Kawahara, Sachi Fukui, Kentaro Sakamaki, Yusuke Ito, Hiroki Ito, Naohito Kobayashi, Koji Izumi, Yumiko Yokomizo, Yasuhide Miyoshi, Kazuhide Makiyama, Noboru Nakaigawa, Takeharu Yamanaka, Masahiro Yao, Hiroshi Miyamoto, Hiroji Uemura

    Oncotarget   6 ( 31 )   32169 - 76   2015.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Neutrophil-to-lymphocyte ratio (NLR), a simple marker of systemic inflammatory response, has been demonstrated as an independent prognosticator for some solid malignancies, including prostate cancer. In the present study, we evaluated the role of NLR in men who underwent prostate needle biopsy for their initial diagnosis of prostatic carcinoma. Both complete blood counts and free/total (F/T) prostate-specific antigen (PSA) ratio were examined in a total of 3,011 men in our institution. Of these, 1,207 had a PSA level between 4 and 10 ng/mL, and 357 of 810 who subsequently underwent prostate needle biopsy were found to have prostatic adenocarcinoma. NLR value was significantly higher in men with PSA of ≥ 20 ng/mL than in those with PSA of < 20 ng/mL (p < 0.001). NLR was also significantly higher in men with positive biopsy than in those with negative biopsy (p < 0.001). Using NLR cut-off point of 2.40 determined by the AUROC curve, positive/negative predictive values of NLR alone and NLR combined with F/T PSA ratio (cut-off: 0.15) were 56.6%/60.8% and 80.7%/60.1%, respectively. Multivariate analysis revealed that not only F/T PSA ratio (HR = 3.13) but also NLR (HR = 2.21) was an independent risk factor for prostate cancer. NLR is thus likely elevated in patients with prostate cancer. Accordingly, NLR, with or without combination with F/T PSA ratio, may function as a new biomarker to predict prostate cancer in men undergoing prostate needle biopsy.

    DOI: 10.18632/oncotarget.5081

    PubMed

    researchmap

  • Clinical factors prolonging the operative time of flexible ureteroscopy for renal stones: a single-center analysis. International journal

    Hiroki Ito, Shinnosuke Kuroda, Takashi Kawahara, Kazuhide Makiyama, Masahiro Yao, Junichi Matsuzaki

    Urolithiasis   43 ( 5 )   467 - 75   2015.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The objective of the study was to evaluate the clinical factors affecting the operative time of flexible ureteroscopy (fURS). We retrospectively evaluated 233 patients with renal stones who had been treated successfully and had stone-free status 3 months after fURS and holmium laser lithotripsy between December 2009 and December 2013 at a single institute. Operative time was divided into three periods (total, before fragmentation, and after starting fragmentation), and associations between possible factors and these periods were analyzed by a multivariate logistic regression model with backward selection. The mean total operative time was 74.0 ± 32.0 min. There were significant differences in the following clinical factors: sex, body height, stone volume, maximum and mean Hounsfield units (HUs), diameter of the ureteral access sheath, and experience of the surgeon, between patients who underwent procedures with a total operative time of less or more than 90 min. A multivariate assessment revealed four independent factors influencing total operative time (P < 0.05): stone volume (P < 0.001), experience of the surgeon (P < 0.001), maximum HUs (P = 0.014), and lack of preoperative stenting (P = 0.027). Larger stone volume, lower experience level of the surgeon, higher HUs, and the absence of preoperative stenting were identified as parameters prolonging the total operative time of fURS and, in particular, the operative time after starting fragmentation. On the other hand, operative time before starting fragmentation, which represented the time required to identify the stone by ureteroscopy and insert the access sheath, was more difficult to predict preoperatively.

    DOI: 10.1007/s00240-015-0789-x

    PubMed

    researchmap

  • Development and Internal Validation of a Classification System for Predicting Success Rates After Endoscopic Combined Intrarenal Surgery in the Modified Valdivia Position for Large Renal Stones. International journal

    Shinnosuke Kuroda, Hiroki Ito, Kentaro Sakamaki, Tadashi Tabei, Takashi Kawahara, Hideyuki Terao, Atsushi Fujikawa, Kazuhide Makiyama, Masahiro Yao, Junichi Matsuzaki

    Urology   86 ( 4 )   697 - 702   2015.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To identify preoperative predictors and to develop a classification system for predicting success rate after endoscopic combined intrarenal surgery (ECIRS) in the modified Valdivia position for renal stone treatment. PATIENTS AND METHODS: We retrospectively analyzed 329 consecutive, single-session ECIRS procedures undertaken in the modified Valdivia position to treat renal stones. The successful status after surgery was determined at 1 month postoperatively using noncontrast computed tomography and was defined as the absence of stones or residual fragments measuring <4 mm. The preoperative factors analyzed included the stone statuses, which were determined by noncontrast computed tomography, and the patients' characteristics. A multivariate logistic regression model with backward selection was used to evaluate the relationships between the preoperative factors and a successful status after ECIRS, and a classification system was developed to predict a stone-free status based on the preoperative factors. RESULTS: The overall successful outcome rate was 65.3%. Multivariate analysis determined 2 independent predictors of ECIRS outcomes, namely, the stone surface areas (P = .001) and the number of involved calyces (P = .001). These parameters were used to develop the classification system for predicting the successful status after ECIRS. CONCLUSION: Stone surface areas and the number of involved calyces independently predicted the successful status after ECIRS. This is the first study to identify the independent predictors and develop a classification table for predicting success rates after ECIRS in the modified Valdivia position.

    DOI: 10.1016/j.urology.2015.07.002

    PubMed

    researchmap

  • [Tubeless Percutaneous Nephrolithotomy].

    Hideyuki Terao, Hiroki Ito, Takashi Kawahara, Yoshitake Kato, Junichi Matsuzaki

    Hinyokika kiyo. Acta urologica Japonica   61 ( 8 )   313 - 6   2015.8

     More details

    Language:Japanese  

    We assessed our initial experience with tubeless percutaneous nephrolithotomy (PCNL). Between February 2011 and December 2013, we performed 155 tubeless PCNL and 54 standard PCNL in which nephrostomy tubes were used postoperatively. Tubeless PCNL was performed when the presence of residual fragments, bleeding, and extravasation were excluded intraoperatively. The incidence of complications, hospital stay duration, analgesic requirements, visual analog scale score, decrease in hemoglobin levels, and stone-free rates were compared between the two groups. The mean hospital stay after tubeless PCNL was shorter (5.1 days) than that after standard PCNL (6.8 days, P<0.05). Transient fever was seen in 20 patients (13.8%) in the tubeless PCNL group and 12 patients (25.5%) in the standard PCNL group. Tubeless PCNL is a safe and effective procedure, and hospital stay is shorter with tubeless PCNL than with standard PCNL.

    PubMed

    J-GLOBAL

    researchmap

  • Long-term caloric restriction in rats may prevent age related impairment of in vitro bladder function. International journal

    Hiroki Ito, Naoki Aizawa, Yasunori Fujita, Motofumi Suzuki, Hiroshi Fukuhara, Yukio Homma, Yoshinobu Kubota, Masafumi Ito, Karl-Erik Andersson, Yasuhiko Igawa

    The Journal of urology   193 ( 6 )   2123 - 30   2015.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: Bladder function is often impaired with aging. In other organs caloric restriction has had a prophylactic effect on the biological changes associated with aging. We tested the hypothesis that long-term caloric restriction can prevent age related impaired bladder function in the rat. MATERIALS AND METHODS: Fisher 344 male rats were divided into 3 groups, including 16 young rats at age 6 months with free access to normal food, 15 old rats at age 25 to 28 months with free access to normal food and 16 old rats at age 25 to 28 months fed with normal food 3 days per week since age 6 weeks (caloric restriction). We performed frequency volume measurements, in vitro organ bath functional studies using full-thickness longitudinal detrusor strips, evaluation of muscarinic and purinergic receptor mRNA expression, and histological examination with Masson trichrome staining of bladder tissue. RESULTS: Frequency volume changes did not significantly differ among the 3 groups. The old group fed normal food showed weaker contractile responses to carbachol and electrical field stimulation (especially in the cholinergic component), lower M3 receptor mRNA expression and higher collagen deposition compared to the young group. These age related bladder changes were milder in the old group with caloric restriction than in the old group fed normal food. CONCLUSIONS: This study suggests that in the rat long-term caloric restriction has a preventive effect against age related functional and morphological bladder changes. These changes include impaired detrusor contractility that may be related to decreased expression of M3 receptors and to bladder wall fibrosis.

    DOI: 10.1016/j.juro.2014.11.005

    PubMed

    researchmap

  • Selective inhibitory effect of imidafenacin and 5-hydroxymethyl tolterodine on capsaicin sensitive C fibers of the primary bladder mechanosensitive afferent nerves in the rat. International journal

    Naoki Aizawa, Hiroki Ito, Rino Sugiyama, Tetsuya Fujimura, Motofumi Suzuki, Hiroshi Fukuhara, Yukio Homma, Yasuhiko Igawa

    The Journal of urology   193 ( 4 )   1423 - 32   2015.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: Imidafenacin and fesoterodine are used to treat overactive bladder. Imidafenacin, fesoterodine and its active metabolite 5-hydroxymethyl tolterodine are muscarinic receptor antagonists. It is believed that these agents act on afferent nerves in addition to smooth muscle. We investigated the effects of imidafenacin and 5-hydroxymethyl tolterodine on single unit afferent activity of mechanosensitive capsaicin sensitive and insensitive primary bladder afferent nerve fibers in rats. MATERIALS AND METHODS: Female Sprague Dawley® rats were anesthetized. Single unit afferent activity was recorded from the L6 dorsal roots and classified by conduction velocity as that of Aδ or C fibers. After measuring control single afferent activity during constant filling cystometry the procedure was repeated with intravenous administration of imidafenacin (0.3 to 30 μg/kg) or 5-hydroxymethyl tolterodine (0.01 to 1 mg/kg) at cumulative doses with or without intravesical capsaicin or oxotremorine-M instillation. RESULTS: A total of 139 single unit afferent fibers were isolated from 111 rats, including 19 Aδ and 120 C fibers. Neither imidafenacin nor 5-hydroxymethyl tolterodine significantly affected the overall single unit afferent activity of Aδ or C fibers. Based on capsaicin sensitivity C fibers were divided into capsaicin sensitive and insensitive groups. Each antimuscarinic inhibited the single unit afferent activity of capsaicin sensitive C fibers but not of capsaicin insensitive C fibers at the highest dose. Moreover, oxotremorine-M facilitated single unit afferent activity in a proportion of C fibers. The facilitated single unit afferent activity was significantly attenuated by the highest dose of imidafenacin. CONCLUSIONS: These findings demonstrate that imidafenacin and 5-hydroxymethyl tolterodine can selectively inhibit capsaicin sensitive C fibers among mechanosensitive bladder afferents by antagonizing bladder muscarinic receptors.

    DOI: 10.1016/j.juro.2014.09.005

    PubMed

    researchmap

  • Preoperative factors predicting spontaneous clearance of residual stone fragments after flexible ureteroscopy. International journal

    Hiroki Ito, Shinnosuke Kuroda, Takashi Kawahara, Kazuhide Makiyama, Masahiro Yao, Junichi Matsuzaki

    International journal of urology : official journal of the Japanese Urological Association   22 ( 4 )   372 - 7   2015.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To investigate factors predicting spontaneous clearance of residual renal fragments after flexible ureteroscopy. METHODS: Among 546 patients who underwent lithotripsy with flexible ureteroscopy, 81 had residual renal fragments, as determined by kidney-ureter-bladder films on postoperative day 1. The final outcome was determined at 3 months after the last flexible ureteroscopy session using non-contrast computed tomography. Patient characteristics and preoperative factors were analyzed using the unpaired t-test and χ(2)-test. Correlations between the possible predictive factors and the spontaneous clearance of residual renal fragments after flexible ureteroscopy were analyzed using a multivariate logistic regression model with backward selection. RESULTS: Non-contrast computed tomography at postoperative month 3 showed that 33 cases (40.7%) had spontaneous clearance of residual renal fragments, whereas 48 (59.3%) showed non-clearance. Significant differences were found between these cases in terms of stone number, stone location, presence of lower pole calculi and preoperative stent placement. Multivariate assessment showed that stone number (P = 0.004), presence of lower pole calculi (P = 0.021) and presence of hydronephrosis (P = 0.024) were independent predictors of the spontaneous clearance of residual renal fragments after flexible ureteroscopy. CONCLUSIONS: Stone number, presence of lower pole calculi and presence of hydronephrosis are independent predictive factors of the spontaneous clearance of residual renal fragments after flexible ureteroscopy.

    DOI: 10.1111/iju.12690

    PubMed

    researchmap

  • Development and internal validation of a nomogram for predicting stone-free status after flexible ureteroscopy for renal stones. International journal

    Hiroki Ito, Kentaro Sakamaki, Takashi Kawahara, Hideyuki Terao, Kengo Yasuda, Shinnosuke Kuroda, Masahiro Yao, Yoshinobu Kubota, Junichi Matsuzaki

    BJU international   115 ( 3 )   446 - 51   2015.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To develop and internally validate a preoperative nomogram for predicting stone-free status (SF) after flexible ureteroscopy (fURS) for renal stones, as there is a need to predict the outcome of fURS for the treatment of renal stone disease. PATIENTS AND METHODS: We retrospectively analysed 310 fURS procedures for renal stone removal performed between December 2009 and April 2013. Final outcome of fURS was determined by computed tomography 3 months after the last fURS session. Assessed preoperative factors included stone volume and number, age, sex, presence of hydronephrosis and lower pole calculi, and ureteric stent placement. Multivariate logistic regression analysis with backward selection was used to model the relationship between preoperative factors and SF after fURS. Bootstrapping was used to internally validate the nomogram. RESULTS: Five independent predictors of SF after fURS were identified: stone volume (P < 0.001), presence of lower pole calculi (P = 0.001), operator with experience of >50 fURS (P = 0.026), stone number (P = 0.075), and presence of hydronephrosis (P = 0.047). We developed a nomogram to predict SF after fURS using these five preoperative characteristics. Total nomogram score (maximum 25) was derived from summing individual scores of each predictive variable; a high total score was predictive of successful fURS outcome, whereas a low total score was predictive of unsuccessful outcome. The area under the receiver operating characteristics for nomogram predictions was 0.87. CONCLUSION: The nomogram can be used to reliably predict SF based on patient characteristics after fURS treatment of renal stone disease.

    DOI: 10.1111/bju.12775

    PubMed

    researchmap

  • Ureteroscopy-assisted retrograde nephrostomy for a large and obstructive renal pelvic stone: a case report. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Journal of medical case reports   9   44 - 44   2015.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: We have previously described the use of ureteroscopy-assisted retrograde nephrostomy. However, reaching the target calyx with the ureteroscope is difficult in patients with obstructive renal pelvic stones. CASE PRESENTATION: A 53-year-old Japanese woman was referred to our department for the treatment of a right renal stone. She was admitted to our department for percutaneous nephrolithotomy of a right renal stone located at her ureteropelvic junction. A Lawson retrograde nephrostomy puncture wire was subsequently inserted into the flexible ureteroscope, and we successfully punctured the calyx from the target spot to the skin. The nephrostomy was dilated, and the stone fragments were obtained and removed. CONCLUSIONS: We here report the case of a large and obstructive renal stone successfully treated with percutaneous nephrolithotomy using the ureteroscopy-assisted retrograde nephrostomy technique.

    DOI: 10.1186/s13256-015-0529-4

    PubMed

    researchmap

  • Double ureteral access sheath (UAS) technique for complicated distal ureteral stone. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Urolithiasis   43 ( 1 )   99 - 100   2015.2

     More details

  • Ureteroscopy-assisted retrograde nephrostomy (UARN) without ureteral access sheath (UAS). International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Hiroji Uemura, Masahiro Yao, Junichi Matsuzaki

    International journal of surgery case reports   10   56 - 8   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: We previously described ureteroscopy assisted retrograde nephrostomy (UARN). In UARN, it is possible to continuously visualize the dilation of the ureter from puncture to insertion of the nephroaccess sheath with minimal complication. But in the course of making nephrostomy, UARN requires ureteral access sheath (UAS). UAS has a potential risk of ureteral stricture. Herein, we report the first case of UARN without the use of UAS. PRESENTATION OF CASE: A 53-year-old female was referred to our hospital for treatment of her right renal stone. Because her stone burden was 27mm, we planned to perform percutaneous nephrolithotomy (PCNL) using UARN without UAS. DISCUSSION: UAS facilitates a decrease in the intrarenal pressure due to irrigation, and it makes controlling the URS easier. However, in terms of the risk of ureteral stricture, unnecessary insertion of a UAS should be avoided. CONCLUSION: We describe the first case of a renal stone successfully treated by PCNL using the UARN method without the use of a UAS.

    DOI: 10.1016/j.ijscr.2015.03.014

    PubMed

    researchmap

  • Discolored ureteral stents: findings in urinalysis and urine culture. International journal

    Takashi Kawahara, Hiroshi Miyamoto, Hiroki Ito, Hideyuki Terao, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    PloS one   10 ( 4 )   e0122984   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: Discolored ureteral stents are sometimes encountered in daily clinical practice; however, the mechanism(s) underlying the development of discolored ureteral stents remain unknown. In this study, we retrospectively analyzed the characteristics of discolored ureteral stents based on the results of a urinalysis and urine culture. MATERIALS & METHODS: We identified a total of 26 patients with discolored ureteral stents and compared the findings in the urinalyses and urine culture in 21 discolored versus 45 non-colored ureteral stents. RESULTS: The median and mean (± SD) duration of stenting time was 78.0 and 81.3 (± 21.3) days for the discolored ureteral stents and 69.0 and 74.9 (± 19.8) days for the non-colored ureteral stents, respectively (P = 0.25). The discolored ureteral stents were associated with a higher mean urine pH than the non-colored ureteral stents (mean: 6.4 vs 6.0, P< 0.05). There were no significant differences between the two groups in the RBC (P = 0.51) and WBC (P = 0.35) counts in the urinalyses. In addition, the rate of a positive culture in the patients with discolored stents [20 of 21 (95.2%)] was significantly (P <0.01) higher than that observed in the patients with non-colored ureteral stents [33 of 45 (73.3%)]. CONCLUSIONS: In this study, the subjects with discolored ureteral stents showed a significantly higher likelihood of having a positive urine culture and also demonstrated higher pH values in the urinalyses. However, no clear cut-off point to predict discoloration was indicated.

    DOI: 10.1371/journal.pone.0122984

    PubMed

    researchmap

  • Inhibition of peripheral FAAH depresses activities of bladder mechanosensitive nerve fibers of the rat. International journal

    Naoki Aizawa, Petter Hedlund, Claudius Füllhase, Hiroki Ito, Yukio Homma, Yasuhiko Igawa

    The Journal of urology   192 ( 3 )   956 - 63   2014.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: FAAH degrades endocannabinoids and fatty acid amides. FAAH inhibition reduces micturition frequency and counteracts bladder overactivity in rats. We studied the effects of the peripherally active selective FAAH inhibitor URB937, and the CB1 and CB2 receptor antagonists rimonabant and SR144528, respectively, on single unit afferent activity of primary bladder afferents in rats. MATERIALS AND METHODS: Female Sprague Dawley® rats were anesthetized. Single unit afferent activity of Aδ or C-fibers from the L6 dorsal roots was recorded during bladder filling before and after URB937 administration with or without rimonabant or SR144528. Drugs (1 mg/kg) were given intravenously. FAAH, CB1 and CB2 expression, and expression of the sensory marker CGRP in the L6 dorsal root ganglion were compared by immunofluorescence. RESULTS: A total of 102 single afferent fibers (48 Aδ and 54 C-fibers) were isolated from 57 rats. URB937 decreased single unit afferent activity of C-fibers to a mean ± SEM of 78% ± 9% and of Aδ-fibers to a mean of 67% ± 7% while increasing bladder compliance to a mean of 116% ± 3%. The effects of URB937 on single unit afferent activity and bladder compliance were counteracted by rimonabant or SR144528. Rimonabant increased single unit afferent activity of each fiber type but SR144528 affected only Aδ-fiber activity. CGRP positive L6 dorsal root ganglion neurons showed strong FAAH, CB1 and CB2 staining. CONCLUSIONS: To our knowledge we report for the first time that inhibiting peripheral FAAH depresses the Aδ and C-fiber activity of primary bladder afferents via CB1 and CB2 receptors. CB antagonists alone exerted facilitatory effects on single unit afferent activity during bladder filling in rats. The endocannabinoid system may be involved in physiological control of micturition as regulators of afferent signals.

    DOI: 10.1016/j.juro.2014.04.008

    PubMed

    researchmap

  • Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas. International journal

    Masahiro Yao, Takayuki Murakami, Koichi Shioi, Nobuhiko Mizuno, Hiroki Ito, Keiichi Kondo, Hisashi Hasumi, Futoshi Sano, Kazuhide Makiyama, Noboru Nakaigawa, Takeshi Kishida, Yoji Nagashima, Shoji Yamanaka, Yoshinobu Kubota

    Cancer medicine   3 ( 4 )   845 - 54   2014.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    High serum calcium (Ca) due to aberrant secretion of tumor parathyroid hormone-like hormone (PTHLH) is a well-known paraneoplastic sign and is associated with poor prognosis in patients with renal cell carcinoma (RCC). However, the status of serum Ca and tumor PTHLH expression have not been verified using the 2004 World Health Organization (WHO) renal tumor classification. We retrospectively reviewed corrected serum Ca levels at initial onset (n = 683) and/or as of recurrence (n = 71) in patients with RCC. We also examined a total of 623 renal parenchymal tumor samples for PTHLH mRNA expressions by quantitative real-time PCR. High serum Ca concomitant with PTHLH overexpression in tumors was observed exclusively in clear cell RCC but not in other non clear cell subtype tumors, including papillary, chromophobe, collecting-duct, unclassified, and other rare subtype RCCs or in benign oncocytomas and angiomyolipomas. In clear cell RCC, PTHLH expression was significantly high in male patients, and was associated with a symptomatic presentation, higher grade, and higher stage cases, whereas it was not associated with VHL gene status. Univariate analyses demonstrated that high PTHLH expression was strongly associated with poor outcome both in overall survival (OS) and disease-free survival (DFS) for patients who underwent standard nephrectomy. Further multivariate Cox analyses revealed that the PTHLH expressions remained as independent prognostic parameters for OS but not for DFS. These data suggest that the previously characterized tumor signatures of high serum Ca due to high PTHLH expression and poor prognosis are clear cell RCC-specific features, whereas these characteristics are rare in non clear cell RCCs.

    DOI: 10.1002/cam4.270

    PubMed

    researchmap

  • Changes in the function and expression of T-type and N-type calcium channels in the rat bladder after bladder outlet obstruction. International journal

    Yasuhiko Igawa, Shintaro Kumano, Naoki Aizawa, Yasuho Saito, Hiroki Ito, Shuzo Watanabe, Nobuyuki Takahashi, Masaomi Tajimi, Hiroaki Nishimatsu, Yukio Homma

    The Journal of urology   191 ( 4 )   1159 - 67   2014.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: We evaluated possible changes in the function and expression of T-type and N-type Ca(2+) channels in the bladder of rats with bladder outlet obstruction. MATERIALS AND METHODS: Female Sprague Dawley® rats were divided into a group with bladder outlet obstruction created by partial urethral ligation and a sham operated group. Six weeks postoperatively we determined the mRNA expression of T-type and N-type Ca(2+) channels in the bladder, dorsal root ganglion and spinal cord. We also cystometrically investigated expression by intravenous administration of the T-Ca blocker RQ-00311610 or the N-type Ca(2+) channel blocker ω-conotoxin GVIA. We then performed in vitro functional studies of detrusor strips using these blockers. RESULTS: mRNA expression of T-type Ca(2+) channels in the bladder detrusor and mucosa layers, and the spinal cord dorsal horn, and N-type Ca(2+) channels in the whole bladder and detrusor layer, and the spinal cord dorsal horn was greater in the obstructed group than the sham operated group. In obstructed rats bladder capacity and voided volume increased after RQ-00311610 administration but the number of nonvoiding contractions decreased after ω-conotoxin GVIA administration. Detrusor strips from obstructed rats showed weaker contractile responses to electrical field stimulation, particularly in regard to the purinergic component. ω-Conotoxin GVIA suppressed electrical field stimulation induced contractions only in the detrusor of obstructed rats, especially the cholinergic component. CONCLUSIONS: Blocking T-type Ca(2+) channels increased bladder capacity while N-type Ca(2+) channel blockade inhibited nonvoiding contractions in rats with bladder outlet obstruction. Decreased bladder efferent neurotransmission occurred after bladder outlet obstruction, predominantly in its purinergic component and detrusor contractions via cholinergic neurotransmission were activated in a compensatory manner, probably via N-type Ca(2+) channel up-regulation.

    DOI: 10.1016/j.juro.2013.10.027

    PubMed

    researchmap

  • Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin. International journal

    Hiroki Ito, Futoshi Sano, Takehiko Ogawa, Masahiro Yao

    International journal of urology : official journal of the Japanese Urological Association   21 ( 1 )   108 - 12   2014.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We investigated the Core Lower Urinary Tract Symptom Score as an outcome assessment tool for the treatment of lower urinary tract symptoms using silodosin. In addition, the ability of the Core Lower Urinary Tract Symptom Score to detect overactive bladder in male patients with lower urinary tract symptoms was examined. The present study included 241 males with benign prostatic hyperplasia treated at 31 medical facilities between June 2009 and December 2010. All patients were given silodosin, and the effects of silodosin intake were measured using four questionnaires: the Core Lower Urinary Tract Symptom Score, International Prostate Symptom Score, Overactive Bladder Symptom Score and Quality-of-Life index. The efficacy of silodosin for treating lower urinary tract symptoms was validated according to the total scores of all four questionnaires weighted equally (P < 0.05). Spearman's ρ among the Core Lower Urinary Tract Symptom Score, International Prostate Symptom Score and Overactive Bladder Symptom Score showed a mild-high correlation. However, the correlation between the baseline values of the Core Lower Urinary Tract Symptom Score and Quality-of-Life index was low in the groups with benign prostatic hyperplasia (ρ = 0.314) and benign prostatic hyperplasia/overactive bladder (ρ = 0.244). Our findings showed the Core Lower Urinary Tract Symptom Score, both its total score and each subscore, is able to show the efficacy of silodosin, similar to other questionnaires. The Core Lower Urinary Tract Symptom Score is also useful for identifying overactive bladder symptoms in patients with benign prostatic hyperplasia. As the Core Lower Urinary Tract Symptom Score does not correlate well with the Quality-of-Life index, these two questionnaires might be better used in combination to assess treatment outcomes.

    DOI: 10.1111/iju.12167

    PubMed

    researchmap

  • Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia. International journal

    Takashi Kawahara, Satoshi Morita, Hiroki Ito, Hideyuki Terao, Ryoko Sakata, Hitoshi Ishiguro, Katsuyuki Tanaka, Hiroshi Miyamoto, Junichi Matsuzaki, Yoshinobu Kubota, Hiroji Uemura

    BMC urology   13   30 - 30   2013.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Nocturia is defined as waking one or more times during the night due to the urge to void. Recently, the effectiveness of several sedatives and analgesics for nocturia has been reported. We herein investigated the effects of ramelteon, an antioxidant and sleep inducer, on nocturia unresponsive to α1-blocker monotherapy in males with lower urinary tract symptoms (LUTS) as a pilot study. METHODS: Subjects were 19 patients who had LUTS suggestive of benign prostate hyperplasia, received α1-blockers (tamsulosin, silodosin, or naftopidil), and continued to have two or more episodes of nocturia per night before starting ramelteon. Ramelteon at 8 mg once daily for one month was added to the α1-blocker. A self-administered questionnaire including the International Prostate Symptom Score (IPSS), quality of life (QoL) index, Overactive Bladder Symptom Score (OABSS), and Nocturia Quality-of-Life Questionnaire (N-QOL) were assessed before and one month after starting ramelteon. RESULTS: The mean score on IPSS question 7 (nocturia) decreased significantly from 2.88 before starting ramelteon to 2.41 one month after starting the medication (P = 0.03). The mean total OABSS decreased significantly from 6.31 to 5.38 (P = 0.03), and the mean for OABSS question 2 (nighttime frequency of nocturia) also significantly decreased from 2.63 to 2.13 (P = 0.01). The mean total N-QOL score did not change significantly. Two patients had dizziness; the remaining patients had no adverse drug-related events. CONCLUSIONS: Ramelteon in combination with an α1-blocker could be a treatment option for reducing nocturia in men with BPH.

    DOI: 10.1186/1471-2490-13-30

    PubMed

    researchmap

  • Evaluation of preoperative measurement of stone surface area as a predictor of stone-free status after combined ureteroscopy with holmium laser lithotripsy: a single-center experience. International journal

    Hiroki Ito, Takashi Kawahara, Hideyuki Terao, Takehiko Ogawa, Masahiro Yao, Yoshinobu Kubota, Junichi Matsuzaki

    Journal of endourology   27 ( 6 )   715 - 21   2013.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: To investigate the utility and limitations of stone surface area (SA) as a predictor of stone-free (SF) status after a single semirigid ureteroscopy (URS), with or without a flexible component, for the treatment of patients with urinary stones. PATIENTS AND METHODS: Cases of patients with urinary stones treated by combined URS with holmium laser lithotripsy at a single institute were retrospectively evaluated. Correlations of possible predictors with SF status were analyzed using a logistic regression model. Two types of SA were measured: "Traced stone surface area" (tSA) and "calculated stone surface area" (cSA). RESULTS: According to the univariate analysis, the following variables were significantly associated with non-SF status: Stone number (P<0.001), ureteral stone location (P=0.045), presence of renal stones (P<0.001), tSA (P<0.001), cSA (P<0.001), stone volume (P<0.001), and operator experience (P=0.02). According to multivariate analysis, stone volume (P=0.016) was an independent predictor of SF status. The scatter diagrams for tSA and cSA showed strong correlations between these parameters, and Spearman ρ was 0.975. CONCLUSIONS: Stone volume and SA were highly indicative of stone status after single semirigid URS, with or without a flexible component. The formula for cSA, maximum diameter×width×π×1/4, was demonstrated to accurately represent SA in this study. SA, however, indicated a lower clinical priority and utility as a predictor of stone status than stone volume. The combination of semirigid and flexible URS could access any ureteral stones, including those that semirigid URS alone could not treat. The cutoff points for these predictors of outcome were 110.0 mm(2) for cSA, 125.0 mm(2) for tSA, and 840.0 mm(3) for stone volume.

    DOI: 10.1089/end.2012.0548

    PubMed

    researchmap

  • Authors' response to Chew and Lange. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Hiroshi Miyamoto, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Journal of endourology   27 ( 4 )   507 - 507   2013.4

     More details

  • Correlation between the operation time using two different power settings of a Ho: YAG laser: laser power doesn't influence lithotripsy time. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Yoshitake Kato, Katsuyuki Tanaka, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    BMC research notes   6   80 - 80   2013.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: This study investigated the correlation between the operation time using two different power settings of a Ho: YAG laser. FINDINGS: A total of 68 patients underwent cystolithotripsy from April 2010 to October 2011 In Fifty-six of these patients underwent cystolithotripsy by one surgeon using a Ho: YAG laser for bladder calculi. This study assessed these patients in two groups; the 30 W laser generator group with the settings of 2.5 J x 5 Hz (30 W group) and the 100 W laser generator group as the settings of 3.5 J x 5 Hz (100 W group). The operation time in these two groups were assessed.A total of 56 patients including 45 male and 11 female patients that underwent cystolithotripsy using a Ho: YAG laser for bladder calculi by one surgeon were enrolled in this study. The patients' characteristics including age (mean; 68.8 vs 68.4 yr), gender (male; 74.2 vs 88.0%), stone burden (mean; 34.9 vs 41.3 mm), number of stones (mean; 3.2 vs 2.0) and stone's CT density (mean; 981.5 vs 902.0 HU) showed no significant differences. All patients were stone free following treatment. The median total length of the operation was 19 minutes (mean: 34.6 ± 36.1) in the 30 W group and 29 minutes (mean: 44.4 ± 38.8) in the 100 W group, which was not significantly different. CONCLUSIONS: The results showed that the power settings of Ho: YAG laser show no differences in the operation time for bladder calculi lithotripsy.

    DOI: 10.1186/1756-0500-6-80

    PubMed

    researchmap

  • Early ureteral catheter removal after ureteroscopic lithotripsy using ureteral access sheath. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Manabu Kakizoe, Yoshitake Kato, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Urolithiasis   41 ( 1 )   31 - 5   2013.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A ureteral access sheath (UAS) can facilitate ureteroscopy (URS) and the retrieval of stone fragments while reducing the intrarenal pressure, thereby improving irrigate flow and decreasing the length of an operation. Ureteral stenting after URS is unnecessary for uncomplicated cases. This study examined the early removal of postoperative ureteral catheterization after URS for cases that used a UAS. A total of 93 patients underwent ureteroscopic lithotripsy with the early removal of ureteral catheterization. Sixty-three of these patients underwent surgery with the use of UAS and were analyzed in this study. Postoperative hydronephrosis was assessed using ultrasonography 3 days after the operation and computed tomography 2 weeks after operation in all patients. Post-operative complications including fever, prolonged hospitalization, frequent usage of painkillers and the re-insertion of ureteral stent were also investigated. Hydronephrosis was detected 3 days after the operation in 34 patients (54.0 %) and 2 weeks after the operation in four patients (6.3 %). No hydronephrosis was detected after a 2-month follow-up in these four patients. The mean operation time in the hydronephrosis group was significantly higher at 58.9 min than in the non-hydronephrosis group at 45.5 min (p < 0.05). Post-operative fever (38 °C) was seen in one case, the frequent usage of painkillers was seen in four cases, a prolonged hospital stay was seen in five cases, and ureteral stent re-insertion was observed in one case. The early removal of ureteral catheterization can be safely performed for the patients that undergo URS with UAS.

    DOI: 10.1007/s00240-012-0518-7

    PubMed

    researchmap

  • Comparison of the loss of renal function after cold ischemia open partial nephrectomy, warm ischemia laparoscopic partial nephrectomy and laparoscopic partial nephrectomy using microwave coagulation. International journal

    Takashi Kawahara, Ryoko Sakata, Kimiko Kawahara, Hiroki Ito, Yasuhide Miyoshi, Futoshi Sano, Noboru Nakaigawa, Hiroji Uemura, Masahiro Yao, Yoshinobu Kubota, Kazuhide Makiyama

    Current urology   6 ( 3 )   118 - 23   2013.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: Nephron sparing surgery is an effective surgical option in patients with renal cell carcinoma. Laparoscopic partial nephrectomy involves clamping and unclamping techniques of the renal vasculature. This study compared the postoperative renal function of partial nephrectomy using an estimation of the glomerular filtration rate (eGFR) for a Japanese population in 3 procedures; open partial nephrectomy in cold ischemia (OPN), laparoscopic partial nephrectomy in warm ischemia (LPN), and microwave coagulation using laparoscopic partial nephrectomy without ischemia (MLPN). MATERIALS AND METHODS: A total of 57 patients underwent partial nephrectomy in Yokohama City University Hospital from July 2002 to July 2008. 18 of these patients underwent OPN, 17 patients received MLPN, and 22 patients had LPN. The renal function evaluation included eGFR, as recommended by The Japanese Society of Nephrology. RESULTS: There was no significant difference between the 3 groups in the reduction of eGFR. eGFR loss in the OPN group was significantly higher in patients that experienced over 20 minutes of ischemia time. eGFR loss in LPN group was significantly higher in patients that experienced over 30 minutes of ischemia time. CONCLUSION: This study showed that all 3 procedures for small renal tumor resection were safe and effective for preserving postoperative renal function.

    DOI: 10.1159/000343524

    PubMed

    researchmap

  • Re: Ito et al.: The most reliable preoperative assessment of renal stone burden as a predictor of stone-free status after flexible ureteroscopy with holmium laser lithotripsy: a single-center experience (Urology 2012;80:524-528). Reply by the authors. International journal

    Hiroki Ito, Takashi Kawahara, Hideyuki Terao, Junichi Matsuzaki, Takehiko Ogawa, Masahiro Yao, Yoshinobu Kubota

    Urology   81 ( 1 )   217 - 217   2013.1

     More details

  • Utility and limitation of cumulative stone diameter in predicting urinary stone burden at flexible ureteroscopy with holmium laser lithotripsy: a single-center experience. International journal

    Hiroki Ito, Takashi Kawahara, Hideyuki Terao, Takehiko Ogawa, Masahiro Yao, Yoshinobu Kubota, Junichi Matsuzaki

    PloS one   8 ( 6 )   e65060   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: To retrospectively assess the clinical utility in ureteroscopy (URS) planning of cumulative stone diameter (CSD), which does not account for stone width or depth, as a predictor of URS outcome and compare it with stone volume. MATERIALS AND METHODS: Patients with renal stones treated at a single institute by flexible URS were retrospectively evaluated. To assess the clinical utility of CSD, relationships between stone-free (SF) status and stone burden (CSD and volume) were analyzed using the area under the receiver operating characteristics (AUROC) curve. To identify stone number impact on CSD, the AUROC of CSD divided by stone number was evaluated. Correlation coefficients of CSD and stone volume were also calculated for groups by stone number. RESULTS: In cases with CSD <20.0 mm, CSD and stone volume revealed equal ability to predict SF status. In cases with CSD ≥20.0 mm, stone volume showed higher predictive ability. The ROC curves for cases with ≥4 stones showed that CSD was less predictive of SF status than stone volume. The correlation coefficients of CSD and stone volume by stone number were 0.922 for 1 stone, 0.900 for 2-3 stones, and 0.661 for ≥4 stones. CONCLUSIONS: In cases with CSD ≥20.0 mm or ≥4 stones, we should evaluate stone volume for a more predictive stone burden, and pretreatment non-contrast CT seems sufficient. In cases with CSD <20.0 mm or 1-3 stones, CSD was as valid a predictor of preoperative stone burden as stone volume, so preoperative kidney-ureter-bladder (KUB) films may be sufficient.

    DOI: 10.1371/journal.pone.0065060

    PubMed

    researchmap

  • Changing to a loop-type ureteral stent decreases patients' stent-related symptoms. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Urological research   40 ( 6 )   763 - 7   2012.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The first indwelling ureteral splint was described in 1967. A ureteral stent can cause unpleasant side effects, such as urinary frequency, urgency, incontinence, hematuria, bladder pain and flank pain, which have a negative impact on a patient's quality of life. It is necessary to minimize the amount of material in the bladder in order to decrease stent-related symptoms. This study investigated the stent-related symptoms after changing from a double pigtail to a loop-type ureteral stent in the same patient group. This study followed 25 patients who underwent ureteral stent exchange from double pigtail to loop-type ureteral stent between September 2009 and February 2010. Ureteral stents were exchanged using topical, conscious sedation and general anesthesia for the various procedures including stent exchange, before/after shock wave lithotripsy and before/after ureteroscopy. The stent length was selected to be the same as whole ureteral length and the caliber based on the previous stent. A self-administered stent-related symptom questionnaire was used to assess stent-related symptoms in comparison to the previous double-pigtail stents. A total of 25 patients with a median age of 56.5 years underwent ureteral stent exchange. All patients had stone disease except two patients who had ureteral stricture. Almost all of stent-related symptoms without nocturia showed a significantly lower score with the loop-type ureteral stent than in double-pigtail stent. None of the patients experienced urinary tract infection either before or after undergoing ureteral stent exchange. Changing to loop-type ureteral stent significantly decreased ureteral stent-related symptoms.

    DOI: 10.1007/s00240-012-0500-4

    PubMed

    researchmap

  • Ureteroscopy-assisted retrograde nephrostomy (UARN) for an incomplete double ureter. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Yoshitake Kato, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Urological research   40 ( 6 )   781 - 2   2012.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00240-012-0486-y

    PubMed

    researchmap

  • Amplatz sheath for cystolithotripsy using Ho: YAG laser in female patients. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Yoshitake Kato, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Urology   80 ( 5 )   1154 - 5   2012.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To evaluate the effectiveness of cystoscopic lithotripsy, we performed Amplatz sheath technique using Ho: YAG laser. Maheshwari first reported the use of an Amplatz sheath in the female urethra in 1998, and Okeke et al reported the use of an Amplatz sheath for male patients during cystolithotripsy in 2004. The usefulness of the holmium (Ho): yttrium aluminum garnet (YAG) laser lithotripsy is widely accepted, even for large bladder calculi. Since then, there have been no more reports of using the sheath with an Ho: YAG laser. TECHNICAL CONSIDERATIONS: We inserted the Amplatz sheath conversely. Because of the clear visualization, we used higher laser settings with 2.5 J × 15 to 20 Hz. RESULTS: We experienced 3 female patients that were successfully treated with the Amplatz sheath technique using Ho: YAG laser lithotripsy. In these 3 patients, whose stone burdens were 4.5, 3.8, and 4.3 cm, they were able to successfully become stone-free with surgeries of 74 minutes, 67 minutes, and 58 minutes, respectively, with no complications. CONCLUSION: We experienced 3 female patients that were successfully treated with the Amplatz sheath technique using Ho: YAG laser lithotripsy.

    DOI: 10.1016/j.urology.2012.07.046

    PubMed

    researchmap

  • [Malignant priapism due to metastatic papillary renal cell carcinoma : a case report].

    Taku Mochizuki, Hiroki Ito, Kayo Kurita, Hanako Ishigaki, Hirofumi Hayashi, Ayako Horita, Ikuo Saito, Kotaro Hirai

    Hinyokika kiyo. Acta urologica Japonica   58 ( 10 )   549 - 52   2012.10

     More details

    Language:Japanese  

    A 70-year-old man presented in December, 2010 with priapism persistent for over a month. The patient had no history of medications for erectile dysfunction, penis trauma, or traumatic sexual activities. A blood gas measurement of the cavernosum was performed, but only fibrosis tissue was aspirated and no blood was obtained. Color-flow Doppler imaging of the penis revealed blood flow in the corpora cavernosa of the penis, suggesting the occurrence of nonischemic priapism. Enhanced chest and abdominal computed tomography revealed a left renal cyst, and the wall of the cyst showed contrast enhancement. No other obvious obstructive mass or tumor was detected in the pelvic cavity. Gradually, necrotic changes of the glans penis appeared, and total penectomy was performed. Histopathological examination of penectomy tissue specimens suggested papillary renal cell carcinoma metastases to the penis. Consequently, open left radical nephrectomy was performed. Pathological diagnosis revealed papillary renal cell carcinoma pT2, and the patient was diagnosed with stage IV (pT2N0M1) renal cell carcinoma. Treatment was provided by intravenous temsirolimus therapy that resulted in partial remission and stable disease, which in turn relieved cancer pain.

    PubMed

    J-GLOBAL

    researchmap

  • Predictive value of attenuation coefficients measured as Hounsfield units on noncontrast computed tomography during flexible ureteroscopy with holmium laser lithotripsy: a single-center experience. International journal

    Hiroki Ito, Takashi Kawahara, Hideyuki Terao, Takehiko Ogawa, Masahiro Yao, Yoshinobu Kubota, Junichi Matsuzaki

    Journal of endourology   26 ( 9 )   1125 - 30   2012.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: To assess the utility of attenuation coefficients as predictors of surgical outcome after a single flexible ureteroscopy (URS) with holmium laser lithotripsy. Many reports indicate that the efficacy of extracorporeal shockwave lithotripsy (SWL) can be predicted by the target's radiofrequency attenuation, measured as Hounsfield units (HUs) on noncontrast CT (NCCT). Studies of flexible URS, however, have not assessed the predictive value of attenuation coefficients on NCCT. PATIENTS AND METHODS: Patients with renal stones who were treated by flexible URS with holmium laser lithotripsy between December 2009 and October 2011 at a single institute were retrospectively evaluated. Stone-free (SF) status was determined by kidneys-ureters-bladder (KUB) radiography at postoperative month 3. Correlations of possible predictors with SF status were analyzed using a logistic regression model. The comparison between groups with low and high HUs was examined using the Mann-Whitney U test. RESULTS: There were 219 eligible procedures. According to the logistic regression model, the maximum attenuation coefficient (P=0.105) and average attenuation coefficient (P=0.175) did not significantly, independently predict SF status. Fragmentation efficiency was significantly different between cases with low and high attenuation coefficients (P=0.001). In groups with less than 20.0-mm diameter stones, overall operative time (P<0.001 and P=0.001) and the time from starting fragmentation (P<0.001 and P=0.002) were significantly high in both attenuation groups. In groups with stones greater than 20.0 mm diameter, the two definitions of operative time revealed no differences between the low and high attenuation groups. The retrospective study design was the major limitation of this study. CONCLUSIONS: We found that both the maximum and average attenuation coefficients on NCCT are significantly related to the fragmentation efficiency. In addition, this study showed that, in patient groups with stone a burden <20.0 mm in diameter, both the maximum and average attenuation coefficients were significantly predictive of operative time.

    DOI: 10.1089/end.2012.0154

    PubMed

    researchmap

  • Ureteroscopy assisted retrograde nephrostomy for complete staghorn renal calculi. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Current urology   6 ( 2 )   102 - 5   2012.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Complete staghorn calculi are typically managed with percutaneous nephrolithotomy (PCNL). However, dilating nephrostomy and inserting a nephro access sheath can be difficult to perform without hydronephrosis. We reported the procedure of ureteroscopy-assisted retrograde nephrostomy (UARN) during PCNL. UARN is effective without dilating the renal collecting system in cases of complete staghorn calculi. A 63-year old female with a left complete staghorn renal calculus was referred to our hospital. Under general and epidural anesthesia, the patient was placed in a modified-Valdivia position. A flexible ureteroscope was inserted and a Lawson retrograde nephrostomy puncture wire was advanced into the flexible ureteroscope. The puncture wire was forwarded along the route from the renal pelvis to the exit skin. Calculus fragmentation was done using a pneumatic lithotripter and the Ho: YAG laser. UARN during PCNL was effective for the treatment of a complete staghorn calculus.

    DOI: 10.1159/000343519

    PubMed

    researchmap

  • The most reliable preoperative assessment of renal stone burden as a predictor of stone-free status after flexible ureteroscopy with holmium laser lithotripsy: a single-center experience. International journal

    Hiroki Ito, Takashi Kawahara, Hideyuki Terao, Takehiko Ogawa, Masahiro Yao, Yoshinobu Kubota, Junichi Matsuzaki

    Urology   80 ( 3 )   524 - 8   2012.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To examine which parameters should be measured to preoperatively determine the stone burden as predictors of stone-free (SF) status after a single flexible ureteroscopy (URS). Although several stone parameters reportedly influence the outcome of treatment for urinary stones, the most reliable indicators of stone burden remain unclear. METHODS: Patients with renal stones treated by flexible URS with holmium laser lithotripsy between October 2009 and December 2011 at a single institute were retrospectively evaluated. The SF status was determined by kidney-ureter-bladder (KUB) films at postoperative day 1. Correlations of possible predictors with the SF status were analyzed using a logistic regression model. RESULTS: According to the univariate analysis, the following variables were significantly associated with failed treatment: number of stones (P = .001), cumulative stone diameter (CSD) (P < .001), stone surface area (SA) (P < .001), stone volume (P < .001), and presence of lower pole calculi (P = .008). According to the multivariate analysis, the stone volume (P < .001) and the CSD (P = .015) were found to be independent predictors of SF status. The SA (P = .598) had no significant independent influence on the SF status. CONCLUSION: Among the several parameters regarding the renal stone burden, the stone volume determined by noncontrast computed tomography and the CSD of the KUB were significantly and independently inversely related to the success rate of URS. Among the 3 parameters of stone burden, the SA was found to have a lower clinical utility and priority as a predictor of a SF status after URS.

    DOI: 10.1016/j.urology.2012.04.001

    PubMed

    researchmap

  • Preoperative stenting for ureteroscopic lithotripsy for a large renal stone. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Hanako Ishigaki, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    International journal of urology : official journal of the Japanese Urological Association   19 ( 9 )   881 - 5   2012.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A large renal stone can be treated ureteroscopically, but the treatment often requires more than one procedure. The use of stenting before ureteroscopy was recently reported. The present study investigated the effectiveness of preoperative stenting before ureteroscopic lithotripsy for large (>15 mm) renal stones. A ureteral stent was intentionally inserted in 25 patients undergoing ureteroscopic surgery. A group of 36 non-prestented patients was used as control. Median stone diameter was 21 mm in both groups. Pre-ureteroscopy stenting significantly improved the stone-free rate, defined as stones <2 mm and <4 mm (P < 0.05), whereas it did not significantly improve the stone-free rate defined as 0 mm (P = 0.12). The uretereoscopy success rate was 72.0% in the stented and 55.6% in the control group (P = 0.09). A 14/16-Fr ureteral access sheath was successfully inserted in 94.7% of the stented patients, and 74.2% of the non-stented patients (P < 0.05). Our findings showed that preoperative stenting is effective for dilation of the ureter, and also to facilitate the insertion of a ureteral access sheath in patients undergoing ureteroscopic lithotripsy for large renal stones.

    DOI: 10.1111/j.1442-2042.2012.03046.x

    PubMed

    researchmap

  • C-reactive protein in patients with advanced metastatic renal cell carcinoma: usefulness in identifying patients most likely to benefit from initial nephrectomy. International journal

    Hiroki Ito, Koichi Shioi, Takayuki Murakami, Akitoshi Takizawa, Futoshi Sano, Takashi Kawahara, Nobuhiko Mizuno, Kazuhide Makiyama, Noboru Nakaigawa, Takeshi Kishida, Takeshi Miura, Yoshinobu Kubota, Masahiro Yao

    BMC cancer   12   337 - 337   2012.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: C-reactive protein (CRP) is considered a useful serum marker for patients with RCC. However, its clinical utility in advanced metastatic renal cell carcinoma (AM-RCC), particularly in deciding whether to perform nephrectomy at the onset, is not well studied. PATIENTS AND METHODS: We retrospectively evaluated 181 patients with AM-RCC, including 18 patients underwent potentially curative surgery, 111 underwent cytoreductive nephrectomy, and 52 received medical treatment only. CRP cutoff points were determined by receiver operating characteristic (ROC) curve analysis. Kaplan-Meier and Cox regression analyses were used for survival tests. RESULTS: ROC analysis suggested that grouping patients according to 3 CRP ranges was a rational model. Patients with highly elevated CRP (≥67.0 mg/L) presented remarkably poor prognosis despite treatment (nephrectomy or medical treatment only). Cox regression models demonstrated that risk factors of overall survival for patients who underwent nephrectomy were the CRP ranges defined in this study (≤18.0 mg/L, >18.0 and <67.0 mg/L, and ≥67.0 mg/L), ECOG PS (0, 1, and ≥2), and number of metastatic organ sites (0-1 and ≥2). The retrospective design is a limitation of this study. CONCLUSION: Our study demonstrated that the serum CRP level is a statistically significant prognostic parameter for patients with AM-RCC. The data also indicated that pretreatment serum CRP level provides useful prognostic information that helps in deciding whether to perform initial nephrectomy for patients with AM-RCC.

    DOI: 10.1186/1471-2407-12-337

    PubMed

    researchmap

  • Ureteroscopy assisted retrograde nephrostomy: a new technique for percutaneous nephrolithotomy (PCNL). International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Minoru Yoshida, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    BJU international   110 ( 4 )   588 - 90   2012.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    UNLABELLED: Study Type - Therapy (case series). Level of Evidence 4. What's known on the subject? and What does the study add? Retrograde nephrostomy was first developed by Lawson et al. in 1983, and Hunter et al. reported 30 cases of retrograde nephrostomy in 1987. This procedure uses less radiation exposure and has a shorter duration compared with the previous percutaneous nephrostomy techniques. Retrograde nephrostomy using Lawson's procedure was reported in the late 1980s by several authors. But since then, few studies have been reported about this procedure due to the development of ultrasonography assisted percutaneous nephrostomy. With the arrival and development of the flexible ureteroscope (URS) both observation and manipulation in the renal pelvis are now easily achieved. The present procedure provides less radiation exposure, less bleeding, and a shorter procedure than previous percutaneous nephrostomy techniques. Using this procedure, after the needle has exited through the skin, no further steps are required in preparation for dilatation. In the present study, we continuously visualised from puncture to inserting the nephron-access sheath with the URS. OBJECTIVE: • To describe a technique for ureteroscopy assisted retrograde nephrostomy. PATIENTS AND METHODS: • Under general and epidural anaesthesia, the patient is placed in a modified-Valdivia position. Flexible ureteroscopy is carried out, and a Lawson retrograde nephrostomy puncture wire is placed in the ureteroscope (URS). • After the needle has exited through the skin, no further steps are required in preparation for dilatation. RESULTS: • After informed consent was obtained, two patients (a 43-year-old man with left renal stones and a 57-year-old woman with right renal stones) underwent this procedure. • The URS was positioned in the middle posterior calyx and punctured toward the skin. CONCLUSIONS: • This procedure involves less radiation exposure and shorter surgery than the previous percutaneous nephrostomy technique. • Our technique represents another new option for percutaneous nephrolithotomy in patients with a non-dilated intrarenal collecting system.

    DOI: 10.1111/j.1464-410X.2011.10795.x

    PubMed

    researchmap

  • Stone area and volume are correlated with operative time for cystolithotripsy for bladder calculi using a holmium: yttrium garnet laser. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Scandinavian journal of urology and nephrology   46 ( 4 )   298 - 303   2012.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: This study investigated the correlation between the operation time and the stone size as determined by multiple modalities and the computed tomography (CT) densities of bladder calculi using holmium: yttrium garnet (Ho:YAG) laser lithotripsy. MATERIAL AND METHODS: A total of 68 patients underwent cystolithotripsy from March 2010 to October 2011. Thirty-six of these patients underwent cystolithotripsy using a Ho:YAG laser for bladder calculi by a single surgeon. The stone size was assessed by six modalities: sum of the stones' diameters: stone burden; maximum stone's diameter; number of stones; sum of the area using axial CT; sum of area using kidney-ureter-bladder (KUB) films; and volume using CT. In addition, the stone's CT density was measured by: the mean CT density of the maximum stone's whole area; maximum CT density of the maximum stone's whole area; and mean CT density of the maximum stone's center area. Correlations between the operation time and the stone size and the stone CT density were assessed. RESULTS: A total of 36 patients (30 male and six female) who underwent cystolithotripsy using a Ho:YAG laser for bladder calculi were enrolled in this study. Spearman correlation showed that the area and volume were strongly correlated with the operative time. The multipliers between the stone size and stone CT density showed no advantages based on the stone area or volume alone. CONCLUSION: The area and volume of the stones correlated more closely with the operation time than the stone burden for bladder calculi lithotripsy using a Ho:YAG laser.

    DOI: 10.3109/00365599.2012.672456

    PubMed

    researchmap

  • Ureteroscopy-assisted retrograde nephrostomy for lower calyx calculi in horseshoe kidney: two case reports. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Katsuyuki Tanaka, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Journal of medical case reports   6   194 - 194   2012.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: We previously reported on the effectiveness of ureteroscopy-assisted retrograde nephrostomy during percutaneous nephrolithotomy and report two cases of lower calyx calculi in horseshoe kidney that were successfully treated with ureteroscopy-assisted retrograde nephrostomy. During the ureteroscopy-assisted retrograde nephrostomy procedure, a ureteroscope is advanced in the desired calyx and a Lawson retrograde nephrostomy puncture wire is inserted. The wire is advanced through the calyx to exit the skin. The wire is then used for the percutaneous dilation. CASE PRESENTATION: Case 1 was a 68-year-old man who was shown on radiography to have left lower calyx calculi (19 × 15mm, 7 × 5mm, and 7 × 3mm) in horseshoe kidney. Case 2 was a 36-year-old woman shown on radiography to have a left lower calyx calculus (10 × 8mm) in horseshoe kidney. CONCLUSIONS: Both patients were stone-free after ureteroscopy-assisted retrograde nephrostomy during percutaneous nephrolithotomy. Ureteroscopy-assisted retrograde nephrostomy is a promising procedure for safely and effectively treating lower calyx stones in horseshoe kidney.

    DOI: 10.1186/1752-1947-6-194

    PubMed

    researchmap

  • Which is the best method to estimate the actual ureteral length in patients undergoing ureteral stent placement? International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Minoru Yoshida, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    International journal of urology : official journal of the Japanese Urological Association   19 ( 7 )   634 - 8   2012.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: To define the best modality for estimating ureteral length in patients undergoing ureteral stent placement. METHODS: This study enrolled 151 patients (169 ureters) undergoing stent insertion. In all of them, an intravenous urography and non-contrast computed tomography were carried out. The actual ureteral length was determined by direct measurement using a 5-Fr ureteral catheter. A multivariate analysis evaluated the association between the ureteral length and each of the following parameters: body height, body surface area, ureteral trace by intravenous urography, linear distance (liner distance 1) from the ureteropelvic junction to the ureterovesical junction by intravenous urography, linear distance (liner distance 2) from the mid kidney to the ureterovesical junction by intravenous urography, and the distance from the level of the renal vein to the ureterovesical junction by axial computed tomography (axial computed tomography distance). RESULTS: The mean actual ureteral length was 23.2 cm (median 24 cm, range 16-29 cm). The Spearman correlation coefficients for body height, body surface area, ureteral trace, liner distance 1, liner distance 2 and axial computed tomography distance were 0.3126, 0.3076, 0.4541, 0.5230, 0.4796 and 0.6168, respectively. Axial computed tomography distance showed the best correlation with the actual ureteral length. CONCLUSION: The axial computed tomography distance as calculated by the axial computed tomography can more reliably predict the actual ureteral length than other parameters. Further studies are required to show the best method for estimating the actual ureteral length in patients undergoing ureteral stent placement.

    DOI: 10.1111/j.1442-2042.2012.02998.x

    PubMed

    researchmap

  • Ureteroscopy-assisted retrograde nephrostomy for percutaneous nephrolithotomy after urinary diversion. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Case reports in nephrology and urology   2 ( 2 )   113 - 7   2012.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A 33-year-old male with an ileal conduit was referred to our department for the treatment of left renal calculi. After inserting a ureteral access sheath, a ureteroscopy-assisted retrograde nephrostomy was made. Percutaneous nephrolithotomy was successfully achieved using this nephrostomy.

    DOI: 10.1159/000342338

    PubMed

    researchmap

  • Ureteral stent encrustation, incrustation, and coloring: morbidity related to indwelling times. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Minoru Yoshida, Junichi Matsuzaki

    Journal of endourology   26 ( 2 )   178 - 82   2012.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND AND PURPOSE: Ureteral stents are a fundamental part of many urologic procedures. Serious complications, including migration, fragmentation, and stone formation, still occur, especially when stents have been forgotten for a long time. No widespread consensus for the type or indwelling time to avoid ureteral stent complications has been reached, however. We investigated the correlation between the indwelling time and encrustation, incrustation, coloration, and resistance to removal. PATIENTS AND METHODS: A total of 330 ureteral stents in 181 patients were examined. RESULTS: Overall, 155 (47.0%) stents were encrusted, and the encrustation rate was 26.8% at less than 6 weeks, 56.9% at 6 to 12 weeks, and 75.9% at more than 12 weeks. A total of 46 (13.9%) stents resisted removal, and 3 of these could not be removed by cystoscopy. The median indwelling time was 72 (14-124) days for stents that resisted removal and 31 (30-60) days for irremovable stents. The frequency of encrustation with coloration was higher than that without coloration in the period of less than 6 weeks and the period between 6 to 12 weeks of indwelling time. CONCLUSIONS: In our study, although ureteral stent encrustation was related to the indwelling time, heavily encrusted ureteral stents necessitating additional procedures for removal occurred within an indwelling time of 3 months. The exact interval for removal of an indwelling ureteral stent to avoid additional procedures for removal is therefore difficult to determine.

    DOI: 10.1089/end.2011.0385

    PubMed

    researchmap

  • [The use of negative pressure wound therapy to treat wound necrosis and groin lymphorrhea after inguinal lymph nodes dissection: a case report].

    Hiroki Ito, Masayuki Arao, Hanako Ishigaki, Akira Shirai, Tomomi Yamasaka, Kotaro Hirai

    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology   103 ( 1 )   22 - 6   2012.1

     More details

    Language:Japanese  

    Wound necrosis and groin lymphorrhea after inguinal lymph nodes dissection are serious complications. But treatment options for these complications are somewhat controversial. We report a patient who underwent an inguinal lymph node dissection for a regional metastasized squamous cell carcinoma of penis. Unfortunately, a extensive wound necrosis occurred with lymphorrhea (300 cc daily). After operative debridement, negative pressure wound therapy was started. We had used the instrument "V.A.C. (Vacuum Assisted Closure) ATS Therapy System" (KCI U.S.A.). After 11 days of negative pressure wound therapy, the good formation granulation tissue was observed and the lymphatic leakage was prominently decreased. This therapy was performed without serious complications but tolerable localized pain due to negative pressure. There were only seven reports that gave the description of an approach using negative pressure wound therapy for the less invasive treatment of lymphocutaneous fistulas and evaluated the efficacy of this therapy as an alternative medical procedure for treating lymphorrhea. This case suggested that negative pressure wound therapy could not only promote wound healing but also improve intractable lymphorrhea.

    PubMed

    J-GLOBAL

    researchmap

  • Ureteroscopy-Assisted Retrograde Nephrostomy (UARN) after Anatrophic Nephrolithotomy. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Yoshitake Kato, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Case reports in medicine   2012   164963 - 164963   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Introduction. Open surgical anatrophic nephrolithotomy (ANL) had been the standard treatment for large renal calculi prior to the development of endoscopic devices and endoscopic techniques. A previous report described the efficacy of ureteroscopy-assisted retrograde nephrostomy (UARN) and presented a case of renal calculi successfully treated with UARN during percutaneous nephrolithotomy (PCNL) in a patient after ANL. Case Presentation. A 61-year-old male with left renal calculi was referred for further treatment. The patient was placed under general and epidural anesthesia, in a Galdakao-modified Valdivia position. A flexible ureteroscope (URS) was inserted, and a Lawson retrograde nephrostomy puncture wire was advanced into the flexible URS. The puncture wire then followed the route from the renal pelvis to the exit skin. Calculus fragmentation was undertaken using a pneumatic lithotripter. Conclusions. UARN for PCNL was therefore found to be a safe, effective, and appropriate treatment for a patient presenting with renal calculi after undergoing ANL.

    DOI: 10.1155/2012/164963

    PubMed

    researchmap

  • Encrusted Ureteral Stent Retrieval Using Flexible Ureteroscopy with a Ho: YAG Laser. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Case reports in medicine   2012   862539 - 862539   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A 23-year-old female had bilateral ureteral stents placed due to bilateral renal stones and hydronephrosis. The bilateral ureteral stents were changed every 3 months. A kidney ureter bladder (KUB) film showed left encrustation along the ureteral stent thus necessitating removal; however, the ureteral stent could not be removed cystoscopically. The ureteral stent was, therefore, extracted using flexible ureteroscopy (URS) with a holmium (Ho): yttrium aluminum garnet (YAG) laser.

    DOI: 10.1155/2012/862539

    PubMed

    researchmap

  • Ureteral stent exchange under fluoroscopic guidance using the crochet hook technique in women. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Yuzo Yamashita, Katsuyuki Tanaka, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Urologia internationalis   88 ( 3 )   322 - 5   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: We developed a method for ureteral stent exchange in female patients under fluoroscopic guidance using a crochet hook technique (CHEX). PATIENTS AND METHODS: A total of 45 female patients (51 stents) underwent exchange of ureteral stents. In these patients, 21 ureteral stents were exchanged using CHEX. All procedures were carried out with the patients under conscious sedation. At the time of the procedures, we extracted the ureteral stent from the external urethral orifice using CHEX under fluoroscopic guidance and inserted the new stent under fluoroscopic guidance without cystoscopy. RESULTS: 20 of the 21 stents (95.2%) were successfully exchanged. Ureteral stent exchange using CHEX was unsuccessful in 1 patient, including migration to the ureter. CONCLUSIONS: Ureteral stent exchange using a crochet hook is easy, safe and cost-effective. This technique was also easy to learn.

    DOI: 10.1159/000336870

    PubMed

    researchmap

  • Ureteral stent retrieval using the crochet hook technique in females. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Takuya Yamagishi, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    PloS one   7 ( 1 )   e29292   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: We developed a method for ureteral stent removal in female patients that requires no cystoscopy or fluoroscopic guidance using a crochet hook. In addition, we also investigated the success rate, complications and pain associated with this procedure. METHODS: A total of 40 female patients (56 stents) underwent the removal of ureteral stents. All procedures were carried out with the patients either under anesthesia, conscious sedation, or analgesic suppositories as deemed appropriate for each procedure including Shock Wave Lithotripsy (SWL), Ureteroscopy (URS), Percutaneous Nephrolithotomy (PCNL), and ureteral stent removal. At the time of these procedures, fluoroscopy and/or cystoscopy were prepared, but they were not used unless we failed to successfully remove the ureteral stent using the crochet hook. In addition, matched controls (comprising 50 stents) which were removed by standard ureteral stent removal using cystoscopy were used for comparison purposes. RESULTS: A total of 47 of the 56 stents (83.9%) were successfully removed. In addition, 47 of 52 (90.4%) were successfully removed except for two migrated stents and two heavily encrusted stents which could not be removed using cystoscopy. Ureteral stent removal using the crochet hook technique was unsuccessful in nine patients, including two encrustations and two migrations. Concerning pain, ureteral stent removal using the crochet hook technique showed a lower visual analogue pain scale (VAPS) score than for the standard technique using cystoscopy. CONCLUSIONS: Ureteral stent removal using a crochet hook is considered to be easy, safe, and cost effective. This technique is also easy to learn and is therefore considered to be suitable for use on an outpatient basis.

    DOI: 10.1371/journal.pone.0029292

    PubMed

    researchmap

  • Choosing an appropriate length of loop type ureteral stent using direct ureteral length measurement. International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Minoru Yoshida, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    Urologia internationalis   88 ( 1 )   48 - 53   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: The ureteral stent is now a fundamental part of many urological procedures. To decrease ureteral stent-related symptoms, loop type ureteral stent was developed. However the most important factor to decrease urinary symptoms is choosing the optimal length of a ureteral stent. We investigated the relationship between the actual ureteral length and the loop type ureteral stent position. MATERIALS AND METHODS: A total of 226 loop type polyurethane ureteral stents (156 patients) were inserted with four options for stent length (20, 22, 24 and 26 cm). The ureteral length was measured using a ruled 5-Fr ureteral catheter. The appropriateness of stent position was defined into three groups based on kidney-ureter-bladder films. RESULTS: Nine stents (3.9%) migrated, 171 stents (75.7%) were in the appropriate position and 46 stents (19.5%) were overlong. The rate of migration rate and overlong stents closely correlated with the ureteral length when the proximal end of the stent was in the renal pelvis. CONCLUSIONS: It is appropriate to choose a loop type ureteral stent that is the same or 1 cm less than the length of the ureter when the proximal end of the stent will be in the renal pelvis.

    DOI: 10.1159/000332431

    PubMed

    researchmap

  • Effectiveness of ureteroscopy-assisted retrograde nephrostomy (UARN) for percutaneous nephrolithotomy (PCNL). International journal

    Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Yoshitake Kato, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki

    PloS one   7 ( 12 )   e52149   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To determine the impact of ureteroscopy-assisted retrograde nephrostomy (UARN) during percutaneous nephrolithotomy (PCNL). MATERIALS AND METHODS: From April 2009 to September 2011, a total of 50 patients underwent PCNL for large renal stones (stone burden >2 cm). We performed UARN in the Galdakao-modified Valdivia position for 27 patients (UARN PCNL) and ultrasonography-assisted percutaneous nephrostomy in the prone position for 23 patients (prone PCNL). RESULTS: UARN PCNL significantly improved the stone-free rate (81.5% vs 52.2%) and the rate of residual stones (<4 mm, 92.6% vs 65.2%, P<0.05). The median length of the operation was significantly shorter for UARN PCNL, at 160 min, compared to 299 min for prone PCNL (P<0.001). There was one intraoperative complication in prone PCNL, namely a hemorrhage that resulted in stopping the initial treatment, but it was cured conservatively. The postoperative complications included a high grade fever that persisted for three days in two UARN PCNL patients (7.4%) and six prone PCNL patients (26.1%). The Clavien grading scores showed significantly lower postoperative complications for UARN PCNL compared to prone PCNL. CONCLUSION: UARN is associated with a higher stone-free rate, shorter operation time, and fewer complications during PCNL than prone PCNL.

    DOI: 10.1371/journal.pone.0052149

    PubMed

    researchmap

  • High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy. International journal

    Takashi Kawahara, Hisashi Oshiro, Zenkichi Sekiguchi, Hiroki Ito, Kazuhide Makiyama, Hiroji Uemura, Yoshinobu Kubota

    International journal of urology : official journal of the Japanese Urological Association   18 ( 12 )   851 - 3   2011.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We report a case of high-grade invasive urothelial carcinoma with plasmacytoid differentiation of the urinary bladder. A 75-year-old woman was referred to our hospital because of macroscopic hematuria. Cystoscopy detected a solid pedunculated bladder tumor, and a transurethral resection of the bladder tumor (TUR-Bt) and the image findings showed pT1N0M0 bladder cancer. The histopathological examination revealed the coexistence of a large component of high-grade invasive urothelial carcinoma and a small component of plasmacytoid carcinoma. Following the TUR-Bt, external beam radiotherapy and chemotherapy with gemcitabine and nedaplatin were carried out. The bladder tumor has not recurred for 2 years after the TUR-Bt.

    DOI: 10.1111/j.1442-2042.2011.02880.x

    PubMed

    researchmap

  • A case of squamous cell carcinoma arising from a suprapubic cystostomy tract. International journal

    Hiroki Ito, Masayuki Arao, Hanako Ishigaki, Noboru Ohshima, Ayako Horita, Ikuo Saito, Kotaro Hirai

    BMC urology   11   20 - 20   2011.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Patients with spinal cord injury and a chronic indwelling urinary catheter are known to have an increased risk of bladder malignancy. However, squamous cell carcinoma (SCC) of the epidermis around a suprapubic cystostomy is relatively rare. Here, we report a case of lower abdominal SCC arising from the suprapubic cystostomy tract. CASE PRESENTATION: A 58-year-old man with a complete spinal cord injury was referred to our hospital with a chief complaint of an abdominal mass. Abdominal enhanced computed tomography (CT) showed a 7-cm mass surrounding the suprapubic cystostomy and bilateral inguinal and para-aortic lymph nodes metastasis. Histopathological examination of percutaneous biopsy specimens was performed. The diagnosis was stage IV (cT4N1M1) epidermal SCC, which was treated with palliative external radiation therapy. CONCLUSION: The SCC in this case was thought to arise from mechanical stimulus of the suprapubic cystostomy. Physicians and patients should pay careful attention to any signs of neoplasms with long-term indwelling catheters, such as skin changes around the suprapubic cystostomy site. This case presentation is only the fourth report of SCC arising from the suprapubic cystostomy tract in the literature. In cases of unresectable tumors and contraindications to chemotherapy, palliative radiotherapy may lead to disease remission and symptom relief.

    DOI: 10.1186/1471-2490-11-20

    PubMed

    researchmap

  • Retroperitoneoscopic radical nephrectomy with a small incision for renal cell carcinoma: comparison with the conventional method. International journal

    Hiroki Ito, Kazuhide Makiyama, Takashi Kawahara, Futoshi Sano, Takayuki Murakami, Narihiko Hayashi, Yasuhide Miyoshi, Noboru Nakaigawa, Masahiro Yao, Yoshinobu Kubota

    Journal of negative results in biomedicine   10   11 - 11   2011.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: When retroperitoneoscopic radical nephrectomy for renal cell carcinoma was introduced into our institution, we performed a combined small skin incision method. In this method, a small incision was made to approach the retroperitoneal space prior to setting trockers and thereafter a LAPDISC was placed in the incision to start the retroperitoneoscopic procedure. In this study, we compared the outcomes between the combined small skin incision method ("A method" hereinafter) and the conventional method ("B method" hereinafter). MATERIAL AND METHODS: Among the cases of T1N0M0 suspicious renal cell carcinoma treated at Yokohama City University between May 2003 and June 2009, the A method was performed in 51 cases and the B method was performed in 33 cases. The factors in the outcomes compared between the A and B methods were the duration of procedure, volume of bleeding, volume of transfusion, weight of the specimen, incidence of peritoneal injury, rate of conversion to open surgery, and perioperative complications. RESULTS: The duration of the procedure was 214.4 ± 46.9 minutes in the A method group and 208.1 ± 36.4 minutes in the B method group (p = 0.518). The volume of bleeding and the weight of the specimen were 105.5 ± 283.2 ml and 335.1 ± 137.4 g in the A method group and 44.8 ± 116 ml (p = 0.247) and 309.2 ± 126 g (p = 0.385) in the B method group. There was no significant difference in all factors analyzed. CONCLUSION: The A method would be highly possible to produce stable results, even during the introduction period when the staff and the institution are still unfamiliar with the retroperitoneoscopic surgery.

    DOI: 10.1186/1477-5751-10-11

    PubMed

    researchmap

  • Efficacy of tension-free vaginal tape compared with transobturator tape in the treatment of stress urinary incontinence in women: analysis of learning curve, perioperative changes of voiding function. International journal

    Hiroki Ito, Hiroyuki Yamanaka, Masayuki Hagiwara, Toru Furuuchi, Kazuhiro Matsumoto, Kunimitsu Kanai, Kiichiro Kodaira, Akiharu Ninomiya, So Nakamura

    BMC urology   11   13 - 13   2011.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: In this study, by comparing TVT surgery and TOT surgery for stress urinary incontinence in women, the characteristics and learning curves of both operative methods were studied. METHODS: A total of 83 women with stress urinary incontinence treated with tension-free vaginal tape (TVT) (n = 38) or transobturator tape (TOT) (n = 45) at Saiseikai Central Hospital between April 2004 and September 2009 were included. We compare the outcomes and learning curves between TVT surgery and TOT surgery. In statistical analysis, Student's t test, Fisher's exact test, and Mann-Whitney's U test were used. RESULTS: The surgical durations were 37.4 ± 15.7 minutes with TVT surgery and 31.0 ± 8.3 minutes with TOT surgery. A longer period of time was required for TVT surgery (p = 0.025). The residual urine at post-operative day 1 was higher in TVT surgery (25.9 ± 44.2 ml) than in TOT surgery (10.6 ± 19.2 ml) (p = 0.0452). The surgical duration of TVT surgery was shortened after the operator had performed 15 operations (p = 0.019). CONCLUSIONS: In comparison of TVT surgery and TOT surgery, the surgical duration of TVT surgery was longer and the residual urine of TVT surgery was higher at post-operative day 1. Surgical experience could shorten the duration of TVT surgery.

    DOI: 10.1186/1471-2490-11-13

    PubMed

    researchmap

  • Spontaneous renal hemorrhage in hemodialysis patients. International journal

    Takashi Kawahara, Kimiko Kawahara, Hiroki Ito, Satoshi Yamaguchi, Hiroshi Mitsuhashi, Kazuhide Makiyama, Hiroji Uemura, Masashi Sakai, Yoshinobu Kubota

    Case reports in nephrology and urology   1 ( 1 )   1 - 6   2011.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Dialysis patients have a tendency to bleed, and clinicians sometimes encounter cases with a significant amount of spontaneous hemorrhage. We herein report two cases of spontaneous renal hemorrhage in hemodialysis patients. CASE 1: A 70-year-old male who had received hemodialysis for 8 years presented with right abdominal pain. He had a history of renal failure due to diabetes mellitus. CT showed a right perirenal hemorrhage. Angiography revealed a right renal artery hemorrhage, and catheter embolization was performed. CASE 2: A 76-year-old male who had undergone 7 years of continuous ambulatory peritoneal dialysis and 1 year of hemodialysis presented with right abdominal pain. He had a history of renal failure due to IgA nephropathy. CT showed a right perirenal hemorrhage. He received a blood transfusion and was put on absolute bed rest. At 2 days after admission, his anemia was found to have improved.

    DOI: 10.1159/000330192

    PubMed

    researchmap

  • [Assessments of quality of life in women with urinary incontinence using: King's Health Questionnaire and International Consultation on Incontinence Questionnaire-Short Form].

    Hiroki Ito, Masayuki Hagiwara, Toru Furuuchi, Kunimitsu Kanai, Kiichiro Kodaira, Akiharu Ninomiya, So Nakamura

    Hinyokika kiyo. Acta urologica Japonica   56 ( 5 )   255 - 9   2010.5

     More details

    Language:Japanese  

    The differences in quality of life (QOL) impairment due to urinary incontinence between elderly and younger women were evaluated using King's Health Questionnaire (KHQ) and International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF). The subjects were 313 women who consulted the Women's Urinary Incontinence Clinic of Saiseikai Central Hospital between March, 2005 and January, 2008. They were divided into those below or above the cut-off age of 55, 60 or 65 years. The difference in QOL impairment was greatest when the cut-off age was 60 years. Similar comparisons were made by dividing the subjects into those aged 65-74 years and those aged 75 years and above, but no significant difference was noted in the score of any KHQ domain or ICIQ-SF between the two groups. The stress urinary incontinence occurred in younger women and caused the severest impairment. The response rate to KHQ in this study was low especially in the elderly, but that to ICIQ-SF was as high in the elderly as in younger age group. Social activities and lifestyle change around age 60 were considered to be associated with the change of QOL impairment in women with urinary incontinence. The stress urinary incontinence caused the severest impairment. KHQ was often difficult for the elderly to complete, but, ICIQ-SF seemed to be easy.

    PubMed

    J-GLOBAL

    researchmap

  • [A case of double cancer involving the urachus and the bladder].

    Hiroki Ito, Masayuki Hagiwara, Toru Furuuchi, Kunimitsu Kanai, Kiichiro Kodaira, Akiharu Ninomiya, So Nakamura

    Hinyokika kiyo. Acta urologica Japonica   56 ( 1 )   41 - 3   2010.1

     More details

    Language:Japanese  

    A 49-year-old male was referred to our hospital with the chief complaint of gross hematuria. We performed cystoscopy, and found a solid tumor at the dome of the bladder. Sagittal magnetic resonance imaging revealed an extravesical tumor at the position of the urachus. Transurethral resection of bladder tumor was performed. A solid tumor at the dome and two papillary tumors at the right lateral region of the bladder were observed. A pathological examination revealed adenocarcinoma from the solid tumor and urothelial carcinoma from the papillary tumors. Under a diagnosis of double cancer, adenocarcinoma of the urachus and urothelial carcinoma of bladder, we performed a total cystectomy, neobladder and total resection of the urachus.

    PubMed

    J-GLOBAL

    researchmap

  • [A case of intravesical foreign body with a vesical rupture invading the peritoneal cavity: a case report].

    Hiroki Ito, Akiharu Ninomiya, Toru Furuuchi, Masayuki Hagiwara, Kunimitsu Kanai, Kiichiro Kodaira, So Nakamura

    Hinyokika kiyo. Acta urologica Japonica   55 ( 7 )   425 - 7   2009.7

     More details

    Language:Japanese  

    A 63-year-old male presented with an intravesical foreign body. We could not remove it by a transurethral operation. We performed open surgery, and found the urinary bladder to be perforated by a foreign body which invaded the peritoneal cavity. To our knowledge, there were 10 similar cases in Japan.

    PubMed

    J-GLOBAL

    researchmap

  • [Primary small cell carcinoma of the ureter: a case report].

    Hiroki Ito, Kiichiro Kodaira, Michio Kosugi, Masayuki Hagiwara, Toru Furuuchi, Kunimitsu Kanai, Akiharu Ninomiya, So Nakamura

    Hinyokika kiyo. Acta urologica Japonica   55 ( 7 )   417 - 20   2009.7

     More details

    Language:Japanese  

    An 84-year-old female was referred to our hospital to be examined for left hydronephrosis. Abdominal pelvic computed tomography and ureteroscopy showed an obstructing mass in the left ureter. A biopsy of the mass revealed the presence of small cell carcinoma. A left nephroureterectomy were thus performed.

    PubMed

    J-GLOBAL

    researchmap

▼display all

MISC

  • 泌尿器科手術ヒヤリ・ハット トラブル対処法109の知恵 II 体腔鏡下手術 腹腔鏡下/ロボット支援腎部分切除術 腫瘍と腎門部が近接していて部分切除により腎動脈を損傷した

    伊藤悠城, 槙山和秀

    臨床泌尿器科   79 ( 4 )   2025

  • 集学的治療により救命し得た肺腫瘍血栓性微小血管症(PTTM)の一例

    竹谷大輝, 小林幸太, 野口剛, 沼田泰弘, 青盛恒太, 西村和大, 本田誠一郎, 蓼沼知之, 上野大樹, 古目谷暢, 伊藤悠城, 伊藤悠亮, 村岡研太郎, 小村直弘, 原田丈太郎, 松本崇宏, 蓮見壽史, 中井川昇, 槙山和秀

    泌尿器外科   38 ( 1 )   2025

  • 泌尿器科手術ヒヤリ・ハット トラブル対処法109の知恵 II 体腔鏡下手術 腹腔鏡下/ロボット支援腎部分切除術 腫瘍が上(下)極にあって視野の確保がむずかしい

    伊藤悠城, 槙山和秀

    臨床泌尿器科   79 ( 4 )   2025

  • 変形分布を用いた腎部分切除術における腎実質縫合手技によるひずみの可視化への試み

    蓼沼知之, 瀧山輝, 軸屋良介, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 山田貴博, 槙山和秀

    日本泌尿器内視鏡・ロボティクス学会(Web)   38th   2024

  • 基礎研究の魅力を伝える-若手医師は基礎研究がしたくないのか?-国内そして海外 ふたつの留学経験から

    伊藤悠城

    日本排尿機能学会誌(Web)   35 ( 1 )   2024

  • 埋没腎腫瘍への理想的なアプローチ

    伊藤悠城, 槙山和秀

    日本泌尿器内視鏡・ロボティクス学会(Web)   38th   2024

  • 安全なICUD回腸導管のための術式の工夫

    蓼沼知之, 軸屋良介, 野口剛, 上野大樹, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 槙山和秀

    日本泌尿器内視鏡・ロボティクス学会(Web)   38th   2024

  • ロボット支援腹腔鏡下膀胱全摘回腸新膀胱造設術におけるICUDとECUDの周術期成績比較

    上野大樹, 村岡研太郎, 軸屋良介, 蓼沼知之, 野口剛, 伊藤悠城, 古目屋暢, 伊藤悠亮, 蓮見壽史, 槙山和秀

    日本泌尿器内視鏡・ロボティクス学会(Web)   38th   2024

  • AIを用いたロボット支援腹腔鏡下前立腺全摘術時の神経温存手技における前立腺被膜の自動認識モデルの開発

    蓼沼知之, 伊藤悠城, 蓮見壽史, 槙山和秀

    日本内視鏡外科学会総会(Web)   37th   2024

  • 正常および膀胱出口部閉塞モデルラットの排尿反射における,髄腔内コルチコトロピン放出ホルモン(CRH)の役割

    篠木理沙, 仁禮卓磨, 深澤武史, 滝澤弘樹, 日置茉莉, 軸屋良介, 滝口雅人, 相澤直樹, 船越健悟, 槙山和秀, 伊藤悠城

    日本排尿機能学会誌(Web)   35 ( 1 )   2024

  • 前立腺肥大症患者に対するHoLEPおよび経尿道的前立腺蒸散術における術後medicationの検討

    伊藤悠城, 伊藤悠城, 沼田泰裕, 高梨将人, 仁禮卓磨, 深澤武史, 滝澤弘樹, 日置茉莉, 篠木理沙, 槙山和秀, 林悠大朗, 林悠大朗, 米山脩子, 滝沢明利, 小林一樹

    日本排尿機能学会誌(Web)   35 ( 1 )   2024

  • 急性尿閉を呈した患者に対するカテーテル抜去テストの複数回施行についての臨床的検討

    高梨将人, 高梨将人, 伊藤悠城, 伊藤悠城, 槙山和秀, 小林一樹

    日本排尿機能学会誌(Web)   35 ( 1 )   2024

  • Reconsidering the indications for partial nephrectomy (RAPN) “How to tackle with partial nephrectomy for completely embedded renal tumors”

    伊藤悠城, 槙山和秀

    Japanese Journal of Endourology and Robotics (Web)   37 ( 2 )   2024

  • 膀胱全摘にて≧ypT2と診断された膀胱癌に対する再発予測因子の検討

    植村公一, 伊藤悠城, 苅部樹里衣, 池田舞子, 軸屋良介, 蓼沼知之, 伊藤悠亮, 古目谷暢, 村岡研太郎, 蓮見壽史, 佐野太, 小林一樹, 上村博司, 槙山和秀

    日本癌治療学会学術集会(Web)   62nd   2024

  • 膀胱癌に対する経尿道的レーザーアブレーション(transurethral laser ablation:TULA)の単施設初期治療経験

    柴田洋佑, 伊藤悠城, 下田萌斗, 青木哲也, 苅部樹里衣, 今野真思, 大竹慎二, 井上雅弘, 小林一樹

    日本泌尿器科学会中部総会プログラム・抄録集   74th   2024

  • 初発時非筋層浸潤性膀胱癌であった患者の中で,のちに膀胱全摘術を要した症例の検討:当院10年間の観察研究

    下田萌斗, 伊藤悠城, 佐々木卓, 青木哲也, 苅部樹里衣, 柴田洋祐, 今野真思, 井上雅弘, 大竹慎二, 小林一樹

    西日本泌尿器科学会総会抄録集(Web)   76th   2024

  • A case of foreign body in the renal pelvic ureter: percutaneous removal in a modified Valdivia position

    松岡充晃, 伊藤悠城, 沼田泰祐, 佐々木卓, 林悠太郎, 渡部貴彦, 井上雅弘, 上野大樹, 小林一樹

    泌尿器外科   37 ( 4 )   2024

  • 心肺圧迫に伴う循環障害をきたした縦隔原発胚細胞性腫瘍の一例

    沼田泰裕, 植村公一, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 林成彦, 槙山和秀

    神奈川医学会雑誌   51 ( 2 )   2024

  • 二大難治性神経変性疾患であるアルツハイマー病およびパーキンソン病に伴う下部尿路機能障害の機序解明と新規治療戦略の構築

    伊藤悠城

    日本泌尿器科学会総会(Web)   111th   2024

  • 腎部分切除により判明した転移性HCG産生膀胱癌の一例

    本田誠一郎, 植村公一, 蓼沼知之, 軸屋良介, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 槙山和秀, 村岡枝里香, 山中正二, 藤井誠志

    泌尿器外科   37 ( 6 )   2024

  • Predictive factors for pentafecta achievement in RAPN for intermediate highly complex renal tumors (RENAL score≧7)

    植村公一, 蓼沼知之, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 槙山和秀

    日本ロボット外科学会学術集会プログラム・抄録集   16th   2024

  • 転移性去勢感受性前立腺癌におけるUpfront Abiraterone治療後の2次治療の検討

    鮎瀬知彦, 植村公一, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 槙山和秀, 上村博司

    日本癌治療学会学術集会(Web)   62nd   2024

  • ロボット支援下腎部分切除術(RAPN)後の再発症例の検討

    池田舞子, 伊藤悠城, 植村公一, 蓼沼知之, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 槙山和秀

    日本癌治療学会学術集会(Web)   62nd   2024

  • 遺伝性腎腫瘍に対する精密外科療法

    蓮見壽史, 軸屋良介, 野口剛, 川浦沙知, 青盛恒太, 入部康弘, 長坂拓学, 蓼沼知之, 上野大樹, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 槙山和秀

    日本癌治療学会学術集会(Web)   62nd   2024

  • 統合的ゲノム解析を用いた進行性腎細胞癌に対する免疫療法の精密化法の開発

    野口剛, 軸屋良介, 村岡枝里香, 井上竜也, 和田知佐, 古目谷暢, 伊藤悠城, 川浦沙知, 青盛恒太, 入部康弘, 伊藤悠亮, 村岡研太郎, 藤井誠志, 槙山和秀, 蓮見壽史

    日本癌治療学会学術集会(Web)   62nd   2024

  • 前立腺肥大症患者における経尿道的前立腺手術後の蓄尿症状遷延の予測因子

    沼田泰裕, 伊藤悠城, 伊藤悠城, 高梨将人, 深澤武史, 滝澤弘樹, 日置茉莉, 篠木理沙, 槙山和秀, 小林一樹

    日本排尿機能学会誌(Web)   35 ( 1 )   2024

  • PS不良患者に対するmini-ECIRSにおける術後の発熱についての検討

    田部井正, 田部井正, 伊藤悠城, 伊藤悠城, 井上貴昭, 渡部貴彦, 福田哲央, 山道深, 柴田洋祐, 小林一樹, 松崎純一

    日本泌尿器内視鏡・ロボティクス学会(Web)   38th   2024

  • ラット膀胱内圧測定実験における膀胱カテーテル挿入時期が下部尿路機能に及ぼす影響

    深澤武史, 日置茉莉, 滝澤弘樹, 篠木理沙, 槙山和秀, 伊藤悠城

    日本排尿機能学会誌(Web)   35 ( 1 )   2024

  • 当院における前立腺肥大症に対するバイポーラ経尿道的前立腺蒸散術204例の報告

    佐々木卓, 伊藤悠城, 青木哲也, 柴田洋佑, 渡部貴彦, 今野真思, 井上雅弘, 上野大樹, 小林一樹

    日本泌尿器内視鏡・ロボティクス学会(Web)   37th   2023

  • Development and internal validation of a nomogram to predict perioperative complications after complete ipsilateral upper urinary tract stone removal by fURS

    古目谷暢, 小高久和, 下木原航太, 植村公一, 蓼沼知之, 伊藤悠城, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 林成彦, 松崎純一, 槙山和秀

    日本泌尿器科学会総会(Web)   110th   2023

  • Predictive factors for the success of trial without catheter for men with acute urinary retention

    高梨将人, 伊藤悠城, 伊藤悠城, 深澤武史, 滝澤弘樹, 篠木理沙, 小林一樹

    日本泌尿器科学会総会(Web)   110th   2023

  • Mini-ECIRSを施行した腎結石症例におけるBMIについての比較検討

    福田哲央, 伊藤悠城, 伊藤悠城, 渡部貴彦, 田部井正, 田部井正, 山道深, 井上貴昭, 小林一樹, 松崎純一

    日本泌尿器内視鏡・ロボティクス学会(Web)   37th   2023

  • IO療法施行中のmRCC患者に対するCytoreductive nephrectomyの治療成績の検討

    鮎瀬知彦, 植村公一, 山本貴之, 近藤拓也, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 林成彦, 蓮見壽史, 槙山和秀

    日本癌治療学会学術集会(Web)   61st   2023

  • 嫌色素性腎細胞癌のがんの自然史および腫瘍内・腫瘍間不均一性獲得機構の解明

    軸屋良介, 軸屋良介, 古屋充子, 加藤生真, 馬場理也, 野口剛, 川浦沙知, 入部康弘, 青盛恒太, 蓼沼知之, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 林成彦, 近藤慶一, 中井川昇, 矢尾正祐, 中川英刀, 蓮見壽史, 槙山和秀

    腎癌研究会会報   ( 53 )   2023

  • 完全埋没型高難度腎腫瘍に対する腎部分切除術はどこまで可能か

    伊藤悠城, 槙山和秀

    日本泌尿器内視鏡・ロボティクス学会(Web)   37th   2023

  • Mini-ECIRS治療成績予測モデルの新規開発

    伊藤悠城, 福田哲央, 山道深, 渡部貴彦, 田部井正, 井上貴昭, 松崎純一, 小林一樹

    日本泌尿器内視鏡・ロボティクス学会(Web)   37th   2023

  • AIを用いたロボット支援手術における疎性結合織の自動認識モデルの有用性の検討

    蓼沼知之, 小林直, 植村公一, 伊藤悠城, 伊藤悠亮, 古目谷暢, 村岡研太郎, 林成彦, 蓮見壽史, 槙山和秀

    日本泌尿器内視鏡・ロボティクス学会(Web)   37th   2023

  • 日本泌尿器科学会NCD事業update 2023

    菊地栄次, 安井孝周, 山本博之, 早川望, 伊藤悠城, 畠山真吾, 河嶋厚成, 森實修一

    日本泌尿器科学会中部総会プログラム・抄録集   73rd   2023

  • RARC/ICUDのクリニカルパス導入前後における周術期成績の検討

    植村公一, 伊藤悠城, 蓼沼知之, 伊藤悠亮, 古目谷暢, 村岡研太郎, 蓮見壽史, 槙山和秀

    日本泌尿器内視鏡・ロボティクス学会(Web)   37th   2023

  • Indications and limitations of RAPN in imaging findings

    蓼沼知之, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 林成彦, 槙山和秀

    泌尿器外科   36   2023

  • 日本泌尿器科学会NCDの現状とこれからの課題~いよいよ始まった「NCDを利用した臨床研究」本邦からのエビデンスの発信~

    菊地栄次, 安井孝周, 早川望, 畠山真吾, 河嶋厚成, 森實修一, 神波大己, 杉元幹史, 北村寛, 伊藤悠城, 伊藤悠城

    日本泌尿器科学会総会(Web)   110th   2023

  • The efficacy and safety of nivolumab plus ipilimumab for clear-cell advanced renal-cell carcinoma in our institute

    鮎瀬知彦, 北川高士, 下木原航太, 蓼沼知之, 野口剛, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 林成彦, 中井川昇, 槙山和秀

    日本泌尿器科学会総会(Web)   110th   2023

  • Recurrence after robot-assisted partial nephrectomy-real world data at Yokohama City University Hospital-

    池田舞子, 植村公一, 蓼沼知之, 伊藤悠城, 古目谷暢, 伊藤悠介, 村岡研太郎, 林成彦, 蓮見壽史, 槙山和秀

    日本泌尿器科学会総会(Web)   110th   2023

  • Surgical complications of mini ECIRS (Endoscopic combined intrarenal surgery): A retrospective multicenter study at Japanese tertiary institutions.

    渡部貴彦, 伊藤悠城, 伊藤悠城, 福田哲央, 山道深, 田部井正, 井上貴昭, 松崎純一, 小林一樹

    日本泌尿器科学会総会(Web)   110th   2023

  • 転移性腎癌に対してcytoreductive nephrectomy施行後にリンパ漏を発症した一例

    上原昂一朗, 北川高士, 鮎瀬知彦, 池田舞子, 下木原航太, 植村公一, 蓼沼知之, 伊藤悠城, 伊藤悠亮, 古目谷暢, 村岡研太郎, 蓮見壽史, 林成彦, 槇山和秀

    神奈川医学会雑誌   50 ( 2 )   2023

  • 日本泌尿器科学会NCD事業update2023

    菊地栄次, 安井孝周, 山本博之, 早川望, 伊藤悠城, 畠山真吾, 河嶋厚成, 森實修一

    日本泌尿器科学会東部総会プログラム・抄録集   88th (CD-ROM)   2023

  • Enfortumab vedotin抵抗性の進行性尿路上皮癌に対し,化学療法再導入が奏功し,Avelumab維持療法に移行できた一例

    沼田泰裕, 植村公一, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 林成彦, 山中正二, 藤井誠志, 槙山和秀

    日本泌尿器科学会東部総会プログラム・抄録集   88th (CD-ROM)   2023

  • Comparison of console time and complication rates by the number of experience with Robot-Assisted Radical Prostatectomy

    横川秀平, 田部井正, 渡部貴彦, 林悠太郎, 上野大樹, 伊藤悠城, 小林一樹

    泌尿器外科   36 ( 9 )   2023

  • A retrospective multicenter study on the feasibility, efficacy and safety of mini ECIRS (Endoscopic combined intrarenal surgery) in patients with large stone

    伊藤悠城, 福田哲央, 山道深, 渡部貴彦, 田部井正, 井上貴昭, 松崎純一, 小林一樹

    日本泌尿器科学会総会(Web)   110th   2023

  • Real-world data of comprehensive genome profiling for mCRPC from Yokohama City University Hospital and Medical Center

    植村公一, 荒木雄至, 鮎瀬知彦, 伊藤悠城, 伊藤悠亮, 古目谷暢, 河原崇司, 三好康秀, 加藤真吾, 上村博司, 槙山和秀

    日本泌尿器科学会総会(Web)   110th   2023

  • Bipolar transurethral vaporization of the prostate (B-TUVP) for benign prostatic enlargement (BPE)

    伊藤悠城, 伊藤悠城, 槙山和秀, 小林一樹

    Prostate Journal   10 ( 2 )   2023

  • 日本泌尿器科学会NCD事業update2023

    菊地栄次, 安井孝周, 山本博之, 早川望, 伊藤悠城, 畠山真吾, 河嶋厚成, 森實修一

    西日本泌尿器科学会総会抄録集(Web)   75th   2023

  • nmCRPCに対するApalutamide及びDarolutamideの安全性と有効性-Real world data at Yokohama City University Hospital and Medical Center-

    池田舞子, 池田舞子, 植村公一, 伊藤悠城, 河原崇司, 古目谷暢, 伊藤悠亮, 村岡研太郎, 三好康秀, 三好康秀, 林成彦, 蓮見壽史, 槙山和秀, 上村博司

    日本泌尿器科学会東部総会プログラム・抄録集   88th (CD-ROM)   2023

  • ロボット支援手術研究助成金A

    伊藤悠城

    日本泌尿器内視鏡・ロボティクス学会(Web)   37th   2023

  • 膀胱全摘術後早期の膀胱癌再発症例に対して,Pembrolizumabが長期奏功している一例

    徳本芽以, 植村公一, 伊藤悠城, 山本貴之, 沼田泰裕, 横川秀平, 鮎瀬知彦, 近藤拓也, 軸屋良介, 蓼沼知之, 古目谷暢, 伊藤悠亮, 村岡研太郎, 林成彦, 蓮見壽史, 槙山和秀, 奥寺康司, 山中正二, 藤井誠志

    泌尿器外科   36 ( 12 )   2023

  • 腎臓に病変を認めない転移性腎細胞癌に対しNivolumab・Cabozantinib併用療法が著効した一例

    清水麻央, 蓼沼知之, 鮎瀬知彦, 池田舞子, 野村洋太, 下木原航太, 植村公一, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 林成彦, 槙山和秀, 山中正二, 藤井誠志

    泌尿器外科   36 ( 12 )   2023

  • AIを用いたロボット支援手術における疎性結合織の自動認識モデルの有用性と今後の展開

    蓼沼知之, 伊藤悠城, 蓮見壽史, 槙山和秀, 小林直

    日本内視鏡外科学会総会(Web)   36th   2023

  • 転移性尿路上皮癌におけるEnfortumab vedotinの有効性と安全性について

    植村公一, 伊藤悠城, 伊藤悠亮, 古目谷暢, 村岡研太郎, 蓮見壽史, 林成彦, 槙山和秀

    日本癌治療学会学術集会(Web)   61st   2023

  • ロボット支援膀胱全摘,体腔内尿路変更(回腸導管)におけるpentafecta達成率の検討

    村岡研太郎, 植村公一, 蓼沼知之, 伊藤悠城, 古目谷暢, 伊藤悠亮, 林成彦, 蓮見壽史, 槙山和秀

    日本泌尿器内視鏡・ロボティクス学会(Web)   37th   2023

  • 遺伝性平滑筋腫症・腎細胞癌症候群(Hereditary Leiomyomatosis and Renal Cell Cancer;HLRCC)関連腎癌と診断された4例

    上原昂一朗, 蓮見壽史, 池田舞子, 植村公一, 蓼沼知之, 伊藤悠城, 伊藤悠亮, 村岡研太朗, 林成彦, 槇山和秀

    日本泌尿器科学会東部総会プログラム・抄録集   87th   2022

  • バイポーラー経尿道的前立腺蒸散術(B-TUVP)~電気という蒸散の選択~

    伊藤悠城, 槙山和秀, 小林一樹

    日本泌尿器内視鏡・ロボティクス学会(Web)   36th   2022

  • 10cm大の腎腫瘍に対するハンドアシスト腹腔鏡下腎部分切除術の経験

    蓼沼知之, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 林成彦, 槙山和秀

    日本泌尿器内視鏡・ロボティクス学会(Web)   36th   2022

  • 前立腺癌閉鎖リンパ節転移に対してEUS-FNAを施行し,BRCA1遺伝子変異を認め,オラパリブが奏功した一例

    北川高士, 鮎瀬知彦, 下木原航太, 蓼沼知之, 古目谷暢, 伊藤悠城, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 林成彦, 槙山和秀

    泌尿器外科   35 ( 11 )   2022

  • Impact of the surgeon’s experience with transurethral resection of the prostate on surgical outcomes and perioperative complications of photoselective vaporization of the prostate

    篠木理沙, 篠木理沙, 伊藤悠城, 伊藤悠城, 深澤武史, 滝澤弘樹, 佐野太, 小林一樹

    日本排尿機能学会誌(Web)   32 ( 2 )   2022

  • Enfortumab VedotinによるToxic Epidermal Necrolysisの一例

    植村公一, 植村公一, 上原昂一朗, 池田舞子, 伊藤悠城, 伊藤悠亮, 佐野太, 池田伊知郎, 槙山和秀

    日本泌尿器科学会東部総会プログラム・抄録集   87th   2022

  • RARCの治療成績・合併症Overviewと当院の治療成績

    村岡研太郎, 蓼沼知之, 伊藤悠城, 古目谷暢, 伊藤悠亮, 林成彦, 蓮見壽史, 槙山和秀

    日本泌尿器科学会東部総会プログラム・抄録集   87th   2022

  • ロボット支援前立腺全摘術導入による治療成績の変化の検討

    小林一樹, 伊藤悠城, 三山健

    共済医報   71 ( 2 )   2022

  • BOOラットモデル膀胱の組織学的・機能的評価と今後の治療戦略の考察~前立腺肥大症手術の経験から~

    篠木理沙, 伊藤悠城, 槙山和秀

    日本排尿機能学会誌(Web)   33 ( 1 )   2022

  • 尿管原発神経内分泌腫瘍の一例

    高梨将人, 渡部貴彦, 山口克哉, 林悠大朗, 三山健, 上野大樹, 伊藤悠城, 小林一樹

    泌尿器外科   35 ( 7 )   2022

  • 前立腺肥大症(BPH)の手術療法-臨床現場の本心〈術式の本心〉すぐ導入したくなるTUVP

    伊藤悠城, 槙山和秀, 小林一樹

    臨床泌尿器科   76 ( 9 )   2022

  • 前立腺肥大症に対するB-TUVPとHoLEPの短期成績の臨床的検討

    林悠大朗, 伊藤悠城, 米山脩子, 滝沢明利, 小林一樹

    日本泌尿器内視鏡・ロボティクス学会(Web)   36th   2022

  • 当院におけるNAC+RARC/ICの治療成績

    上原昂一朗, 植村公一, 池田舞子, 伊藤悠城, 伊藤悠亮, 村岡研太郎, 蓮見壽史, 林成彦, 槇山和秀

    日本泌尿器内視鏡・ロボティクス学会(Web)   36th   2022

  • R.E.N.A.L.Nephrometry Score≧7の腎腫瘍に対するロボット支援腎部分切除術の検討

    池田舞子, 植村公一, 蓼沼知之, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 林成彦, 蓮見壽史, 槙山和秀

    日本泌尿器内視鏡・ロボティクス学会(Web)   36th   2022

  • 当院における転移性尿路上皮癌に対するEnfortumab Vedotinの初期投与経験

    池田舞子, 上原昂一朗, 植村公一, 蓼沼知之, 伊藤悠城, 古目谷暢, 伊藤悠亮, 村岡研太郎, 林成彦, 蓮見壽史, 槙山和秀

    日本泌尿器科学会東部総会プログラム・抄録集   87th   2022

  • 当院でのロボット支援前立腺全摘除術(RARP)におけるアセトアミノフェン定時投与の効果の検討

    横川秀平, 田部井正, 山口克哉, 堤壮吾, 今野真思, 三山健, 伊藤悠城, 小林一樹

    日本泌尿器科学会総会(Web)   109th   2021

  • Male LUTSに対する術前ウロダイナミクスに臨床的意義はあるのか:英国多施設RCT UPSTREAMスタディーからの最終回答

    伊藤悠城, ABRAMS Paul, CHAPPLE Chris, 矢尾正祐, 小林一樹, DRAKE Marcus

    日本泌尿器科学会総会(Web)   109th   2021

  • 高齢者に対する経尿道的前立腺電気蒸散術TUVPの治療成績

    伊藤悠城, 高梨将人, 山口克哉, 渡部貴彦, 林悠大朗, 三山健, 上野大樹, 篠木理沙, 小林一樹

    日本泌尿器内視鏡学会(Web)   35th   2021

  • 腎動脈瘤破裂後の血腫感染に対して穿刺ドレナージを施行した1例

    仁禮卓磨, 田部井正, 伊藤悠城, 深澤武史, 篠木理沙, 堤壮吾, 今野真思, 小林一樹

    神奈川医学会雑誌   48 ( 1 )   2021

  • バリントン核を標的とした加齢に伴う下部尿路機能障害発症機序の解明と新規治療薬の開発

    伊藤悠城

    日本泌尿器科学会総会(Web)   109th   2021

  • 神経因性膀胱患者における間欠式バルーンカテーテルの使用経験

    鮎瀬知彦, 古屋一裕, 田中克幸, 伊藤悠城

    日本泌尿器科学会総会(Web)   109th   2021

  • 急性尿閉を呈した女性の神経因性膀胱患者に対する自排尿テストの臨床的検討

    高梨将人, 伊藤悠城, 小林一樹, 上野大樹, 三山健, 林悠大朗, 渡部貴彦, 山口克哉

    日本排尿機能学会誌(Web)   32 ( 1 )   2021

  • 私の基礎研究は素晴らしい!臨床屋と,基礎屋と。

    伊藤悠城, 伊藤悠城, 篠木理沙

    日本排尿機能学会誌(Web)   32 ( 1 )   2021

  • 当院における光選択的前立腺レーザー蒸散術(PVP)の術者の経験年数についての比較検討

    篠木理沙, 伊藤悠城, 小林一樹

    日本排尿機能学会誌(Web)   32 ( 1 )   2021

  • 横須賀市前立腺癌検診導入から15年間における高齢前立腺癌患者の予後調査

    仁禮卓磨, 仁禮卓磨, 田部井正, 酒井直樹, 黄英茂, 吉田実, 古畑壮一, 伊藤悠城, 堤壮吾, 小林一樹, 野口純男

    日本老年泌尿器科学会誌   34 ( 1 )   2021

  • Future treatment for under active bladder/detrusor under activity (UAB/DU)

    伊藤悠城, 伊藤悠城

    泌尿器外科   34 ( 7 )   2021

  • ロボット支援前立腺全摘導入による治療成績の変化の検討

    小林一樹, 伊藤悠城, 三山健

    共済医報   70 ( Supplement )   2021

  • 当院におけるECIRSの治療成績の検討

    渡部貴彦, 伊藤悠城, 高梨将人, 山口克哉, 林悠大朗, 三山健, 上野大樹, 小林一樹

    日本泌尿器内視鏡学会(Web)   35th   2021

  • 光選択的前立腺レーザー蒸散術(PVP)周術期合併症の術前予測におけるCharlson comorbidity index(CCI)の有用性

    篠木理沙, 伊藤悠城, 小林一樹

    日本泌尿器科学会総会(Web)   109th   2021

  • 前立腺容積100ml以上の前立腺腫大に対する第2世代バイポーラによる経尿道的前立腺電気蒸散術の有効性

    深澤武史, 伊藤悠城, 伊藤悠城, 篠木理沙, 田部井正, 河原崇司, マーカス ドレイク, 小林一樹

    日本泌尿器科学会総会(Web)   109th   2021

  • Prostate cancer with disseminated carcinomatosis of the bone marrow: Two case reports

    深澤武史, 田部井正, 仁禮卓磨, 篠木理沙, 堤壮吾, 今野真思, 伊藤悠城, 小林一樹, 津浦幸夫

    泌尿器外科   33 ( 12 )   2020

  • 結石治療における合併症:ECIRS

    伊藤悠城

    日本泌尿器内視鏡学会(Web)   34th   2020

  • 横須賀共済病院におけるf-TUL施行時の砕石困難例のリスク因子の検討

    今野真思, 今野真思, 田部井正, 伊藤悠城, 小林一樹

    日本泌尿器内視鏡学会(Web)   34th   2020

  • Model of a parasympathetic preganglionic neuron (implemented in NEURON) with a synaptic drive from Barrington’s nucleus.

    伊藤悠城, 伊藤悠城, ANNA Sales, 篠木理沙, 小林一樹, TONY Pickering, 矢尾正祐

    日本泌尿器科学会総会(Web)   108th   2020

  • 喫煙習慣が日本人女性の排尿障害に与えるインパクト

    河原崇司, 伊藤悠城, 上村博司

    日本排尿機能学会誌   31 ( 1 )   2020

  • 30mmにわたる球部尿道完全閉塞に対しAugmented anastomotic urethroplastyを施行した1例

    深澤武史, 田部井正, 仁禮卓磨, 篠木理沙, 堤壮吾, 今野真思, 伊藤悠城, 小林一樹

    泌尿器外科   33 ( 5 )   2020

  • A case of puncture drainage for infected hematoma after rupture of giant renal aneurysm

    仁禮卓磨, 田部井正, 伊藤悠城, 深澤武史, 篠木理沙, 堤壮吾, 今野真思, 小林一樹

    泌尿器外科   33 ( 6 )   2020

  • 完全重複腎盂尿管に伴う腎盂癌の一例

    仁禮卓磨, 田部井正, 伊藤悠城, 深澤武史, 篠木理沙, 堤壮吾, 今野真思, 小林一樹

    神奈川医学会雑誌   47 ( 1 )   2020

  • Clinical outcomes of prostate cancer patients over 80 years old in Yokosuka city

    仁禮卓磨, 田部井正, 酒井直樹, 黄英茂, 古畑壮一, 伊藤悠城, 堤壮吾, 小林一樹, 野口純男

    日本泌尿器科学会総会(Web)   108th   2020

  • Investigation of incidence and risk factor of difficult ureter during TUL in Yokosuka Kyosai Hospital

    今野真思, 田部井正, 伊藤悠城, 仁禮卓磨, 深澤武史, 堤壮吾, 篠木理沙, 小林一樹

    日本泌尿器科学会総会(Web)   108th   2020

  • TUVP for large BPH (larger than 80ml in prostate volume)

    伊藤悠城, 仁禮卓磨, 深澤武史, 篠木理沙, 堤壮吾, 今野真思, 田部井正, 小林一樹

    日本泌尿器科学会総会(Web)   108th   2020

  • 当院における光選択的前立腺レーザー蒸散術(PVP)の治療成績の検討

    篠木理沙, 仁禮卓磨, 深澤武史, 堤壮吾, 今野真思, 田部井正, 伊藤悠城, 小林一樹

    日本泌尿器科学会東部総会プログラム・抄録集   84th   2019

  • 前立腺肥大症に対する,TURisシステムを用いた経尿道的前立腺蒸散術TUVPの治療経験

    伊藤悠城, 仁禮卓磨, 深澤武史, 篠木理沙, 堤壮吾, 今野真思, 田部井正, 佐野太, 小林一樹

    日本泌尿器内視鏡学会(Web)   33rd   2019

  • TULにおける透視時間低減策の有用性についての検討

    仁禮卓磨, 深澤武史, 篠木理沙, 堤壮吾, 今野真思, 田部井正, 伊藤悠城, 小林一樹

    日本泌尿器内視鏡学会(Web)   33rd   2019

  • 当院における尿道形成術の治療成績

    田部井正, 堀口明男, 仁禮卓磨, 深澤武史, 堤壮吾, 篠木理沙, 今野真思, 伊藤悠城, 小林一樹

    日本泌尿器科学会東部総会プログラム・抄録集   84th   2019

  • 横須賀共済病院におけるロボット支援前立腺全摘除術の初期治療成績

    今野真思, 小林一樹, 仁禮卓磨, 深澤武史, 堤壮吾, 篠木理沙, 田部井正, 伊藤悠城

    西日本泌尿器科   81   2019

  • 当院におけるロボット支援前立腺全摘除術の初期治療成績

    深澤武史, 仁禮卓磨, 篠木理沙, 堤壮吾, 今野真思, 田部井正, 伊藤悠城, 小林一樹

    日本泌尿器科学会中部総会プログラム・抄録集   69th   2019

  • 当院における去勢抵抗性前立腺癌に対するエンザルタミドの治療成績

    今野真思, 小林一樹, 仁禮卓磨, 深澤武史, 堤壮吾, 篠木理沙, 田部井正, 伊藤悠城

    日本泌尿器科学会中部総会プログラム・抄録集   69th   2019

  • 単一術者による,ロボット支援下腎部分切除術および腹腔鏡下腎部分切除術の比較・検討

    伊藤悠城, 小林一樹, 中井川昇, 矢尾正祐, 槙山和秀

    日本泌尿器内視鏡学会(Web)   33rd   2019

  • 当院におけるロボット支援腹腔鏡下前立腺全摘術と腹腔鏡下前立腺全摘術の比較

    堤壮吾, 仁禮卓磨, 深澤武史, 篠木理沙, 今野真思, 田部井正, 伊藤悠城, 小林一樹

    日本泌尿器内視鏡学会(Web)   33rd   2019

  • 腎盂癌に対してペムブロリズマブが奏効し,根治切除が可能となった一例

    森永亮太, 河原崇司, 杉村留実子, 高本大路, 望月拓, 黒田晋之介, 竹島徹平, 伊藤悠城, 泉浩司, 寺西淳一, 湯村寧, 三好康秀, 上村博司

    泌尿器外科   32 ( 9 )   2019

  • 光遺伝学(optogenetics)および薬理遺伝学(DREADDs)を用いた,橋排尿中枢(PMC)における副腎皮質刺激ホルモン放出ホルモン(CRH)陽性ニューロンの機能解明

    伊藤悠城, 伊藤悠城, DRAKE Marcus, 矢尾正祐, PICKERING Tony

    日本泌尿器科学会総会(Web)   107th   2019

  • 当院におけるロボット支援腎部分切除術の初期経験と腹腔鏡下腎部分切除術,開腹腎部分切除術の比較検討

    福田哲央, 二禮卓磨, 深澤武史, 堤壮吾, 篠木理沙, 今野真思, 田部井正, 伊藤悠城, 小林一樹

    日本泌尿器科学会中部総会プログラム・抄録集   69th   2019

  • 完全重複腎盂尿管に腎盂癌を合併した一例

    仁禮卓磨, 深澤武史, 篠木理沙, 堤壮吾, 今野真思, 田部井正, 伊藤悠城, 小林一樹

    日本泌尿器科学会中部総会プログラム・抄録集   69th   2019

  • ホスホジエステラーゼ5(PDE5)阻害剤Sildenafilは膀胱求心路を増幅させ,マウス排尿における外尿道括約筋活動を促進する

    伊藤悠城, 伊藤悠城, 伊藤悠城, 矢尾正祐, 上村博司, DRAKE Marcus, 小林一樹, PICKERING Tony

    日本排尿機能学会誌   30 ( 1 )   2019

  • 当院におけるロボット支援下前立腺全摘除術前後の尿禁制,排尿機能および性機能変化の検討

    笠原亮, 伊藤悠城, 今野真思, 田部井正, 佐野太, 小林一樹

    日本泌尿器科学会東部総会プログラム・抄録集   84th   2019

  • 加齢と下部尿路機能

    亀井潤, 亀井潤, 伊藤悠城, 伊藤悠城, 相澤直樹, 相澤直樹, 井川靖彦

    日本排尿機能学会誌   30 ( 1 )   2019

  • 当院におけるECIRSの破砕効果予測因子の検討

    深澤武史, 仁禮卓磨, 篠木理沙, 堤壮吾, 今野真思, 田部井正, 伊藤悠城, 小林一樹

    西日本泌尿器科   81   2019

  • Quantifying tartrate-resistant acid phosphatase type 5b to evaluate the efficacy of bisphosphonate treatment in prostate cancer patients receiving androgen deprivation therapy

    井上雅弘, 望月拓, 三條博之, 伊藤悠城, 栗田華代, 石垣華子, 竹島徹平, 平井耕太郎, 平井耕太郎

    泌尿器外科   31 ( 7 )   2018

  • 結石治療後の尿管狭窄症に対する尿管鏡併用腹腔鏡下尿管尿管吻合術の経験

    新堀萌香, 槙山和秀, 逢坂公人, 伊藤悠城, 横溝由美子, 河原崇司, 近藤慶一, 中井川昇, 松崎純一, 矢尾正祐

    Japanese Journal of Endourology   30 ( 1 )   2017

  • Everolimus治療を受ける進行性腎細胞癌患者に対するFDG PET/CT評価の有用性

    平松功太郎, 伊藤悠城, 上野大樹, 近藤慶一, 小林一樹, 池田伊知郎, 塩井康一, 大古美治, 槙山和秀, 林成彦, 蓮見壽史, 矢尾正祐, 中井川昇

    日本泌尿器科学会東部総会プログラム・抄録集   81st   2016

  • FDG PET/CTを用いた進行性腎細胞癌に対するeverolimus治療効果予測

    伊藤悠城, 中井川昇, 楢原正基, 立石宇貴秀, 槙山和秀, 林成彦, 井上登美夫, 矢尾正祐

    泌尿器外科   29   2016

  • 当院における乳頭状腎癌に対する分子標的治療の経験

    篠木理沙, 伊藤悠城, 横溝由美子, 逢坂公人, 蓮見壽史, 林成彦, 槙山和秀, 近藤慶一, 中井川昇, 矢尾正祐, 梅田茂明, 立石陽子, 大橋健一

    日本泌尿器科学会総会(Web)   104th   2016

  • Mucinous tubular and spindle cell carcinomaに対してmTOR阻害剤を使用した1例

    笠原亮, 佐藤元己, 篠木理沙, 福井沙知, 新堀萌花, 伊藤悠城, 逢坂公人, 横溝由美子, 蓮見壽史, 林成彦, 槙山和秀, 近藤慶一, 中井川昇, 矢尾正祐

    神奈川医学会雑誌   43 ( 1 )   2016

  • 上部尿路結石症に対する尿管ステント留置における適切なステント長の検討

    臼井公紹, 田部井正, 伊藤悠城, 藤川敦, 松崎純一

    日本泌尿器科学会総会(Web)   104th   2016

  • 4年間放置された尿管ステントに形成された腎尿管膀胱結石に対して内視鏡的治療にてstone freeが得られた一例

    臼井公紹, 田部井正, 伊藤悠城, 伊藤悠城, 藤川敦, 松嶋純一

    泌尿器外科   29 ( 4 )   2016

  • 当院におけるエンザルタミド,アビラテロンの使用経験

    横溝由美子, 上村博司, 川畑さゆき, 新堀萌香, 伊藤悠城, 逢坂公人, 蓮見壽史, 林成彦, 槙山和秀, 近藤慶一, 中井川昇, 矢尾正祐

    日本泌尿器科学会総会(Web)   104th   2016

  • 横浜市大附属病院におけるロボット支援腹腔鏡下前立腺全摘術の初期経験

    佐藤元己, 中井川昇, 篠木理沙, 笠原亮, 川畑さゆき, 新堀萌香, 伊藤悠城, 横溝由美子, 逢坂公人, 蓮見壽史, 林成彦, 槙山和秀, 矢尾正祐

    日本泌尿器科学会総会(Web)   104th   2016

  • 30Frアクセスシースを用いた巨大膀胱結石の内視鏡的治療成績

    田部井正, 黒田晋之介, 伊藤悠城, 藤川敦, 松崎純一

    泌尿器外科   29 ( 1 )   2016

  • 膀胱全摘+回腸導管患者の腎・尿管結石に対するPNL+TULの臨床的検討

    藤川敦, 松崎純一, 田部井正, 臼井公紹, 伊藤悠城

    日本泌尿器科学会総会(Web)   104th   2016

  • 当院における去勢抵抗性前立腺癌に対するカバジタキセルの使用経験

    横溝由美子, 上村博司, 篠木理沙, 伊藤悠城, 逢坂公人, 蓮見壽史, 林成彦, 槙山和秀, 近藤慶一, 中井川昇, 矢尾正祐

    泌尿器外科   29   2016

  • 当院における類上皮型腎血管筋脂筋腫の治療経験

    篠木理沙, 伊藤悠城, 横溝由美子, 逢坂公人, 蓮見壽史, 林成彦, 槙山和秀, 近藤慶一, 中井川昇, 矢尾正祐

    泌尿器外科   29   2016

  • 当院において経験した希少腎癌(Tubulocystic renal cell carcinoma)の2例

    笠原亮, 伊藤悠城, 蓮見壽史, 横溝由美子, 逢坂公人, 林成彦, 槙山和秀, 近藤慶一, 中井川昇, 矢尾正祐

    泌尿器外科   29   2016

  • 膀胱尿管逆流症術後に発症した多発腎結石に対しEndoscopic Combined Intrarenal Surgeryが有用であった1例

    田部井正, 臼井公紹, 伊藤悠城, 藤川敦, 松崎純一

    Japanese Journal of Endourology   29 ( 2 )   2016

  • 尿路閉塞による腎実質形態的変化を定量化するための基準値の検討

    田部井正, 臼井公紹, 藤川敦, 松崎純一, 伊藤悠城

    泌尿器外科   29 ( 1 )   2016

  • 単腎患者の腎・尿管結石に対するPNL+TULの臨床的検討

    藤川敦, 田部井正, 黒田晋之助, 伊藤悠城, 寺尾秀行, 松崎純一

    泌尿器外科   29 ( 1 )   2016

  • ラット膀胱伸展受容一次求心性神経活動に及ぼす選択的α1Aアドレナリン受容体拮抗薬シロドシンの膀胱内投与による効果

    相澤直樹, 伊藤悠城, 杉山梨乃, 杉山梨乃, 藤村哲也, 福原浩, 久米春喜, 本間之夫, 井川靖彦

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   103rd   2015

  • CT値による尿路結石成分予測

    河原崇司, 河原崇司, 河原崇司, 伊藤悠城, 伊藤悠城, 上村博司, 矢尾正祐, 松崎純一

    日本尿路結石症学会誌   14 ( 2 )   2015

  • 当院における類上皮型腎血管筋脂肪腫の治療経験

    篠木理沙, 伊藤悠城, 横溝由美子, 逢坂公人, 蓮見壽史, 林成彦, 槙山和秀, 近藤慶一, 中井川昇, 矢尾正祐

    日本泌尿器科学会東部総会プログラム・抄録集   80th   2015

  • 当院において経験した希少腎癌(Tubulocystic renal cell carcinoma)の2例

    笠原亮, 伊藤悠城, 蓮見壽史, 横溝由美子, 逢坂公人, 林成彦, 槙山和秀, 近藤慶一, 中井川昇, 矢尾正祐

    日本泌尿器科学会東部総会プログラム・抄録集   80th   2015

  • 前立腺癌化学療法導入時におけるペグフィルグラスチム(ジーラスタ)の使用経験

    横溝由美子, 上村博司, 篠木理沙, 笠原亮, 佐藤元己, 福井沙知, 新堀萌香, 伊藤悠城, 逢坂公人, 蓮見壽史, 林成彦, 槙山和秀, 近藤慶一, 中井川昇, 矢尾正祐

    日本癌治療学会学術集会(Web)   53rd   2015

  • ラット膀胱の加齢性変化に対する長期食餌カロリー制限の予防効果の検討

    伊藤悠城, 伊藤悠城, 相澤直樹, 藤田泰典, 鈴木基文, 福原浩, 小島俊男, 本間之夫, 窪田吉信, 伊藤雅史, 井川靖彦

    日本老年泌尿器科学会誌   28   2015

  • 網羅的遺伝子解析を用いた,マウス膀胱における遺伝子発現の加齢性変化と性差の検討

    相澤直樹, 亀井潤, 亀井潤, 伊藤悠城, 堀田晴美, 藤田泰典, 伊藤雅史, 小島俊男, 本間之夫, 井川靖彦

    排尿障害モデル動物研究会プログラム・抄録集   8th   2015

  • 腹腔鏡下腎部分切除術における,術中腫瘍切込みと腫瘍偽被膜形成の検討

    槙山和秀, 伊藤悠城, 逢坂公人, 中井川昇, 矢尾正祐

    日本癌治療学会学術集会(Web)   53rd   2015

  • 当院における去勢抵抗性前立腺癌に対するカバジタキセルの使用経験

    横溝由美子, 上村博司, 篠木理沙, 伊藤悠城, 逢坂公人, 蓮見壽史, 林成彦, 槙山和秀, 近藤慶一, 中井川昇, 矢尾正祐

    日本泌尿器科学会東部総会プログラム・抄録集   80th   2015

  • FDG PET/CTを用いた進行性腎細胞癌に対するeverolimus治療効果予測

    伊藤悠城, 中井川昇, 楢原正基, 立石宇貴秀, 槙山和秀, 林成彦, 井上登美夫, 矢尾正祐

    日本泌尿器科学会東部総会プログラム・抄録集   80th   2015

  • 上部尿路結石症に対する尿管ステント挿入不可症例の処置前診断の検討

    臼井公紹, 田部井正, 黒田晋之介, 伊藤悠城, 藤川敦, 松崎純一

    Japanese Journal of Endourology   28 ( 3 )   2015

  • 当院で施行したECIRS(endoscopic intrarenal surgery)における術後感染症のrisk factorの検討

    田部井正, 黒田晋之介, 伊藤悠城, 藤川敦, 松崎純一

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   103rd   2015

  • 筋層非浸潤膀胱癌に対する軟性膀胱鏡を用いた粘膜下腫瘍一塊切除(fTURBO)

    藤川敦, 松崎純一, 伊藤悠城, 伊藤悠城, 黒田晋之助, 田部井正, 臼井公紹

    Japanese Journal of Endourology   28 ( 3 )   2015

  • 小径腎腫瘍に対する腹腔鏡下腎部分切除術における,術中腫瘍への切り込みの臨床的意義

    伊藤悠城, 槙山和秀, 泉浩司, 横溝由美子, 逢坂公人, 中井川昇, 矢尾正祐

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   103rd   2015

  • 進行性腎細胞癌に対するeverolimus治療効果予測の臨床的検討:FDG PET/CTの可能性

    伊藤悠城, 中井川昇, 立石宇貴秀, 槙山和秀, 林成彦, 池田伊知郎, 井上登美夫, 矢尾正祐

    日本癌治療学会学術集会(Web)   53rd   2015

  • ハンナ型間質性膀胱炎の一部はB細胞のクローナル増殖を伴う慢性炎症・免疫疾患群である

    秋山佳之, 秋山佳之, 前田大地, 森川鉄平, 新美文彩, 野宮明, 山田幸央, 相澤直樹, 杉山梨乃, 亀井潤, 亀井潤, 伊藤悠城, 伊藤悠城, 市原浩司, 市原浩司, 藤村哲也, 中川徹, 福原浩, 久米春喜, 井川靖彦, 深山正久, 本間之夫

    日本排尿機能学会誌   26 ( 1 )   2015

  • 小径腎腫瘍に対する腹腔鏡下腎部分切除術における術後腎機能の検討

    伊藤悠城, 槙山和秀, 泉浩司, 横溝由美子, 逢坂公人, 中井川昇, 矢尾正祐

    Japanese Journal of Endourology   28 ( 3 )   2015

  • 単腎患者の腎・尿管結石に対するPNL・TULの臨床的検討

    藤川敦, 田部井正, 黒田晋之介, 伊藤悠城, 松崎純一

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   103rd   2015

  • 15-25mm単発腎尿管結石に対するTULとPNLの有用性の比較検討

    黒田晋之介, 伊藤悠城, 伊藤悠城, 田部井正, 藤川敦, 松崎純一

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   103rd   2015

  • 加齢に伴うラット排尿動態の変化と長期カロリー制限による予防効果:排尿行動測定(FV測定)および膀胱内圧測定(CMG)による検討

    亀井潤, 亀井潤, 伊藤悠城, 相澤直樹, 杉山梨乃, 杉山梨乃, 秋山佳之, 秋山佳之, 市原浩司, 藤田泰典, 伊藤雅史, 本間之夫, 井川靖彦

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   103rd   2015

  • 除脳マウスにおいてToll like receptor(TLR)7刺激薬イミキモドの膀胱内注入は頻尿を誘発する

    市原浩司, 市原浩司, 相澤直樹, 杉山梨乃, 伊藤悠城, 亀井潤, 秋山佳之, 舛森直哉, 本間之夫, 井川靖彦

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   103rd   2015

  • 横浜市立大学附属病院における尿路結石症手術症例の臨床的検討

    逢坂公人, 槙山和秀, 新堀萌香, 伊藤悠城, 横溝由美子, 林成彦, 近藤慶一, 中井川昇, 矢尾正祐

    Japanese Journal of Endourology   28 ( 3 )   2015

  • 腎結石に対するECIRS:砕石効果予測因子の検討

    黒田晋之介, 伊藤悠城, 伊藤悠城, 田部井正, 藤川敦, 松崎純一

    Japanese Journal of Endourology   28 ( 2 )   2015

  • ラット膀胱伸展受容一次求心性神経のAδおよびC線維の活動性に及ぼすresiniferatoxin脱感作の直接作用

    相澤直樹, 伊藤悠城, 杉山梨乃, 杉山梨乃, 亀井潤, 亀井潤, 秋山佳之, 秋山佳之, 市原浩司, 本間之夫, 井川靖彦

    日本排尿機能学会誌   26 ( 1 )   2015

  • 単腎患者の腎・尿管結石に対するTULの臨床的検討

    黒田晋之介, 保田賢吾, 伊藤悠城, 寺尾秀行, 松崎純一

    泌尿器外科   28 ( 4 )   2015

  • ラット膀胱の加齢性変化に対する長期食餌カロリー制限の予防効果の検討

    伊藤悠城, 伊藤悠城, 相澤直樹, 藤田泰典, 鈴木基文, 福原浩, 小島俊男, 本間之夫, 窪田吉信, 伊藤雅史, 井川靖彦

    日本老年泌尿器科学会プログラム・抄録集   28th   2015

  • 雄性下部尿路閉塞ラットにおける膀胱伸展受容一次求心性神経活動の解析:膀胱微小収縮との関連性の検討

    杉山梨乃, 杉山梨乃, 相澤直樹, 伊藤悠城, 亀井潤, 亀井潤, 秋山佳之, 秋山佳之, 市原浩司, 本間之夫, 井川靖彦

    日本排尿機能学会誌   26 ( 1 )   2015

  • 前立腺癌密封小線源療法後の下部尿路症状に対するα1拮抗剤予防的投与:タムスロシンおよびシロドシンの有用性

    伊藤悠城, 上村博司, 今野真思, 野口剛, 泉浩司, 林成彦, 横溝由美子, 逢坂公人, 向井佑希, 糟谷健夫, 播多政治, 井上登美夫, 矢尾正祐

    日本排尿機能学会誌   26 ( 1 )   2015

  • Toll-like receptor(TLR)7の活性化はマウスにおいて頻尿・膀胱癌・膀胱炎を惹起しうる

    市原浩司, 市原浩司, 相澤直樹, 杉山梨乃, 伊藤悠城, 亀井潤, 亀井潤, 秋山佳之, 秋山佳之, 舛森直哉, 本間之夫, 井川靖彦

    日本排尿機能学会誌   26 ( 1 )   2015

  • 加齢性膀胱機能障害の責任遺伝子の究明

    伊藤悠城, 伊藤悠城, 相澤直樹, 藤田泰典, 鈴木基文, 福原浩, 小島俊男, 本間之夫, 窪田吉信, 伊藤雅史, 井川靖彦

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   103rd   2015

  • 当院におけるStentless TULの検討

    保田賢吾, 黒田晋之介, 伊藤悠城, 河原崇司, 寺尾秀行, 松崎純一

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   102nd   2014

  • ラット膀胱の加齢性収縮能減弱とそれに対する長期カロリー制限による予防効果の背景因子の検討:脂質酸化ストレスおよび線維化の関与

    伊藤悠城, 伊藤悠城, 相澤直樹, 杉山梨乃, 亀井潤, 秋山佳之, 鈴木基文, 市原浩司, 小島俊男, 藤田泰典, 伊藤雅史, 本間之夫, 窪田吉信, 井川靖彦

    日本排尿機能学会誌   25 ( 1 )   2014

  • 腎結石に対するECIRS:砕石効果予測因子の検討

    黒田晋之介, 伊藤悠城, 伊藤悠城, 田部井正, 寺尾秀行, 藤川敦, 松崎純一

    Japanese Journal of Endourology   27 ( 3 )   2014

  • Propiverine hydrochloride improved N-QOL (Nocturia Quality-of-Life) score as well as OABSS in Japanese patients wiht nocturnal frequency

    石田寛明, 野口和美, 寺西淳一, 公平昭男, 伊藤悠城, 平井耕太郎, 原芳紀, 澤田卓人, 北見一夫, 古畑哲彦, 福田百邦, 酒井直樹, 野口純男, 野村栄, 朝倉智行, 河上哲, 関口由紀, 長田裕, 菅野ひとみ, 森山正敏, 池田伊知郎, 斉藤竜一, 窪田吉信

    泌尿器外科   27 ( 7 )   2014

  • ラット膀胱伸展受容一次求心性神経のC線維の活動性に対する膀胱ムスカリン受容体の促進的寄与

    相澤直樹, 伊藤悠城, 杉山梨乃, 杉山梨乃, 亀井潤, 亀井潤, 秋山佳之, 秋山佳之, 市原浩司, 藤村哲也, 鈴木基文, 福原浩, 久米春喜, 本間之夫, 井川靖彦

    日本排尿機能学会誌   25 ( 1 )   2014

  • ラット膀胱伸展受容求心性神経活動制御における膀胱アドレナリンα1D受容体の生理的役割

    相澤直樹, 伊藤悠城, 杉山梨乃, 亀井潤, 秋山佳之, 杉山梨乃, 亀井潤, 秋山佳之, 市原浩司, 藤村哲也, 鈴木基文, 福原浩, 久米春喜, 本間之夫, 井川靖彦

    日本排尿機能学会誌   25 ( 1 )   2014

  • 腎結石に対するTULにおける尿管アクセスシース径と砕石抽出効率の検討

    保田賢吾, 伊藤悠城, 黒田晋之介, 河原崇司, 寺尾秀行, 松崎純一

    泌尿器外科   27 ( 6 )   2014

  • Complications of transurethral lithotripsy for over 80 years old patients: clinical considerations of 48 procedures

    柿添学, 柿添学, 伊藤悠城, 河原崇司, 寺尾秀行, 加藤喜健, 松崎純一, 窪田吉信

    泌尿器外科   27 ( 4 )   2014

  • 抗アンドロゲン療法を行っている前立腺癌患者に対するビスホスホネート製剤の治療効果判定に対するTRACP-5bの有用性

    井上雅弘, 望月拓, 伊藤悠城, 栗田華代, 石垣華子, 竹島徹平, 林博文, 平井耕太郎

    西日本泌尿器科   76   2014

  • 亜急性期下部尿路部分閉塞雄性ラットにおける各種Transient Receptor Potential(TRP)チャネルの発現変化

    杉山梨乃, 杉山梨乃, 相澤直樹, 伊藤悠城, 伊藤悠城, 本間之夫, 井川靖彦

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   102nd   2014

  • 尿管長予測ノモグラムを用いた包括的な尿管ステント関連症状の低減

    河原崇司, 河原崇司, 伊藤悠城, 伊藤悠城, 寺尾秀行, 松崎純一

    Japanese Journal of Endourology   27 ( 3 )   2014

  • 修正Valdivia体位によるPNL+TUL同時治療における軟性尿管鏡下の腎瘻造設術(UARN)の有用性について

    松崎純一, 寺尾秀行, 保田賢吾, 伊藤悠城, 河原崇司, 小川毅彦

    泌尿器外科   27   2014

  • 珊瑚状結石に対するPNL+TUL同時治療54例の成績

    松崎純一, 寺尾秀行, 保田賢吾, 黒田晋之介, 伊藤悠城, 河原崇司

    日本尿路結石症学会誌   12 ( 2 )   2014

  • 亜急性期下部尿路閉塞雄性ラットの膀胱機能におけるTRPA1チャネルの役割

    杉山梨乃, 杉山梨乃, 相澤直樹, 伊藤悠城, 亀井潤, 亀井潤, 秋山佳之, 秋山佳之, 市原浩司, 本間之夫, 井川靖彦

    排尿障害モデル動物研究会プログラム・抄録集   7th   2014

  • ラット下部尿路機能調節におけるTRPM8チャネルの役割:覚醒・無拘束下膀胱内圧測定法による検討

    伊藤悠城, 相澤直樹, 杉山梨乃, 渡邉修造, 高橋伸行, 多治見政臣, 本間之夫, 窪田吉信, 井川靖彦

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   102nd   2014

  • 単腎患者の腎・尿管結石に対するTULの臨床的検討

    黒田晋之介, 保田賢吾, 伊藤悠城, 寺尾秀行, 松崎純一

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   102nd   2014

  • Totally tubeless PNLの臨床的検討

    松崎純一, 保田賢吾, 黒田晋之介, 伊藤悠城, 河原崇司, 寺尾秀行

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   102nd   2014

  • 膀胱出口部閉塞後亜急性期の雄性ラットの尿流動態に対するTRPA1およびTRPV1チャネルの関与

    杉山梨乃, 杉山梨乃, 相澤直樹, 伊藤悠城, 亀井潤, 亀井潤, 秋山佳之, 秋山佳之, 市原浩司, 藤村哲也, 鈴木基文, 福原浩, 久米春喜, 本間之夫, 井川靖彦

    日本排尿機能学会誌   25 ( 1 )   2014

  • Transient receptor potential melastatin2(TRPM2)チャネルの膀胱機能調節における生理的意義-ノックアウトマウスを用いた機能解析

    亀井潤, 亀井潤, 相澤直樹, 中川貴之, 中川貴之, 伊藤悠城, 杉山梨乃, 杉山梨乃, 秋山佳之, 秋山佳之, 市原浩司, 新美文彩, 金子周司, 藤村哲也, 鈴木基文, 福原浩, 久米春喜, 本間之夫, 井川靖彦

    日本排尿機能学会誌   25 ( 1 )   2014

  • fTUL術後残石の自然排石を予測する因子の検討

    伊藤悠城, 田部井正, 黒田晋之介, 河原崇司, 寺尾秀行, 藤川敦, 矢尾正祐, 松崎純一

    Japanese Journal of Endourology   27 ( 3 )   2014

  • 腎結石治療におけるfTUL手術時間に関する術前予測因子の検討

    伊藤悠城, 田部井正, 黒田晋之介, 河原崇司, 寺尾秀行, 藤川敦, 矢尾正祐, 松崎純一

    Japanese Journal of Endourology   27 ( 3 )   2014

  • 除脳マウスにおいてToll like receptor(TLR)7刺激薬イミキモドの膀胱内注入は頻尿を誘発する

    市原浩司, 市原浩司, 相澤直樹, 杉山梨乃, 伊藤悠城, 亀井潤, 秋山佳之, 舛森直哉, 本間之夫, 井川靖彦

    排尿障害モデル動物研究会プログラム・抄録集   7th   2014

  • tubeless PNLの検討

    寺尾秀行, 保田健吾, 黒田晋之助, 伊藤悠城, 河原崇司, 松崎純一

    日本泌尿器科学会総会プログラム抄録集(CD-ROM)   102nd   2014

  • 尿管結石に対するESWL後のα1ブロッカーの排石効果についての検討

    松崎純一, 河原崇司, 寺尾秀行, 加藤喜健, 伊藤悠城

    日本泌尿器科学会雑誌   104 ( 2 )   2013

  • ラット排尿筋収縮反応の加齢性変化に対するカロリー制限食の効果

    伊藤悠城, 相澤直樹, 藤田泰典, 伊藤雅史, 堀田晴美, 本間之夫, 窪田吉信, 井川靖彦

    基礎老化研究   37 ( 2 )   2013

  • 80歳以上の上部尿路結石症に対するTUL手術の臨床的検討

    柿添学, 伊藤悠城, 寺尾秀行, 加藤喜健, 松崎純一

    日本老年泌尿器科学会プログラム・抄録集   26th   2013

  • カロリー制限食による,加齢に伴うラット排尿筋収縮機能障害ならびに膀胱・L6後根神経節の遺伝子発現変化に対する予防効果

    伊藤悠城, 相澤直樹, 杉山梨乃, 小島俊男, 藤田泰典, 伊藤雅史, 本間之夫, 窪田吉信, 井川靖彦

    日本排尿機能学会誌   24 ( 1 )   2013

  • 軟性尿管鏡補助下逆行性腎ろう造設(Ureteroscopy Assisted Retrograde Nephrostomy)

    河原崇司, 伊藤悠城, 伊藤悠城, 寺尾秀行, 柿添学, 加藤喜健, 上村博司, 窪田吉信, 松崎純一

    Japanese Journal of Endourology   26 ( 3 )   2013

  • ラット膀胱伸展受容一次求心性神経単一活動調節におけるTRPM8チャネルの末梢レベルでの機能的意義:新規Ex vivo測定法による解析

    伊藤悠城, 相澤直樹, 杉山梨乃, 渡邉修造, 高橋伸行, 多治見政臣, 本間之夫, 窪田吉信, 井川靖彦

    日本排尿機能学会誌   24 ( 1 )   2013

  • PNL200例における軟性尿管鏡下の腎瘻造設術(UARN)の有用性の検討

    松崎純一, 寺尾秀行, 保田賢吾, 黒田晋之介, 伊藤悠城, 河原崇司

    Japanese Journal of Endourology   26 ( 3 )   2013

  • 大口東総合病院での高齢者ESWLの検討

    寺尾秀行, 伊藤悠城, 柿添学, 加藤喜健, 松崎純一

    日本老年泌尿器科学会誌   26   2013

  • マウス排尿筋収縮反応の加齢性変化の検討

    伊藤悠城, 伊藤悠城, 相澤直樹, 堀田晴美, 本間之夫, 窪田吉信, 井川靖彦

    日本老年泌尿器科学会誌   26   2013

  • 80歳以上の上部尿路結石症に対するTUL手術の臨床的検討

    柿添学, 伊藤悠城, 寺尾秀行, 加藤喜健, 松崎純一

    日本老年泌尿器科学会誌   26   2013

  • 尿管アクセスシース径と砕石抽出効率の検討

    保田賢吾, 伊藤悠城, 黒田晋之介, 河原崇司, 寺尾秀行, 松崎純一

    Japanese Journal of Endourology   26 ( 3 )   2013

  • 単一術者によるTUL learning curveの検討

    寺尾秀行, 保田賢吾, 黒田晋之介, 伊藤悠城, 河原崇司, 松崎純一

    Japanese Journal of Endourology   26 ( 3 )   2013

  • 修正バルディビア体位保持の実践報告~患者の安全性に対する1考察~

    山口晴美, 松崎純一, 寺尾秀行, 伊藤悠城, 保田賢吾

    Japanese Journal of Endourology   26 ( 3 )   2013

  • 大きな結石に対するf-TUL

    松崎純一, 保田賢吾, 黒田晋之介, 河原崇司, 伊藤悠城

    Japanese Journal of Endourology   26 ( 3 )   2013

  • 珊瑚状結石に対するPNL+TUL同時治療50例の成績

    松崎純一, 寺尾秀行, 保田賢吾, 黒田晋之介, 伊藤悠城, 河原崇司

    日本尿路結石症学会誌   12 ( 1 )   2013

  • HENOCH-SCHOENLEIN PURPURA DEVELOPED AFTER RADICAL CYSTECTOMY

    石垣華子, 伊藤悠城, 竹島徹平, 河合正記, 平井耕太郎, 白井明, 堀田綾子, 斉藤生朗

    泌尿器科紀要   59 ( 10 )   2013

  • マウス排尿筋収縮反応の加齢性変化の検討

    伊藤悠城, 伊藤悠城, 相澤直樹, 堀田晴美, 本間之夫, 窪田吉信, 井川靖彦

    日本老年泌尿器科学会プログラム・抄録集   26th   2013

  • 当院での高齢者ESWLの検討

    寺尾秀行, 伊藤悠城, 柿添学, 加藤喜健, 松崎純一

    日本老年泌尿器科学会プログラム・抄録集   26th   2013

  • 亜急性期下部尿路部分閉塞雄性ラットの非排尿性膀胱収縮に及ぼすシロドシンおよびイミダフェナシンの併用投与における相乗効果

    杉山梨乃, 相澤直樹, 伊藤悠城, 本間之夫, 井川靖彦

    日本排尿機能学会誌   24 ( 1 )   2013

  • 腎結石に対して施行した310例のf-TULの治療成績の検証と治療成績予測ノモグラムの作成

    伊藤悠城, 坂巻顕太郎, 河原崇司, 保田賢吾, 黒田晋之介, 寺尾秀行, 加藤喜健, 松崎純一, 森田智視

    Japanese Journal of Endourology   26 ( 3 )   2013

  • 大口東総合病院におけるPNLの臨床的検討

    寺尾秀行, 伊藤悠城, 河原崇司, 松崎純一

    日本泌尿器科学会雑誌   103 ( 2 )   2012

  • 10~30mmの腎結石に対するPNLの治療成績(TULと比較して)

    松崎純一, 寺尾秀行, 河原崇司, 伊藤悠城

    泌尿器外科   25   2012

  • 主要下部尿路症状質問票(CLSS:Core LUTS symptom score)の検討~下部尿路症状に対する治療効果判定の指標として~

    伊藤悠城, 小川毅彦, 上村博司, 佐野太, 矢尾正祐, 窪田吉信

    日本排尿機能学会誌   23 ( 1 )   2012

  • 前立腺癌患者のアンドロゲン除去療法による骨量減少に対する経口Bisphosphonate製剤の予防効果とTRACP-5bの有用性に関する検討

    栗田華代, 望月拓, 石垣華子, 伊藤悠城, 林博文, 平井耕太郎

    泌尿器外科   25   2012

  • Effect of silodosin on patients with OAB symptoms associated with benign prostatic hyperplasia: A prospective multicenter study in Japanese males

    伊藤悠城, 小川毅彦, 上村博司, 佐野太, 中井川昇, 窪田吉信

    泌尿器外科   25 ( 9 )   2012

  • Transurethral lithotripsy with flexible ureteroscopy for renal and ureteral stones f-TUL

    松崎純一, 河原崇司, 寺尾秀行, 加藤喜健, 伊藤悠城

    Japanese Journal of Endourology   25 ( 3 )   2012

  • 長径20-30mm腎結石に対するTUL・PNLの比較

    寺尾秀行, 伊藤悠城, 河原崇司, 松崎純一

    泌尿器外科   25   2012

  • 夜間頻尿特異的QOL質問票を用いた塩酸プロピベリンの治療効果

    野口和美, 窪田吉信, 寺西淳一, 公平昭男, 伊藤悠城, 原芳紀, 福田百邦, 古畑哲彦, 北見一夫, 朝倉知行, 酒井直樹, 野口純男, 野村栄, 森山正敏, 池田伊知郎, 河上哲, 齋藤竜一, 澤田卓人, 関口由紀, 長田裕

    日本排尿機能学会誌   23 ( 1 )   2012

  • 第1回 実例から学ぶ泌尿器科診断のコツ Q.陰茎癌の鼠径部リンパ節郭清後に遷延するリンパ漏の対処方法についておしえてください 鼠径リンパ節郭清術後に生じた皮膚壊死・難治性リンパ漏への対処方法-局所陰圧閉鎖療法の可能性-

    伊藤悠城, 平井耕太郎, 矢尾正祐, 窪田吉信

    泌尿器外科   25 ( 6 )   2012

  • 高齢進行性膀胱癌症例に対する動脈内注入化学療法の検討

    石垣華子, 石垣華子, 伊藤悠城, 平井耕太郎, 平井耕太郎, 杉浦晋平, 太田純一, 岸田健, 三浦猛

    泌尿器外科   25   2012

  • 軟性尿管鏡補助下逆行性腎ろう造設を用いた経皮的腎結石破砕術

    河原崇司, 河原崇司, 伊藤悠城, 伊藤悠城, 寺尾秀行, 松崎純一

    日本泌尿器科学会雑誌   103 ( 2 )   2012

  • 軟性尿管鏡補助下逆行性腎瘻造設を用いた経皮的腎結石破砕術(PNL)の検討

    河原崇司, 伊藤悠城, 寺尾秀行, 山下雄三, 小川毅彦, 松崎純一

    泌尿器外科   25   2012

  • 泌尿器癌の手術侵襲に伴う好中球上CD64分子発現量の検討

    林博文, 望月拓, 三條博之, 石垣華子, 栗田華代, 伊藤悠城, 平井耕太郎, 小宮明子, 松井利浩

    西日本泌尿器科   74   2012

  • tubelessPNL症例の臨床的検討

    伊藤悠城, 河原崇司, 寺尾秀行, 松崎純一

    泌尿器外科   25   2012

  • 軟性尿管鏡補助下逆行性腎瘻造設を用いた完全珊瑚状結石に対する治療

    河原崇司, 伊藤悠城, 寺尾秀行, 松崎純一

    泌尿器外科   25 ( 7 )   2012

  • tubelessPNL症例の臨床的検討

    寺尾秀行, 伊藤悠城, 河原崇司, 加藤喜健, 松崎純一

    Japanese Journal of Endourology   25 ( 3 )   2012

  • ラット排尿筋収縮反応の加齢性変化に対するカロリー制限食の効果

    伊藤悠城, 相澤直樹, 藤田泰典, 伊藤雅史, 本間之夫, 窪田吉信, 井川靖彦

    日本排尿機能学会誌   23 ( 2 )   2012

  • 尿管ステント結石付着についての検討

    河原崇司, 伊藤悠城, 寺尾秀行, 山下雄三, 小川毅彦, 松崎純一

    泌尿器外科   25   2012

  • 間質性膀胱炎の経過中に扁平上皮化生によると考えられる尿道・膀胱頸部狭窄を来した一例

    伊藤悠城, 河合正記, 平井耕太郎, 堀田綾子, 齋藤生朗

    神奈川医学会雑誌   38 ( 1 )   2011

  • 転移性腎細胞癌における術前CRP値の検討

    伊藤悠城, 矢尾正祐, 佐野太, 林成彦, 中井川昇, 塩井康一, 滝沢明利, 近藤慶一, 小林一樹, 窪田吉信

    日本泌尿器科学会雑誌   102 ( 2 )   2011

  • A case of effective multidisciplinary therapy for septic shock due to acute pyelonephritis

    南村和宏, 佐野太, 伊藤悠城, 林成彦, 中井川昇, 窪田吉信

    臨床泌尿器科   65 ( 11 )   2011

  • 腎結石に対するf-TULにおけるprestentingの検討

    河原崇司, 伊藤悠城, 寺尾秀行, 松崎純一

    Japanese Journal of Endourology   24 ( 3 )   2011

  • 長期膀胱瘻留置患者に生じた膀胱瘻刺入部有棘細胞癌の一例

    伊藤悠城, 荒尾正亨, 石垣華子, 平井耕太郎, 大島昇, 朝比奈昭彦, 堀田綾子, 齋藤生朗

    神奈川医学会雑誌   38 ( 2 )   2011

  • TULにおけるstone burdenの有効性に関する検討

    伊藤悠城, 河原崇司, 寺尾秀行, 松崎純一

    Japanese Journal of Endourology   24 ( 3 )   2011

  • Pushup防止カテーテル(Accordion)の使用経験

    松崎純一, 寺尾秀行, 河原崇司, 伊藤悠城

    Japanese Journal of Endourology   24 ( 3 )   2011

  • 4cm以上の巨大腎結石に対するTUL加療

    寺尾秀行, 伊藤悠城, 河原崇司, 松崎純一

    Japanese Journal of Endourology   24 ( 3 )   2011

  • 術前生検により診断し得た,尿管神経内分泌腫瘍(小細胞癌)の1例

    伊藤悠城, 古平喜一郎, 小杉道男, 古内徹, 二宮彰治, 中村聡

    泌尿器外科   24 ( 9 )   2011

  • Ho:YAG laserを用いた経尿道的膀胱結石砕石術の検討(30W vs100W)

    河原崇司, 伊藤悠城, 寺尾秀行, 松崎純一

    日本レーザー医学会誌   32 ( 3 )   2011

  • 横浜市大病院における,術前にホルモン治療を施行した密封小線源治療成績の検討

    林成彦, 佐野太, 河原崇司, 伊藤悠城, 南村和宏, 村上貴之, 三好康秀, 上村博司, 窪田吉信

    日本泌尿器科学会雑誌   101 ( 2 )   2010

  • Interstitial Pneumonitis associated with docetaxel therapy for hormone refractory prostate cancer

    河原崇司, 上村博司, 寺西淳一, 関口善吉, 南村和宏, 伊藤悠城, 佐野太, 喜多かおる, 服部祐介, 村上貴之, 槇山和秀, 三好康秀, 近藤慶一, 中井川昇, 小川毅彦, 矢尾正祐, 野口和美, 窪田吉信

    泌尿器外科   23 ( 1 )   2010

  • 根治的前立腺全摘術後尿失禁に対する干渉低周波治療についての検討

    南村和宏, 上村博司, 喜多かおる, 関口善吉, 河原崇司, 伊藤悠城, 佐野太, 林成彦, 槙山和秀, 中井川昇, 小川毅彦, 矢尾正祐, 窪田吉信

    日本泌尿器科学会雑誌   101 ( 2 )   2010

  • 当院における前立腺癌に対するIMRTの治療経過

    河原崇司, 上村博司, 幡多政治, 関口善吉, 南村和宏, 伊藤悠城, 佐野太, 河路かおる, 村上貴之, 槙山和秀, 中井川昇, 小川毅彦, 矢尾正祐, 寺西淳一, 皆川由美子, 小田切一将, 南澤素子, 野口和美, 井上登美夫, 窪田吉信

    泌尿器外科   23 ( 8 )   2010

  • A Case of Neoadjuvant Therapy with Sorafenib in Advanced Renal Cell Carcinoma with Vena Cava thrombus Submitted to Radical Nephrectomy

    南村和宏, 村上貴之, 関口善吉, 河原崇司, 伊藤悠城, 佐野太, 喜多かおる, 林成彦, 槙山和秀, 中井川昇, 小川毅彦, 上村博司, 矢尾正祐, 窪田吉信

    泌尿器外科   23 ( 6 )   2010

  • 腎細胞癌有転移症例における術前CRP値の検討

    伊藤悠城, 矢尾正祐, 南村和宏, 関口善吉, 河原崇司, 佐野太, 林成彦, 中井川昇, 塩井康一, 滝沢明利, 近藤慶一, 小林一樹, 窪田吉信

    日本泌尿器科学会雑誌   101 ( 2 )   2010

  • 進行性腎癌に対するソラフェニブ,スニチニブの使用経験

    関口善吉, 中井川昇, 矢尾正祐, 南村和宏, 伊藤悠城, 河原崇司, 佐野太, 喜多かおる, 村上貴之, 槙山和秀, 小川毅彦, 上村博司, 窪田吉信

    泌尿器外科   23   2010

  • 腎原発滑膜肉腫の1例

    関口善吉, 河原崇司, 喜多かおる, 槙山和秀, 南村和宏, 伊藤悠城, 佐野太, 村上貴之, 林成彦, 中井川昇, 小川毅彦, 上村博司, 矢尾正祐, 窪田吉信

    神奈川医学会雑誌   37 ( 2 )   2010

  • A case of liposarcoma of scrotum

    阿部宏一, 河原崇司, 山中正二, 関口善吉, 南村和宏, 伊藤悠城, 佐野太, 喜多かおる, 林成彦, 槙山和秀, 中井川昇, 小川毅彦, 上村博司, 矢尾正祐, 窪田吉信

    泌尿器外科   23 ( 10 )   2010

  • 前立腺肉腫に対してIMRTが有効であった一例

    河原崇司, 上村博司, 関口善吉, 南村和宏, 伊藤悠城, 佐野太, 河路かおる, 林成彦, 槙山和秀, 中井川昇, 小川毅彦, 矢尾正祐, 窪田吉信

    泌尿器外科   23 ( 11 )   2010

  • 腎原発の滑膜肉腫にIFO+ADMが著効した一例

    河原崇司, 関口善吉, 南村和宏, 伊藤悠城, 佐野太, 河路かおる, 林成彦, 槙山和秀, 中井川昇, 小川毅彦, 上村博司, 矢尾正祐, 窪田吉信, 中山崇, 長島洋司

    泌尿器外科   23 ( 11 )   2010

  • 間質性膀胱炎の治療経過中に膀胱上皮内癌(CIS)を認めた症例

    伊藤悠城, 石垣華子, 平井耕太郎, 堀田綾子, 齋藤生朗, 山田哲夫

    日本排尿機能学会誌   21 ( 1 )   2010

  • A case of priapism after intracavernous injection

    関口善吉, 河原崇司, 喜多かおる, 槙山和秀, 南村和宏, 伊藤悠城, 佐野太, 村上貴之, 林成彦, 中井川昇, 小川毅彦, 上村博司, 矢尾正祐, 窪田吉信

    泌尿器外科   23 ( 5 )   2010

  • 女性の腹圧性尿失禁に対するTVT手術とTOT手術の臨床的検討~ICIQ-SF,排尿機能の変化,learning curveなどについて~

    伊藤悠城, 山中弘行, 萩原正幸, 松本一宏, 金井邦光, 二宮彰治, 中村聡

    泌尿器外科   23   2010

  • 尿膜管癌と尿路上皮癌の二重癌の一例

    伊藤悠城, 古内徹, 古平喜一郎, 二宮彰治, 中村聡

    泌尿器外科   22 ( 2 )   2009

  • 男性尿失禁患者に対して男性transobturator tape(TOT)法を施行した一例

    伊藤悠城, 古平喜一郎, 萩原正幸, 古内徹, 金井邦光, 二宮彰治, 中村聡

    泌尿器外科   22   2009

  • 陰嚢内に発生したAngiomyofibroblastoma-like tumorの1例

    古内徹, 二宮彰治, 伊藤悠城, 古平喜一郎, 中村聡

    泌尿器外科   22   2009

  • 小径腎癌に対する腎部分切除術後の腎機能の検討~開腹阻血法,腹腔鏡下阻血法,腹腔鏡下無阻血法の比較~

    河原崇司, 槙山和秀, 伊藤悠城, 佐野太, 三好康秀, 村上貴之, 中井川昇, 矢尾正祐, 窪田吉信

    Japanese Journal of Endourology and ESWL   22 ( 3 )   2009

  • 後腹膜鏡下根治的腎摘出術の臨床的検討~皮膚小切開併用法と従来法の比較~

    伊藤悠城, 槙山和秀, 河原崇司, 佐野太, 河路かおる, 林成彦, 中井川昇, 矢尾正祐, 窪田吉信

    Japanese Journal of Endourology and ESWL   22 ( 3 )   2009

  • 膀胱穿孔を伴った膀胱異物の症例

    伊藤悠城, 古内徹, 二宮彰治, 萩原正幸, 金井邦光, 古平喜一郎, 中村聡

    泌尿器外科   22 ( 3 )   2009

  • A case of adult T-cell leukemia/lymphoma with primary lung cancer

    宮原裕美, 伊藤悠城, 関根亜由美, 谷山大輔, 勝井智子, 田中若恵, 佐藤亮太, 栗原亜子, 佐藤由里香, 坂巻文雄

    日本呼吸器学会雑誌   47 ( 4 )   2009

  • 当院における腎細胞癌手術施行例の臨床的検討

    伊藤悠城, 金井邦光, 萩原正幸, 二宮彰治, 中村聡, 原智

    日本泌尿器科学会雑誌   100 ( 2 )   2009

  • 当院における根治的前立腺全摘除術後のPSA再発に関する臨床的検討

    萩原正幸, 金井邦光, 伊藤悠城, 二宮彰治, 中村聡, 石田勝

    日本泌尿器科学会雑誌   100 ( 2 )   2009

  • 薬剤耐性を持たないE.coliが原因菌となり,急激に精巣壊死にまで発展した精巣上体炎の一例

    伊藤悠城, 中村聡, 二宮彰治, 古平喜一郎, 井手広樹, 古内徹

    泌尿器外科   22 ( 2 )   2009

  • 黄色肉芽腫性腎盂腎炎の1例

    古内徹, 伊藤悠城, 井手広樹, 古平喜一郎, 二宮彰治, 中村聡, 関口れいし, 山崎一人

    泌尿器外科   21   2008

  • 泌尿器科における退院時病名のICDコーディングについて

    古平喜一郎, 伊藤悠城, 橋本正弘, 高橋新, 古内徹, 二宮彰治, 中村聡, 三田村秀雄

    診療録管理   20 ( 2 )   2008

  • 成人T細胞リンパ腫に合併した肺腺癌の1剖検例

    伊藤悠城, 坂巻文雄, 渡部香織, 佐藤亮太, 平田直己, 大橋洋綱, 町田裕美, 余語由里香, 渡辺健太郎, 森泰昌

    日本内科学会関東地方会   543rd   2007

  • 盲腸軸捻転症の一例

    伊藤悠城, 今津嘉宏, 鳥海史樹, 赤松秀敏, 村山剛也, 米山公康, 大山廉平

    日本消化器外科学会雑誌   39 ( 7 )   2006

▼display all

Research Projects

  • Mechanism of lower urinary tract dysfunction associated with neurodegenerative diseases, focusing on the mouse Barrington's nucleus

    Grant number:24K12470  2024.4 - 2029.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    researchmap

  • Functional analysis of the Barrington's nucleus of the pons in aged mice and elucidation of the developmental mechanism of age-related lower urinary tract dysfunction.

    Grant number:20K18121  2020.4 - 2024.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Early-Career Scientists

    ITO Hiroki

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    Cre-dependent adeno-associated virus was injected into the Barrington's nucleus of old CRH-ires-Cre knock-in mice, and the Barrington's nucleus was stimulated optogenetically. The response rate of bladder contraction in the old group was significantly higher in response to photogenetic stimulation of the Barrington nucleus. Next, after causing cell death of Barrington's nucleus CRH-positive neurons by diphtheria toxin, the urinary behavior was observed. The results showed that the old group developed urinary retention, while the young group showed only a change in urinary drainage pattern and did not develop urinary retention.
    It is possible that urinary drainage in old mice is more dependent on Barrington's nucleus CRH-positive neurons, and that these events may be the cause of age-related lower urinary tract symptoms.

    researchmap

  • Optogenetic investigation of neural circuit of mice micturition

    Grant number:19K23781  2019.8 - 2021.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Research Activity Start-up

    ITO Hiroki

      More details

    Grant amount:\2730000 ( Direct Cost: \2100000 、 Indirect Cost:\630000 )

    Bladder function is controlled by several resion of the brain and Barrington’s nucleus is believed to be main controller of voiding function in micturition cycle. Our team recorded the neural activity of Barrington’s nucleus and analyzed those activity associated with mice micturition. Barrington’s nucleus neural activity facilitated voiding and also small contraction of the bladder during micturition cycle indicating that Barrington’s nucleus seemingly control the voiding but also storage function. Furthermore investigation of Barrington’s nucleus will uncover the pathological etiology of bladder dysfunction associated with Barrington’s nucleus.

    researchmap